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Abstract
The development of an improved synthesis of nucleophilic planar-chiral catalysts is
described in Chapter 1. This route is amenable to scale-up and preparative chiral HPLC is
unnecessary to resolve the racemic catalysts.
Using planar-chiral catalysts, two synthetic methodology projects have been developed:
Chapter 2 describes the first asymmetric synthesis of trans P-lactams, and Chapter 3 describes
the asymmetric synthesis of tertiary a-chloroesters. In the chapter describing the asymmetric
synthesis of trans P-lactams, we present mechanistic data supporting a novel mechanism, in
which the N-triflylimine, rather than the ketene, reacts with the catalyst first. In the chapter
describing the asymmetric synthesis of tertiary a-chloroesters, we introduced an under-utilized
commercially available chlorinating reagent (2,2,6,6-tetrachlorocyclohexanone).
Finally, in chapter 4, the Cu-catalyzed asymmetric synthesis of a-aminoesters via an N-H
insertion is described. We have demonstrated that carbamates such as BocNH2 and CbzNH 2 are
efficient coupling partners in reactions with a-diazoesters to generate highly useful Boc- or Cbz-
protected ca-aminoesters.
Thesis Supervisor: Professor Gregory C. Fu
Title: Professor of Chemistry
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Chapter 1
Improved Synthesis of Nucleophilic Planar-Chiral Catalysts
1.1 Introduction
During the past decade, our group have established that planar-chiral derivatives of 4-
(dimethylamino)pyridine (DMAP) and 4-(pyrrolidino)pyridine (PPY) serve as effective
enantioselective catalysts for a wide variety of transformations (e.g., eq 1-3).1,2
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However, one impediment to the use of these methods was the difficulty of the catalyst
synthesis. Specifically, the synthesis of catalyst 1 and 2 required 10 steps to obtain the racemic
catalyst and HPLC was employed to resolve the enantiomers. Recognizing this limitation, we
pursued the development of a more efficient route.
IVIl
racemic
1.2 Previous Work
Scheme 1. Assembly of Complexes (-)-1 or 2
X NR2
1) (C5R5)Li 1FeCI 2  - R Fe R X =
2) X® R RRR
S NR2 = NMe 2 or pyrrolidino
In order to construct complexes 1 and 2, we adopted the modular approach illustrated in
Scheme 1, which involved a one-pot assembly from FeCl2, a cyclopentadienyllithium, and a
heterocycle. The initial route to the bicyclic DMAP derivatives (X-H) required six steps from
commercially available 2,3-cyclopentenopyridine (3) and proceeded in ~5% overall yield
(Scheme 2).3
Scheme 2. Initial Synthesis of 4-Dimethylaminopyridine
aq H2 0 2 H2SO4/ NO2 Acetyl chloride CI
AcOH fuming HNOz 
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94%N
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+
V- 7
The racemic planar-chiral DMAP derivatives 1 and 2 were then synthesized as in Scheme
1, and they were resolved via HPLC on a chiral stationary phase.3 However, it was later
determined that intermediate 5 can decompose violently at >100 oC.4 As a consequence, our
laboratory developed an alternative nine-step synthesis of the bicyclic pyridines that began with
adipoyl chloride (Scheme 3). 5
YV
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1.3 Results and Discussion
1.3.1. Efficient Synthesis of Bicyclic DMAP Derivatives
We began our investigation with various retrosynthetic strategies towards building the
bicyclic DMAP derivative (X), one of which (acrolein route) is outlined in eq 4.
A
NR2
1) BuLi
2) acrolein N
OH
We used the method described by Fort6 to direct the C2 lithiation of DMAP, and then trapped the
organolithium intermediate with acrolein to obtain Y in 30% yield. However, all attempts to
effect the cyclization (e.g., using TFAA, H2SO 4, HBF 4, BF3.Et 2O, TsOH, MgCl2, AgOTf, InCl3,
CeC13, or PPh3, at various temperatures) to generate X failed. Other retrosynthetic routes7
investigated include Nazarov and RCM routes, but they were also unsuccessful.
Our new route (Scheme 3) commenced with a two-step procedure that involved the
chlorination of the 4-position of the pyridine ring of 2,3-cyclopentenopyridine.8 This new route
0
0
13
was optimized in collaboration with Dr. Ryan Wurz. Thus, treatment of 3 with H20 2/AcOH 9 and
then POCl3 furnished target compound 15 in good overall yield (83% for two steps). The
selective chlorination of 4 in the para position is noteworthy, since reactions of pyridine-N-
oxides with POC 3 are typically not highly selective for this position.1 o
Scheme 3. Efficient Synthesis of Bicyclic DMAP Derivatives
aq H202  POCI3  CI 0.3% MeReO 3  CI
AcOH CICH 2CH2CI aq H20 2
80 oC A CH2CI2, r.t.
E I N0N5 N 87%963 O 4 15 6
NR2  NR2  NP2  NHR2
HNR 2 (K2CO3) Ac20, A H2SO4, AH20, A II - +
I+. N N
_)O OAc
7a: NR2 = pyrrolidino: 92% 8a: NR2 = pyrrolidino: 58% 9a: NR2 = pyrrolidino: 83%
7b: NR2 = NMe 2 :92% 8b: NR2 = NMe 2:74% (35% over six steps)9b: NR2 = NMe 2 :98%
(53% over six steps)
Next, the pyridine nitrogen of 15 was oxidized in almost quantitative yield (H20 2 and catalytic
MeReO3;11 96%), thereby setting the stage for amination of the 4 position and oxidation of the
fused five-membered ring. This three-step sequence was conducted on a large scale (>100 g)
without chromatographic purification of any intermediate. 12,13
Pyridine-N-oxide 6 is well-suited for the synthesis of a variety of derivatives via
substitution of the halide. For our purposes, we needed to effect displacement of the chloride
with pyrrolidine and dimethylamine, which was accomplished simply by heating 6 in the
presence of aqueous base (92% yield). 14 Treatment of the resulting 4-aminopyridines (7) with
Ac 20 furnished the desired acetates (8), which underwent elimination under acidic conditions to
afford the target bicyclic pyridines as mixtures of olefin isomers (9).15 The relative simplicity and
low cost of the reagents that are used in this synthetic sequence is noteworthy (Scheme 3). The
heterocycles (9a and 9b) can then be complexed to iron in good yield (eq 5 and eq 6).
NN
+ isomer
9a
Me Fe Me (±)-1
Me(±Me
Me
resolved via two crystallizations
of the di-p-toluoyltartaric acid sal
Me2N
Ph• Fe Ph (±)-2
1) n-BuLi, THF
2) "Cp*FeCI"
0 oC -- r.t.
91%
1) n-BuLi, THF
2) "CsPhsFeCI"
r.t. -- 60 oC
93%
1.3.2. Classical Resolution of I and 2
As indicated above, in our early studies, we obtained enantiopure 1 and 2 from the
racemic catalysts via preparative HPLC on a chiral stationary phase. The development of
classical resolutions of 1 and 2 was achieved with tartaric acid derivatives that furnished the
catalysts in >99% ee. These processes were developed by Dr. Ryan Wurz. In the case of 1, di-p-
toluoyltartaric acid is the resolving agent of choice (eq 5), whereas, for 2, dibenzoyltartaric acid
has proved to be the most efficient (eq 6).
1.4 Conclusions
We have developed an improved route to enantiopure planar-chiral DMAP derivatives
that addresses several drawbacks associated with earlier approaches. Specifically, a potentially
hazardous intermediate is avoided, improved yields are obtained, and preparative chiral HPLC is
unnecessary.
Ph Ph
Ph
resolved via two crystallizations
of the dibenzoyltartaric acid salt
+ isomer
9b
N
1.5 Experimental Procedures
1.5.1. General
Unless otherwise specified, reactions were performed in the air with no precautions to
exclude moisture. Analytical HPLC analyses were carried out on an Agilent Technologies 1100
Series instrument with Daicel Chiralpak® or Regis columns in hexanes/2-propanol or
hexanes/CH 2C12 mixtures; data are reported as follows: column type, eluent, flow rate, and
retention time (tr). Low-resolution mass spectrometric measurements were performed on an
Agilent Technologies LC/MSC SL Multimode (ES/APCI) instrument using a Zorbax Eclipse
(Agilent) XDB-C18 column (5 [tm particle size, 4.6 x 150 mm).
Materials. 2,3-Cyclopentenopyridine (6,7-dihydro-5H-cyclopenta[b]pyridine) (Kinbester Co.,
Limited (China); >98%16) was used as received. Other reagents and solvents were obtained from
Strem or Aldrich and used as received.
\2,3-Cyclopentenopyridine N-oxide (6,7-dihydro-5H-cyclopenta[b]pyridine 1-
oxide; 4).9 Glacial acetic acid (500 mL) was added over ~2 min (to control the
O0 exotherm) to a 2-liter flask that contained 2,3-cyclopentenopyridine (100 g, 0.84
mol). Then, an aqueous solution of H20 2 (30%; 90 mL, 0.87 mol) was added, and the flask was
fitted with a reflux condenser capped with a septum and a needle (vent). The reaction mixture
was heated to 80 'C behind a blast shield (as a precaution; no accidents have occurred). After
stirring at 80 'C for 6 h, the solution was treated with additional aqueous H20 2 (90 mL, 0.87
mol) and stirred for 18 h at 80 "C. Then, the reaction mixture was allowed to cool to room
temperature, and the acetic/peracetic acid was removed on a rotary evaporator. The resulting
pale-yellow residue was cooled in an ice bath and then carefully treated with aqueous K2CO3
(100 g in 250 mL of distilled water) until the solution reached pH~10. The mixture was then
extracted with CHC13 (4 x 250 mL), dried over anhydrous MgSO4, filtered, and concentrated on a
rotary evaporator. The product crystallized as a white solid, which was rinsed with methyl tert-
butyl ether (2 x 200 mL). The washings were concentrated on a rotary evaporator, which led to
the precipitation of additional N-oxide 4. This precipitated solid was washed with methyl tert-
butyl ether (3 x 30 mL) and then combined with the initial batch of product. Compound 4 was
dried under vacuum overnight to afford a free-flowing, white crystalline solid (108 g, 95%).
m.p. 121-123 °C;
'H NMR (400 MHz, CDC13) 8 8.04 (d, J = 6.2, 0.8 Hz, 1H), 7.13 (d, J = 6.2 Hz, 1H), 7.05-7.11
(m, 1H), 3.17 (t, J = 7.7 Hz, 2H), 3.02 (t, J = 7.7 Hz, 2H), 2.14-2.22 (m, 2H);
13C NMR (100 MHz, CDCl3) 8 153.3, 142.4, 137.4, 124.0, 122.7, 31.7, 29.7, 22.2; IR (film) v
3391, 2957, 1602, 1441, 1260, 1063, 1011, 800 cml;
LRMS (ES/APCI) calcd for CsHgNO [M+Na+] 158.2, found: 158.1.
CI 4-Chloro-6,7-dihydro-1,5-pyrindane (4-chloro-6,7-dihydro-5H-
cyclopenta[b]pyridine; 15). Under argon, POCl3 (234 g, 142 mL, 1.52 mol) was
N added slowly (dropwise over 30 min) to a 0 *C solution of 2,3-cyclopentenopyridine
N-oxide (4; 103 g, 0.76 mol) in anhydrous 1,2-dichloroethane (500 mL) in a 2-L flask that was
placed in an ice bath. The reaction mixture, which turned orange-brown, was stirred for 1 h at
room temperature (Note: this procedure should be adhered to, in order to avoid a substantial
exotherm). The reaction vessel was then fitted with a condenser and slowly heated to reflux for
2 h. Next, the reaction mixture was allowed to cool to room temperature, and the solvent and the
excess POC13 were removed on a rotary evaporator, leading to a viscous brown oil. The flask
was placed in an ice bath, and small pieces of ice were cautiously added (~50 g; Note: if too
much ice is added initially, then a substantial exotherm will result). The mixture was then
treated with a solution of 6 N NaOH (~500 mL) via a dropping funnel (ice was added, in order to
keep the reaction at ~5 °C) until pH=7. The mixture was transferred to a separatory funnel and
extracted with diethyl ether (6 x 350 mL), and the combined extracts were dried over MgSO 4,
filtered, and concentrated on a rotary evaporator, affording a dark-orange oil (102 g, 87%). This
material was judged to be 94% pure by 'H NMR spectroscopy, and it was used in the next step
without further purification.
Rf 0.17 (20% EtOAc:hexanes).
1H NMR (400 MHz, CDC13) 8 8.24 (d, J = 5.5 Hz, 1H), 7.07 (d, J = 5.4 Hz, 1H), 3.10 (t, J = 7.8
Hz, 2H), 3.01 (t, J= 7.6 Hz, 2H), 2.12-2.20 (m, 2H);
S3C NMR (100 MHz, CDCI3) 8 167.1, 148.4, 140.5, 135.6, 121.2, 34.9, 29.8, 21.9;
IR (film) v 2959, 1583, 1558, 1458, 1390, 903, 817 cm- ;
LRMS (ES/APCI) calcd for C8HCIN [M+H ÷] 154.6, found: 154.1.
CI 4-Chloro-6,7-dihydro-1,5-pyrindane-N-oxide (4-chloro-6,7-dihydro-5H-
cyclopenta[b]pyridine 1-oxide; 6). MeReO 3 (500 mg, 2.01 mmol, 0.31 mol%) was
added to a solution of 4-chloro-6,7-dihydro-1,5-pyrindane (5; 100 g, 0.65 mol) in
®Go CH 2Cl 2 (200 mL) in a 2-L round-bottomed flask. To this stirred solution was added
an aqueous solution of H20 2 (30%; 130 mL, 1.26 mol; in one portion). The flask was then
capped with a septum and a needle (vent), and the mixture was allowed to stir at room
temperature for 25 h (the reaction mixture turned orange, and then bright yellow as the reaction
progressed). Next, the excess H20 2 was quenched by the addition of small portions of activated
MnO 2 powder (10-20 mg), which resulted in the rapid evolution of 02. After the effervescence
had subsided (~30 min), the dark-green reaction mixture was treated with brine (200 mL) and
extracted with CH2C12 (4 x 200 mL). The combined organic extracts were dried over MgSO4 and
filtered through a pad of celite. Removal of the solvent on a rotary evaporator resulted in the
formation of olive-green crystals, which were dried under vacuum overnight (106 g, 96%). The
product was judged to be 92% pure by 'H NMR spectroscopy, and it was used in the next step
without further purification.
m.p. 110-113 'C;
R, 0.16 (acetone);
'H NMR (400 MHz, CDCl3) 8 7.99 (d, J = 6.8 Hz, 1H), 7.09 (d, J = 6.8 Hz, 1H), 3.24 (t, J = 7.8
Hz, 2H), 3.07 (d, J= 7.7 Hz, 2H), 2.19-2.27 (m, 2H);
13C NMR (75 MHz, CDCl3) 8 154.4, 140.7, 139.4, 127.0, 125.1, 31.8, 31.2, 21.8;
IR (film) v 3406, 3077, 2962, 1662, 1437, 1311, 1264, 1236, 1014, 825, 726 cm-;
LRMS (ES/APCI) calcd for C8H8CINO [M+H +] 170.6, found: 170.0.
4-Pyrrolidino-6,7-dihydro-1,5-pyrindane-N-oxide (7a). Pyrrolidine (189 g, 221
mL, 2.65 mol) was added slowly (to avoid an exotherm) to a solution of 4-chloro-
, 6,7-dihydro-1,5-pyrindane-N-oxide (6; 90.0 g, 0.53 mol) and K2CO 3 (89.4 g, 0.54
mol) in distilled water (300 mL) in a 2-L round-bottomed flask. The flask was fitted
80 with a reflux condenser, and the mixture was heated, with stirring, under air at 90-95
'C for 17 h. Then, the reaction mixture was cooled to room temperature, and the solvent was
removed on a rotary evaporator, furnishing a black solid. Toluene (100 mL) was added in order
to azeotropically remove the remaining water. The product was extracted from the black solid
with 1:1 acetone:CH2Cl2 (6 x 300 mL). The dark-purple extracts were combined, dried over
anhydrous Na2SO4, filtered, and concentrated on a rotary evaporator. The resulting purple-black
solid was dissolved in warm acetone (120 mL; 40-50 *C), and then methyl tert-butyl ether (600
mL) was added. This solution was heated to 70 'C for 10 min, and then it was cooled in an ice
bath, leading to the precipitation of N-oxide 7a. The product was collected by filtration (washed
with methyl tert-butyl ether (300 mL) to remove a purple impurity) and then dried under vacuum
overnight, affording a gray, free-flowing solid (100 g, 92%). The product was judged to be
>99% pure by 'H NMR spectroscopy.
m.p. 80-83 °C;
1H NMR (400 MHz, CDCl3) 6 7.84 (d, J = 7.1 Hz, 1H), 6.20 (d, J = 7.1 Hz, 1H), 3.47-3.50 (m,
4H), 3.27 (t, J = 7.5 Hz, 2H), 3.15 (t, J = 7.8 Hz, 2H), 2.06-2.14 (m, 2H), 1.97-2.02 (m, 4H);
13C NMR (100 MHz, CDCI3) 8 153.7, 145.2, 137.4, 122.8, 107.7, 49.5, 33.1, 29.9, 25.6, 22.3;
IR (film) v 3375, 2963, 1624, 1495, 1457, 1230, 982 cm-;
LRMS (ES/APCI) calcd for C12HI6N20 [M+H÷] 205.3, found: 205.1.
NMe 2  4-(Dimethylamino)-6,7-dihydro-1,5-pyrindane-N-oxide (7b). With stirring, 4-
chloro-6,7-dihydro-1,5-pyrindane-N-oxide (6; 40.0 g, 236 mmol) was dissolved in a
N solution of Me2NH in water (40 wt%; 100 mL, 790 mmol) in a 500-mL round-
EO bottomed flask. The solution was transferred to a 250-mL stainless steel Parr
apparatus (due to the volatility of Me2NH) using additional Me2NH solution (80 mL, 632 mmol)
in order to ensure quantitative transfer. The Parr apparatus was sealed and heated to 75 °C in an
oil bath with stirring for 24 h (behind a blast shield, as a precaution). Next, the Parr apparatus
was cooled in an ice bath, and the reaction mixture was poured into an Erlenmyer flask. K2C0 3
(39.8 g, 241 mmol) was added, and the mixture was stirred for 30 min. The solution was
transferred to a 1-L round-bottomed flask, and the solvent was removed on a rotary evaporator,
leading to a black solid. The product was extracted from the solid with 1:1 acetone:CH2Cl2 (6 x
200 mL). The dark-purple extracts were combined, dried over anhydrous Na2SO4, filtered, and
concentrated on a rotary evaporator, providing a black crystalline solid that was judged to be
95% pure by 'H NMR spectroscopy (38.7 g, 92%).
m.p. 150-156 °C;
'H NMR (400 MHz, CDCl3) 8 7.90 (d, J = 7.2 Hz, 1H), 6.40 (d, J = 7.2 Hz, 1H), 3.16 (t, J = 7.8
Hz, 2H), 3.11 (t, J = 7.4 Hz, 2H), 2.96 (s, 6H), 2.13 (pent. J = 7.5 Hz, 2H);
13C NMR (100 MHz, CDCl3) 8 153.7, 147.9, 137.3, 126.4, 109.3, 41.4, 33.1, 29.7, 22.6;
IR (film) v 3379, 2957, 1621, 1509, 1434, 1236, 976, 816, 735 cm-';
LRMS (ES/APCI) calcd for CloH 14N20 [M+H'] 179.2, found: 179.2.
4-Pyrrolidino-7-acetoxy-6,7-dihydro-1,5-pyrindane acetic acid adduct (8a).
In a 1-L flask, a mixture of acetic anhydride (200 g, 185 mL, 1.96 mol) and
distilled water (2.1 mL; 117 mmol) was stirred at room temperature for 10 min
under nitrogen. The flask was then cooled in an ice bath, and 4-pyrrolidino-6,7-
OAc
dihydro-1,5-pyrindane-N-oxide (7a; 50.0 g, 0.24 mol) was added slowly via a
glass funnel over 15 min (to prevent an exotherm). The flask was purged with nitrogen, and the
mixture was stirred at room temperature for 1 h. The flask was then fitted with a reflux
condenser, and the reaction mixture was heated to 80 °C with stirring under nitrogen for 25 h.
The solvent was removed on a rotary evaporator from the resulting dark-brown reaction mixture,
leading to a brown solid. This solid was dissolved in the minimum amount of CH2CI2 (~100
mL), and the solution was passed through a 7-cm pad of silica gel on a 2-L sintered coarse glass
frit. The silica gel was rinsed with 30:70 EtOAc:hexane (1 L), 30:60:10 EtOAc:hexane:Et 3N
(~1.5 L), and 60:30:10 EtOAc:hexane: Et3N (5 L), collecting 1-L "fractions". The solvent was
removed on a rotary evaporator from the appropriate fractions (as judged by TLC). The resulting
beige solid was suspended in methyl tert-butyl ether (150 mL) and filtered through a Buechner
funnel. The solid was rinsed with additional portions of methyl tert-butyl ether (2 x 50 mL; the
product is somewhat soluble in this solvent, so large volumes should not be used), resulting in a
free-flowing, cream-colored solid. The desired product was dried under vacuum overnight (98-
99% pure according to 1H NMR spectroscopy; acetic acid adduct; 43.5 g, 58%).
m.p. 119-120 *C;
R10.51 (9:1 EtOAc:Et3N);
1H NMR (400 MHz, CDC13) 8 11.38 (br s, 1H), 8.17 (d, J = 6.0 Hz, 1H), 6.28 (d, J = 6.0 Hz,
1H), 6.05 (dd, J = 7.5, 5.1 Hz, 1H), 3.54-3.58 (m, 4H), 3.33-3.42 (m, 1H), 3.11-3.18 (m, 1H),
2.50-2.59 (m, 1H), 2.13 (s, 3H), 2.07 (s, 3H), 1.95-2.02 (m, 5H);
13C NMR (100 MHz, CDCl3) 6 175.6, 171.1, 158.7, 152.0, 147.3, 120.4, 107.2, 49.3, 30.5, 29.4,
25.6, 22.0, 21.3;
IR (film) v 2976, 2871, 1736, 1606, 1515, 1372, 1243, 834 cm-1;
LRMS (ES/APCI) calcd for C14Hl8N20 2 [M+H ÷] 247.3, found: 247.1.
NMe 2  4-(Dimnethylamino)-7-acetoxy-6,7-dihydro-1,5-pyrindane acetic acid adduct
(8b). Acetic anhydride (149 g, 138 mL, 1.46 mol) was added to a 1-L flask (in a
N 0 'C ice bath) that contained 4-(dimethylamino)-6,7-dihydro-1,5-pyrindane-N-
OAc
oxide (7b; 26.0 g, 0.146 mol). Distilled water (1.25 mL, 69.4 mmol)7 was added,
and the solution was stirred at 0 *C for 30 min. The flask was then fitted with a reflux condenser
and heated to 75-80 'C for 24 h under nitrogen. Next, the dark-brown reaction mixture was
concentrated on a rotary evaporator, leading to a brown solid, which was dissolved in the
minimum amount of CH2C12 (~50 mL) and passed through a pad of silica gel, eluting with 2:3
EtOAc:hexane (500 mL) and then 45:45:10 EtOAc:hexane:Et 3N (800 mL). The desired product
was dried under vacuum overnight (tan solid; 98-99% pure according to 'H NMR spectroscopy;
acetic acid adduct; 30.4 g, 74%).
m.p. 62-67 'C;
RI 0.53 (9:1 EtOAc:Et 3N);
'H NMR (400 MHz, CDC13) 8 11.03 (br s, 1H), 8.22 (d, J = 5.9 Hz, 1H), 6.43 (d, J = 5.9 Hz,
1H), 6.05 (dd, J = 7.4, 5.2 Hz, 1H), 3.16-3.22 (m, 1H), 3.05 (s, 6H), 3.00-3.05 (m, 1H), 2.52-2.58
(m, 1H), 2.14 (s, 3H), 2.07 (s, 3H), 1.97-2.03 (m, 1H);
13C NMR (100 MHz, CDC13) 8 174.9, 170.9, 159.8, 155.0, 148.1, 122.3, 108.0, 41.2, 30.7, 29.7,
21.8, 21.2;
IR (film) v 3383, 2945, 1733, 1587, 1509, 1439, 1371, 1243, 1024, 962, 816 cml;
LRMS (ES/APCI) calcd for Cl2H,6N20 2[M+H ÷] 221.3, found: 221.1.
4-Pyrrolidinopyrindine 
(4-(pyrrolidin-1-yl)-7H-cyclopenta[b]pyridine; 
9a). 4-
Pyrrolidino-7-acetoxy-6,7-dihydro-1,5-pyrindane 
acetic acid adduct 
(Sa; 20.0 g,
, 81.2 mmol) 
was slowly 
added in small 
portions (to avoid 
an exotherm) 
to a flask
t aht contained concentrated 
H SO (35 mL; in a 0 oC 
ice bath). The flask was
capped under air with a septum and a needle (vent), and then it was heated to 60-65 °C in an oil
bath for 80 min. Next, the reaction mixture was cooled in an ice bath, and ice was added. A
solution of NaOH (6 N; ~240 mL) was added slowly over 30-40 min until pH~-11 (white
precipitate formed). The reaction mixture was extracted with EtOAc (3 x 300 mL) and CH 2C12
(3 x 250 mL), and the organic extracts were dried over Na 2SO 4 (Et3N (15 mL) was added, since
the product is stabilized by the presence of a weak base), filtered, and concentrated on a rotary
evaporator. The resulting brown residue was purified by column chromatography, eluting with
45:45:10 EtOAc:hexane:Et 3N (200 mL) and then 90:10 EtOAc:Et3N (600 mL). The product, a
yellow-green crystalline solid, was judged to be >98% pure by 'H NMR spectroscopy (~60:40
mixture of olefin isomers; 10.1 g, 83%). Note: This compound is somewhat sensitive, and it is
best to use it immediately. Alternatively, it can be stored in a freezer under an inert atmosphere
for several weeks without noticeable degradation.
m.p. 84-86 'C (mix of isomers);
Rf 0.27 (45:45:10 EtOAc:hexanes:Et 3N);
'H NMR (400 MHz, CDCl3) 8 Major isomer: 8.17 (d, J= 5.9 Hz, 1H), 6.98 (dt, J= 5.7, 1.8 Hz,
1H), 6.80 (dt, J = 5.7, 2.0 Hz, 1H), 6.26 (d, J = 5.9 Hz, 1H), 3.74-3.78 (m, 2H), 3.60-3.66 (m,
4H), 2.00-2.11 (m, 4H); Minor isomer: 8.10 (d, J = 5.9 Hz, 1H), 7.22 (dt, J = 6.1, 2.0 Hz, 1H),
6.37 (dt, J = 6.2, 2.1 Hz, 1H), 6.34 (d, J = 5.9 Hz, 1H), 3.60-3.66 (m, 4H), 3.46-3.48 (m, 2H),
2.00-2.11 (m, 4H);
13C NMR (100 MHz, CDCl3) 6 Major isomer: 164.6, 149.4, 148.5, 136.9, 134.1, 118.7, 104.7,
48.6, 38.9, 25.5; Minor isomer: 166.9, 147.0, 146.0, 130.6, 128.1, 121.7, 105.7, 49.5, 40.8, 25.7;
IR (film) v 3367, 2969, 2868, 1693, 1591, 1570, 1484, 1395, 1357, 1059, 900, 800, 708 cm-';
LRMS (ES/APCI) calcd for C12H14N2 [M+H +] 187.3, found: 187.1.
NMe 2  4-(Dimethylamino)pyrindine (NN-dimethyl-7H-cyclopenta[b]pyridin-4-amine;
I 9b). 4-(Dimethylamino)-7-acetoxy-6,7-dihydro-1,5-pyrindane acetic acid adduct
N (8b; 2.70 g, 9.63 mmol) was added in one portion to concentrated H2 SO 4 (6.0 mL) in
an ice bath. The mixture was stirred for 10 min at 0 'C, and then it was heated to 60-65 'C in an
oil bath for 75 min. Next, the reaction mixture was cooled in an ice bath, and ice was added.
The reaction was then slowly quenched over 15 min by the dropwise addition of NaOH (6 N
solution; ~45 mL) until pH~ 1 (white precipitate formed). The reaction mixture was extracted
with EtOAc (6 x 100 mL), and the organic extracts were dried over Na2 SO 4 (Et3N (5 mL) was
added, since the product is stabilized by the presence of a weak base), filtered, and concentrated
on a rotary evaporator. The resulting yellow residue was purified by column chromatography,
eluting with 45:45:10 EtOAc:hexane:Et 3N (300 mL), which yielded a yellow-green crystalline
solid (judged to be >99% pure by 'H NMR spectroscopy; ~70:30 mixture of olefin isomers; 1.52
g, 98%). Note: This compound is somewhat sensitive, and it is best to use it immediately.
Alternatively, it can be stored in a freezer under an inert atmosphere for several weeks without
noticeable degradation.
m.p. 59-63 °C (mix of isomers);
RI 0.39 (9:1 EtOAc:Et 3N);
'H NMR (400 MHz, CDC13) 8 Major isomer: 8.18 (d, J = 5.9 Hz, 1H), 6.93-6.96 (m 1H), 6.76-
6.78 (m, 1H), 6.35 (d, J = 5.9 Hz, 1H), 3.63 (s, 2H), 3.14 (s, 6H); Minor isomer: 8.10 (d, J = 5.9
Hz, 1H), 7.14 (dt, J = 8.1, 1.9 Hz, 1H), 6.46 (d, J = 5.9 Hz, 1H), 6.42 (dt, J = 6.1, 2.1 Hz, 1H),
3.43 (s, 2H), 3.11 (s, 6H);
13C NMR (100 MHz, CDC13) 8 Major isomer: 165.2, 152.6, 148.8, 137.0, 134.2, 120.1, 105.5,
41.4, 39.6; Minor isomer: 167.1, 150.8, 146.3, 130.4, 129.4, 123.9, 106.8, 42.2, 40.9;
IR (film) v 2885, 1691, 1589, 1570, 1386, 1373, 1189, 1029, 801 cm-;
LRMS (ES/APCI) calcd for C1oH12N2 [M+H ÷] 161.2, found: 161.1.
1.5.2. Synthesis and Resolution of 1 and 2
4-Pyrrolidinopyrindinyl-pentamethylcyclopentadienyl iron (1).
A solution of n-BuLi (1.6 M in hexanes; 24.1 mL, 38.6 mmol) was
Me Fe Me ()1 added dropwise over 2 min to a solution of
Me Me pentamethylcyclopentadiene (5.26 g, 38.6 mmol) in anhydrous THF
Me (200 mL) in a 0 °C ice bath under nitrogen. The resulting white
suspension was stirred for 1 h at 0 *C.
Separately, anhydrous THF (80 mL) was added to powdered FeCl2 (4.90 g, 38.6 mmol) in a 2-L
round-bottomed flask. The mixture was sonicated for 1 h, resulting in a fine suspension. Next,
the mixture was cooled to 0 *C, and the solution that contained the Cp*Li was added by cannula
over 10 min to the suspension of FeCl2, leading to a homogeneous green solution, which was
stirred at 0 'C for 2.5 h.
In a 250-mL round-bottomed flask, a 0 'C solution of 4-pyrrolidinopyrindine (6.54 g, 35.1
mmol) in anhydrous THF (80 mL) was treated with n-BuLi (1.6 M solution in hexanes; 22.4 mL,
35.8 mmol; dropwise addition), and the resulting dark yellow-brown solution was stirred at 0 °C
for an additional 1.5 h. This solution was then added by cannula over 15 min to the 0 'C
solution of Cp*FeC1, resulting in a dark-purple solution. This mixture was stirred for 18 h,
during which time it was allowed to slowly warm to room temperature. Next, the reaction
mixture was poured onto a column of silica gel, eluting first with 65:30:5 hexane:EtOAc:Et 3N
(600 mL) and then with 90:10 EtOAc:Et3N (1.5 L). The purple fractions were collected, and the
solvents were removed on a rotary evaporator, thereby providing racemic 1 in >99% purity as
judged by 'H NMR spectroscopy (12.0 g, 91%).
'H NMR (400 MHz, CDCl3) 8 8.21 (d, J = 5.1 Hz, 1H), 5.59 (d, J = 5.2 Hz, 1H), 4.54 (dd, J =
2.7, 1.1 Hz, 1H), 4.35 (dd, J = 2.8, 1.1 Hz, 1H), 3.74 (t, J = 2.8 Hz, 1H), 3.57 (br s, 4H), 2.07-
2.10 (m, 4H), 1.65 (s, 15H);
13C NMR (75 MHz, CDCl3) 8 156.3, 156.3, 152.1, 111.3, 93.8, 78.4, 74.4, 73.2, 67.1, 64.0, 49.3,
25.7 (br), 9.9;
IR (KBr) v 2966, 2902, 2865, 1538, 1487, 1380, 1338, 1021, 907, 730 cm-;
LRMS (ES/APCI) calcd for C22H28FeN 2 [M+H'] 377.3, found: 377.2;
Elem. anal. calcd for C22H28FeN 2: C, 70.22; H, 7.50; N, 7.44, found: C, 70.02; H, 7.54; N, 7.44;
Classical resolution of 4-pyrrolidinopyrindinyl-pentamethylcyclopentadienyl iron (1). First
crystallization: Under nitrogen, a solution of di-p-toluoyl-D-tartaric acid (531 mg, 1.37 mmol) in
nitrogen-purged EtOAc (40 mL) was added dropwise over 5 min to a stirred solution of pure,
racemic 4-pyrrolidinopyrindinyl-pentamethylcyclopentadienyl iron (1; 2.07 g, 5.48 mmol) in
anhydrous CH 2C12 (20 mL) in a 250-mL flask. The resulting dark-purple suspension was stirred
at room temperature for 14 h under nitrogen, and then it was allowed to stand for 1-3 h. Next,
the suspension was filtered, and the solid was rinsed with hexanes (10 mL). The filtrate was
concentrated and then purified by passage through a column of silica gel (the column should be
loaded using 100% EtOAc), washing first with EtOAc to remove traces of degradation products
(yellow-brown bands) and then with 90:10 EtOAc:Et3N (~150 mL) to elute catalyst 1 as a blood-
red solution. The appropriate fractions were collected and concentrated on a rotary evaporator.
HPLC analysis revealed an enantiomeric excess of 57% (950 mg, 46%; fast-eluting enantiomer
on chiral HPLC, (+)-(R) configuration). Daicel OD column, flow: 1.0 mL/min, eluent: 50:50:0.4
2-propanol:hexane:Et 2NH. t, (+)-(R): 4.67 min; (-)-(S): 11.22 min.
The purple solid from the filter cake was dissolved in CH2C12 (25 mL), and the solution was
treated with a small amount of Et3N (0.5 mL) and passed through a column of silica gel, eluting
with 90:10 EtOAc:Et3N (~150 mL). The bright-red fractions were collected. HPLC analysis
revealed an enantiomeric excess of 91% (810 mg, 39%; slow-eluting enantiomer on chiral
HPLC, (-)-(S) configuration).
Note: Column chromatography of catalyst 1 can be performed in the air. However, solutions of
catalyst 1 that are exposed to air for extended periods of time (i.e., hours) will decompose
slightly, leading to the formation of a polar compound that leaves a brown band on the top of
silica gel columns.
Recrystallization of the solid from the first crystallization: Calculation of the required amount of
resolving agent: mmol of resolving agent = (mmol of catalyst 1) x 0.5 x (fraction of the major
enantiomer (e.g., 0.955 for 91% ee)).
A solution of di-p-toluoyl-D-tartaric acid (397 mg, 1.03 mmol) in nitrogen-purged EtOAc (14
mL) was added dropwise over 5 min to a stirred solution of enantioenriched 1 (the solid from the
first crystallization; 810 mg, 2.15 mmol, 91% ee) in anhydrous CH2C12 (8 mL) in a 250-mL flask
under nitrogen. The resulting dark-purple suspension was stirred at room temperature for 14 h
under nitrogen, and then it was allowed to stand for 1-3 h. The suspension was filtered, and the
purple solid was "worked up" as described for the first crystallization: 719 mg, 35% (based on
the starting amount of racemic 1). HPLC analysis revealed >99% enantiomeric excess of the
slow-eluting enantiomer on chiral HPLC, (-)-(S)- configuration.
Recrystallization of the filtrate from the first crystallization: A solution of di-p-toluoyl-L-tartaric
acid (383 mg, 0.990 mmol) in nitrogen-purged EtOAc (17 mL) was added dropwise over 5 min
to a stirred solution of enantioenriched 1 (the filtrate from the first crystallization; 950 mg, 2.53
mmol, 57% ee) in anhydrous CH 2C12 (9 mL) in a 250-mL flask under nitrogen. Within a few
minutes, a dark-purple suspension had formed. This mixture was stirred at room temperature for
14 h under nitrogen, and then it was allowed to stand for 1-3 h. The suspension was filtered, and
the purple solid was "worked up" as described for the first crystallization: 665 mg, 32% (based
on the starting amount of racemic 1). HPLC analysis revealed >99% enantiomeric excess of the
fast-eluting enantiomer on chiral HPLC, (+)-(R) configuration.
(-)-(S)-1: [a]20D = -2,2800 (c = 0.00046, CHCI3).
m.p. 155-160 oC (decomp.; >99% ee);
Me2N 4-(Dimethylamino)pyrindinyl-pentaphenylcyclopentadienyl
I iron (2). A solution of n-BuLi (1.6 M in hexanes; 5.45 mL, 8.73
Ph Fe Ph (±)-2 mmol) was added dropwise over 2 min to a mixture of
Ph Ph h pentaphenylcyclopentadiene (3.90 g, 8.72 mmol) suspended inPh
anhydrous THF (86 mL) under nitrogen. The solution, which was
initially homogenous and yellow, was allowed to stir for 2 h, at which time it was red-orange.
Separately, anhydrous THF (40 mL) was added to powdered FeCl2 (1.07 g, 8.44 mmol) in a 500
mL round-bottomed flask. The mixture was sonicated for 30 min, yielding a fine suspension.
The solution that contained the pentaphenylcyclopentadienyl anion was then added by cannula
over 2 min to the suspension of FeCl2, resulting in a beige solution. The reaction mixture was
stirred at room temperature for 2 h.
A solution of n-BuLi (1.6 M solution in hexanes; 4.54 mL, 7.27 mmol) was added dropwise over
2 min to a solution of 4-(dimethylamino)pyrindine (1.17 g, 7.27 mmol) in anhydrous THF (35
mL) at 0 oC in a 250-mL round-bottomed flask. The resulting dark yellow-brown solution was
stirred at 0 oC for 1.5 h. Then, this solution was added by cannula over 2 min to the solution of
C5PhsFeCl (at room temperature), resulting in a brown solution. The reaction mixture was
heated to 60 oC for 3.5 h. Next, the reaction mixture was poured onto a column of silica gel,
which was eluted with 45:45:10 EtOAc:hexane:Et 3N (200 mL). The resulting solution was
concentrated to a dark-purple solid on a rotary evaporator, and this crude material was purified
by column chromatography, first eluting with CH2CI2 (400 mL) to remove the excess CsPhsH
and then with 90:10 CH2Cl2:Et3N (400 mL), which provided the catalyst as a tight purple band.
The purple fractions were collected and concentrated on a rotary evaporator to afford the title
compound in >99% purity as judged by 'H NMR spectroscopy (purple powder; 4.51 g, 93%).
m.p. 238-241 'C;
'H NMR (400 MHz, CDCI3) 8 8.17 (d, J= 5.2 Hz, 1H), 7.13-7.16 (m, 5H), 7.05-7.12 (m, 10H),
6.94-6.96 (m, 10H), 5.87 (d, J = 5.2 Hz, 1H), 5.11 (br s, 1H), 4.92-4.94 (m, 1H), 4.28-4.30 (m,
1H), 2.94 (br s, 6H);
13C NMR (75 MHz, CDC13) 8 158.6, 153.9, 135.3, 132.6, 127.1, 126.2, 113.4, 99.5, 86.0, 77.9,
77.7, 69.6, 66.1, 41.7;
IR (film) v 3055, 2952, 1537, 1502, 1351, 1075, 1027, 741, 700 cm-;
LRMS (ES/APCI) calcd for C45H36FeN2 [M+H ÷] 661.6, found: 661.2;
Elem. anal. calcd for C45H36FeN2 (660.64): C, 81.81; H, 5.49; N, 4.24, found: C, 81.62; H, 5.49;
N, 4.41;
Classical resolution of 4-(dimethylamino)pyrindinyl-pentaphenylcyclopentadienyl iron (2).
First crystallization: In the air, a suspension of racemic 4-(dimethylamino)pyrindinyl-
pentaphenylcyclopentadienyl iron (2; 2.62 g, 3.97 mmol) and CH2C12 (45 mL) in a 250-mL flask
was sonicated for ~10 min until all of catalyst 2 had dissolved. Next, the solution was diluted
with THF (18 mL), and then a solution of anhydrous dibenzoyl-L-tartaric acid (711 mg, 1.98
mmol) 17 in THF (18 mL)'" was added dropwise by pipette over 1 min to the stirred solution of
catalyst 2. The resulting dark-purple solution was sonicated for -6 min. The flask was then
fitted with a septum, and the flask was vigorously stirred and purged with nitrogen until a purple
suspension formed. This suspension was stirred for 20 h, and then it was allowed to stand for 1.5
h without stirring. Next, the mixture was filtered, and the purple solid that was collected was
rinsed with hexanes (10 mL). The material in the filtrate was purified by passing it through a
column of silica gel, rinsing first with EtOAc to remove traces of degradation products (yellow
or brown) and then with 90:10 EtOAc:Et 3N (~100 mL) to elute the catalyst as a dark-purple
band. The highly colored fractions were collected and concentrated on a rotary evaporator.
HPLC analysis revealed an enantiomeric excess of 44% (1.71 g, 65%; fast-eluting enantiomer on
chiral HPLC, (+)-(R) configuration). Regis Whelk 0-2 column, flow: 0.9 mL/min, eluent:
60:40:0.4 CH2C12:hexanes:Et 2NH. tr (+)-(R): 6.4 min; (-)-(S): 9.6 min.
The purple solid from the filter cake was dissolved in CH2C12 (10 mL) and Et3N (1 mL). This
solution was passed through a column of silica gel, eluting with 90:10 EtOAc:Et3N (~100 mL).
The dark-purple fractions were collected and concentrated on a rotary evaporator. HPLC
analysis revealed an enantiomeric excess of 97% (910 mg, 35%; slow-eluting enantiomer on
chiral HPLC, (-)-(S) configuration).
Notes: 1) Column chromatography of catalyst 2 can be performed in the air with essentially no
concern for decomposition. 2) The equivalents of the resolving agent that are used for the
resolution of catalyst 2 is double that used in the resolution of catalyst 1.
Recrystallization of the solid from the first crystallization: Calculation of the required amount of
resolving agent: mmol of resolving agent = (mmol of catalyst 2) x (fraction of the major
enantiomer (e.g., 0.965 for 93% ee)).
A mixture of enantioenriched 2 (the solid from the first crystallization; 910 mg, 1.38 mmol; 97%
ee) and CH 2C12 (21 mL) in a 250-mL flask under air was sonicated until all of catalyst 2 had
dissolved (~10 min). Next, the solution was diluted with THF (9 mL), and then a solution of
anhydrous dibenzoyl-L-tartaric acid (486 mg, 1.36 mmol) in THF (10 mL; this solution was
filtered before use) was added dropwise via pipette over 1 min to the stirred solution of 2. The
resulting dark-purple mixture was sonicated for ~5 min, leading to the formation of a large
amount of a purple precipitate. The mixture was stirred for ~20 min, during which time it
became less viscous. The flask was purged with nitrogen for 2-3 min, and then it was stoppered
with a septum and allowed to stir for 20 h. Next, the mixture was allowed to stand without
stirring for 3 h, and then it was filtered. The purple solid was "worked up" as described for the
first crystallization. HPLC analysis revealed an enantiomeric excess >99% (830 mg, 32% (based
on the starting amount of racemic 2); slow-eluting enantiomer on chiral HPLC, (-)-(S)
configuration).
Recrystallization of the filtrate from the first crystallization: A mixture of enantioenriched 2 (the
filtrate from the first crystallization; 1.71 g, 2.59 mmol; 44% ee) and CH 2C12 (39 mL) in a 250-
mL flask was sonicated until all of the catalyst had dissolved (~10 min). Next, the solution was
diluted with THF (17 mL), and a solution of dibenzoyl-D-tartaric acid monohydrate (701 mg,
1.86 mmol) in THF (17 mL; this solution was filtered before use) was added dropwise via pipette
over 1 min to the stirred solution of 2. The resulting dark-purple mixture was sonicated for ~6
min. Next, while stirring the mixture, the flask was purged with nitrogen for 2-3 min. Stirring
was continued overnight (20 h), leading to a slurry. The mixture was allowed to stand without
stirring for 1 h, and then it was filtered through a sintered glass frit. The purple solid was rinsed
with hexanes (10 mL) and then suspended in CH2C12 (10 mL). Et3N (~1 mL) was added until the
solution was homogeneous. The solution was passed through a column of silica gel, eluting with
95:5 EtOAc:Et3N (~100 mL). The dark-purple fractions were collected and concentrated on a
rotary evaporator. HPLC analysis revealed an enantiomeric excess of >99% (1.01 g, 39% (based
on the starting amount of racemic 2); fast-eluting enantiomer on chiral HPLC, (+)-(R)
configuration).
(+)-(R)-2: [a]2D = +9400 (c = 0.00024, CHCI3).
m.p. 280-281 *C (decomp.; >99% ee);
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16. Purchase price (September 2006): $900/kg (including airborne delivery).
17. Either anhydrous dibenzoyl-L-tartaric acid or its monohydrate can be employed.
18. Because the solution was somewhat cloudy, it was filtered before it was used.
Chapter 2
Asymmetric Synthesis of Trans (3-Lactams Catalyzed by a Planar-Chiral
Nucleophilic Catalyst
2.1 Introduction
The development of methods for the synthesis of P-lactam-containing compounds has
been well-established in the literature' mainly due to the importance of Penicillin and
cephalosphorin 2 based antibiotics. However, the need for more potent antibiotics exists as a
consequence of the growing resistance of microbial organisms toward common antibiotics. In
addition to their importance as targets for medicinal chemistry, enantiopure 13-lactams are
versatile chiral building blocks in organic synthesis. For instance, j-lactams are found in
semisynthesis of compounds displaying anti-cancer activity, such as paclitaxel (Taxol)3 and
docetaxel (Taxotere),4 where an enantiopure 1-lactam is used to install the 13-amino acid-derived
side chain. As a result, much effort has been expended towards the development of uniquely
functionalized P-lactams. 5 Among the numerous methods of constructing P-lactams, the well-
known Staudinger reaction, 6 i.e., the coupling of a ketene and an imine, is one of the most
attractive methods as it offers an efficient and convergent route to 13-lactams (eq 1).
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(1)
Although asymmetric P-lactams have received considerable attention, many of the
methods for their synthesis are based on the utilization of chiral auxiliaries, and there are
currently a limited number of reports on catalytic asymmetric processes that produce 13-lactams.
Specifically, there are examples of asymmetric Staudinger reactions of monosubstitued ketenes
and imines to afford predominately cis P-lactams.7 In such cases, the trans diastereomer can be
accessed through a base induced epimerization.
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N >95% ee
o N cis:transH 99:1
10 mol% 36-65% yield
In contrast, Staudinger reactions of disubstituted ketenes are much less common,8 despite
the fact that P3-lactams that bear two a substituents are an important class of target molecules.9
Recently, contributions from both the Lectka (eq 2 )7b,10 and our laboratory (eq 3)" have
broadened the scope in this area through the use of nucleophilic catalysts, which have been found
to be highly efficient for the production of enantiomerically enriched cis P-lactams.
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88-98% yield
Of course, for such a,ca'-disubstituted P-lactams, the trans diastereomer cannot be generated
from the cis isomer through base-induced epimerization. Interestingly, Lectka reported one
example of a catalyst system in which the trans isomer is the predominant product (eq 4).10b
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EtO 2C -- "MePh
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3:97
one example
More recently, along with our published report, 13 Lectka reported a diastereoselective
synthesis of trans P-lactams with monosubstituted ketenes (eq 5).14
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2.2 Previous Work
Previous work in our laboratories demonstrated that planar-chiral nucleophile (-)-2
catalyzes the asymmetric Staudinger reaction to generate cis fP-lactams in excellent ee (81-98%)
with good substrate scope (13 examples, eq 3)." Since it was believed that the electron-
withdrawing protecting group on the nitrogen of the imine plays a crucial role in the success of
the catalytic version of the Staudinger reaction, various protecting groups were screened in order
to determine their effect on the coupling reaction. Unlike in the case of p-toluenesulfonyl (Ts)
protected imines, which affords cis P-lactams,1 it was discovered that trifluoromethanesulfonyl
(triflyl, Tf) protected imines resulted primarily in the formation of trans P-lactams (eq 6)!12
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Figure 1. Planar-chiral nucleophilic catalysts used for the synthesis of P3-lactams.
2.3 Results and Discussion
2.3.1. Synthesis of Ketenes
To demonstrate the generality of trans-selective 13-lactam transformations, we began by
evaluating a more diverse set of ketenes to expand the substrate scope. Unlike many aryl
ketenes, mono- and dialkyl ketenes are known to be unstable, 15 and, in nearly all cases, they were
generated in situ for the subsequent reaction. Among the several well-established procedures for
generating ketenes, 16 it was determined that the zinc-mediated di-dehalogenation of ca-bromo
acid bromides' 7 would be most compatible with our reaction (this method avoids the use of an
amine base that can also catalyze the reaction of a ketene with an imine). The zinc-mediated di-
dehalogenation typically requires prolonged stirring, and it is often assisted by microwave
irradiation or sonication to accelerate the reaction. Exposing unstable mono- and/or dialkyl
ketenes to such conditions is problematic since Lewis acid catalyzed
dimerization/polymerization is also accelerated; thus resulting in poor and irreproducible yields
of the desired ketenes. In order to synthesize ketenes more reliably, an iodine-accelerated zinc-
mediated di-dehalogenation method was developed that does not require any external assistance
such as sonication (Table 1). Iodine is postulated to not only aid in activation of the zinc metal,
but may also be involved in a halogen exchange, generating a more reactive acyl iodide during
the reaction.
Table 1. Optimized Conditions for the Generation of Mono- and Dialkyl Ketenes
O O
RR1 Zn / cat. 12Br
R2 Br THF, l h RIR 2
entry R R2  temp yield (%)a
1 Et H -40 OC 67
2 b Cy H -40 OC 30
3 i-Pr H 00 C 50
4 t-Bu H 00 C 62
5 i-Pr Me 0 OC 76
6 t-Bu Me r.t. 84
7 c CH2Cyp Me r.t. 41
a Isolated yield after quenching with propylamine. b Reaction
time: 30 min reaction. c Toluene was used as a co-solvent.
Ketene formation via the iodine-promoted zinc-mediated di-dehalogenation reaction can
be performed at temperatures varying from -40 oC to room temperature. A range of monoalkyl
ketenes, including unstable ethyl and cyclohexyl ketenes (entries 1 and 2), can be generated in
moderate yields. However, these substrates were not employed in the cycloaddition reaction
with imines due to the rapid background reaction (i.e., reaction occurred without catalyst; hence,
low enantioselectivites were observed). Mono-substituted isopropyl and tert-butyl ketenes
(entries 3 and 4), as well as isopropyl-, tert-butyl-, and cyclopentyl methyl- substituted methyl
ketenes (entries 5, 6, and 7) were also generated in moderate yields.
Aryl alkyl ketenes were generated from the corresponding acid chloride, which was
dehydrohalogenated with an amine base. The resulting aryl alkyl ketene is stable to purification
via distillation and able to be stored at low temperature (-30 °C) for an extended period of time.
2.3.2. Asymmetric Trans-Selective Staudinger Reactions of Unsymmetrical Mono- and Dialkyl
Ketenes Catalyzed by (-)-2
The initial result obtained with a triflyl-protected imine to generate a trans P3-lactam (eq
6) prompted us to explore various protecting groups in order to determine if better
diastereoselectivity could be achieved (Table 2). Hence, we explored the electronic and steric
effect of the protecting groups (mesyl vs. tosyl vs. triflyl). Additionally, a variety of ketenes
(monoalkyl, dialkyl and arylalkyl ketenes) were subjected to the reaction conditions to determine
the role of the structure of the ketene on the diastereoselectivity of the reaction. For the reactions
of monoalkyl and dialkyl ketenes, generation of the trans P-lactam was favored when the imine
was protected with a more electron-deficient protecting group (i.e., triflate) whereas tosylate- or
mesylate- protected imines generated little to no selectivity (entry 1 vs. 2 and entries 3-5).
Interestingly, DMAP-catalyzed reactions afforded poor stereoselectivity (entries 11-12). These
results support the hypothesis that the trans-selectivity stems from the more electron-deficient
nature of triflyl-protected imines (versus mesylate- or tosylate-protected imines).
Table 2. Probing Trans-Selectivity with Respect to the Imine Protecting Group
SNO
S NP 10% catalyst P PRii R1  . ph-•~,,,R
RR2 0.019 M RR R1 R
entry catalyst R R' R2  temp P dr (trans:cis)
a (-)-1 t-Bu H Ph -78 OC to r.t. Ts 50:50
2a  (-)-1 t-Bu H Ph -78 OC to r.t. Tf 91: 9
3b  (-)-2 i-Pr Me Ph -78 OC to r.t. Ts 50:50
4b  (-)-2 i-Pr Me Ph -78 °C to r.t. Tf 89:11
5b  (-)-2 i-Pr Me Ph -78 OC to r.t. Ms 33:67
6a  DMAP Ph i-Bu Ph r.t. Ts 67:33
7a  DMAP Ph i-Bu Ph r.t. Tf 67:33
a In dichloromethane. b In toluene.
Next, a comprehensive screening study for determining optimal conditions for the
synthesis of trans f3-lactams was conducted with respect to catalyst, solvent, and temperature.
The results of this study are summarized in Table 3. During the course of our optimization
studies, we have found that the highly sensitive nature of this reaction necessitated modification
of reaction conditions based on ketene to obtain acceptable enantioselectivity. As exemplified in
Table 3, catalyst (-)-2 performed better overall compared to (-)-1 (entry 5 vs. 8) in generating
good enantioselectivity. However, a decrease in catalyst loading from 10% to 5% yielded poorer
enantioselectivity (entry 3 vs. 4 and 5 vs. 6). The solvent employed in the reaction was crucial in
obtaining good stereoselection. Since the ketenes are generated in situ in THF, a suitable co-
solvent was investigated and was found to be either DCM or toluene, depending on the substrate
(entries 1 vs. 5). Additionally, the effect of concentration was examined (0.09 M vs. 0.019 M)
and it was determined that more dilute conditions afforded better ee for all substrates examined.
Table 3. Reaction Optimization with Respect to Catalyst and Solvent
0 0
NTf NTf
RR2 RRR2R R1 Ri
entry R R1  R2  catalyst (mol%) solvent temp trans:cisa ee (%)b
1 t-Bu H Ph (-)-2 (10) THF/DCM -78 OC 95:5 78
2 t-Bu H Ph (-)-2(10) THF/toluene -78 OC 75:15 28
3 t-Bu H Ph (-)-1 (10) THF/DCM -78 OC 91:9 85
4 t-Bu H Ph (-)-1 (5) THF/DCM -78 OC 86:14 71
5 i-Pr Me Ph (-)-2(10) THF/toluene -78 oC 89:11 90
6 i-Pr Me Ph (-)-2(5) THF/toluene -78 oC 86:14 82
7 i-Pr Me Ph (-)-2 (10) THF/DCM -78 OC 80:20 62
8 i-Pr Me Ph (-)-1 (10) THF/toluene -78 OC 92:8 47
a Diastereomeric ratios determined by 1H NMR of crude product mixtures. b Enantiomeric excess determined by
chiral GLC or HPLC.
On the basis of these observations, we applied the optimized conditions to a variety of
substrate combinations (Table 4). Thus, a mono-substituted alkyl ketene (entry 1) and
unsymmetrical dialkyl ketenes (entries 2 and 3) reacted to form trans 13-lactams in good
stereoselection (up to 93:7 dr and 53-81% ee) and yield (52-95%). It should be noted that a
tetrasubstituted stereogenic center is constructed in the reactions involving disubstituted
unsymmetrical ketenes (entries 2-8). For a mono-substituted isopropyl ketene, no
diastereoselectivity was observed for reaction with (-)-2 whereas with (-)-1, relatively poor yield
and stereoselectivity was observed (81:19 dr, 45% ee; 22% yield). Imines with electron-
deficient aryl groups worked well to provide moderate stereoselection (up to 83:17 dr and 67-
95% ee) and yields (77-87%, entries 4-5). Additionally, an electron-rich imine (entry 6) and a
sterically demanding imine (entry 7) were both well tolerated in the reaction. In most of the
reactions, catalyst recovery (70-85%) was easily achieved by column chromatography.
Table 4. Scope with Respect to the Mono- and Dialkylketenes and Imines
0IIC
R )ý R1
NTfIR2
10% (-)-2
THF and
CH2CI2 or toluene
0RI NTf
,R2
R
1
entry R R' R2  Trans:cisa ee (%)a yield (%)a
1 t-Bu H Ph 93:7 78 52
2 i-Pr Me Ph 86:14 81 95
3 CH2Cyp Me Ph 69:31 53 81
4 i-Pr Me 4-F-C 6H4  83:17 95 77
5 i-Pr Me 4-(CF 3)C6H4  79:21 67 87
6 i-Pr Me 4-(OMe)C 6H4  90:10 68 92
7 i-Pr Me o-tolyl 68:32 78 96
8 i-Pr Me 2-napthyl 84:16 75 87
a Average of two runs. See Supporting Experimental for details.
f-Lactams are interesting targets not only because of their bioactivity, but also because
they are useful precursors to other important families of compounds, such as P-amino acids. In
order to demonstrate the utility of the P-lactams generated by our catalytic system, we further
transformed several P-lactams into useful intermediates. A ring-opening reaction was conducted
on an a-monosubstitued P-lactam with an amine to afford a P-amino amide (eq 7). Additionally,
the N-triflyl protecting group was cleaved (eq 8) to obtain the desired product in 58% yield. 18
Both of these transformations proceeded without an erosion in stereochemical purity.
Br
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2.3.3. Asymmetric Trans-Selective Staudinger Reactions of Unsymmetrical Aryl Alkyl Ketenes
Catalyzed by (-)-2
We have also explored the electronic effect of the N-protecting group with respect to aryl
alkyl ketenes. As was observed with reactions with mono- and dialkyl ketenes, reactions with
aryl alkyl ketenes generated acceptable diastereoselectivity favoring the desired trans 3-lactams
when the imine was protected with a triflyl group (Table 5).
Table 5. Probing Trans-Selectivity with Respect to the Imine Protecting Group
oO
NTf 10% (-)-2IC ______Ph_,,
Ph R1  Ph 0.019 M Ph 1 Ph
entry R1  temp P dr (trans:cis)
lb Me 0 °C to r.t. Tf 97:3
2a  Me 0 OC to r.t. Ms 80:20
3a Et 0 OC to r.t. Ms 17:83
4a i-Bu r.t. Tf 96:4
5a i-Bu r.t. Ms 50:50
a In dichloromethane. b In toluene.
A second comprehensive screening study was conducted for the reactions of
unsymmetrical aryl alkyl ketenes with N-triflyl imines (Table 6). The stereoselectivity was
found to be sensitive to the choice of reaction temperature (0 °C to room temperature) and the
choice of solvent (DCM and/or toluene).
Table 6. Reaction Optimization with Respect to Solvent and Temperature
0 0NTf 10%(-)-2 Tf
Ph R R
entry R R' solvent temp trans:cisa ee (%)b
1 Me Ph toluene 0 OC 92:8 58
2 Me Ph DCM 0 oC 98:2 83
3 i-Bu Ph DCM 0 OC 94:6 36
4 i-Bu Ph DCM r.t. 98:2 74
5 Me 4-(OMe)C6H 4  toluene 0 OC 86:14 70
6 Me 4-(OMe)C6H4  DCM 0 OC 67:33 61
7 Me 4-(OMe)C6H4  toluene/DCM 0 oC 88:12 58
8 Me 4-F-C6H4  toluene 0 OC 98:2 79
9 Me 4-F-C 6H4  DCM 0 OC 98:2 78
10 Me 4-F-C 6H4  toluene/DCM 0 OC 96:4 89
a Diastereomeric ratios determined by 1H NMR analysis of crude product mixtures.
b Enantiomeric excess determined by chiral GLC or HPLC.
We were pleased to find that a range of aryl alkylketenes and imines react to produce an
array of P-lactams not only with good trans diastereoselectivity, but also with useful
enantioselectivity (Table 7). It is interesting to note that a sterically hindered imine was tolerated
extremely well (entry 7), forming the 3-lactam in 99% ee. Imines with varying degrees of
electron density also led to useful stereoselectivities (up to 97:3 dr and 69-85% ee; entry 4-6). In
addition, we examined the coupling of a symmetrical disubstituted ketene (entry 10);
gratifyingly, the desired P3-lactam was generated in excellent ee.
Table 7. Scope: Aryl Alkylketenes and Imines
o 0
C NTf 10% (-)-2 TfI•R1  = Ph-' ,, R
Ph "R R CH2Cl2 and/or toluene R1
entry R RI trans:cis ee (%)b yield (%)c
1 Et Ph 86:14 63 60
2 Me Ph 98:2 81 83
3 i-Bu Ph 97:3 63 72
4 Me 4-FC6H4  96:4 85 84
5 Me 4-(CFz)C 6H4  97:3 69 80
6 Me 4-(OMe)C6H4  81:19 82 76
7 Me o-tolyl 81:19 99 89
8 Me 2-Br-C6H 4  80:20 84 79
9 Me 2-naphthyl 98:2 94 76
10 Ph Ph - 98 62
a All data are the average of two experiments. b Enantiomeric excess of
the trans diastereomer. c Yield of the mixture of diastereomers.
Various a,a'-disubstitued 13-lactams were derivatized in good yields without an erosion
in stereochemical purity (eq 9-12) to obtain useful families of compounds. For example, an
ca,a'-disubstitued 13-lactam was reduced to generate a protected y-amino alcohol (eq 9) or
subjected to hydrolysis to generate a P-amino acid (eq 10). Additionally, a ring-opening reaction
was conducted with an amine to afford a P-amino amide (eq 11) and the N-triflyl protecting
group was cleaved (eq 12) to obtain the unprotected P-lactam. 18 All of these transformations
proceeded without an erosion in stereochemical purity. To the best of our knowledge, only one
report has described the synthesis of an N-triflyl p-lactam, 9 and no investigations of their
reactivity have been reported.
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2.3.4. Mechanistic Discussion
There are at least two possible mechanisms for the catalytic asymmetric Staudinger
reaction. In the first mechanism, the nucleophilic catalyst first reacts with a ketene to generate a
reactive zwitterionic enolate (A), which can then add to the electrophilic imine to form B.
Subsequently, ring closure can occur to afford the desired P-lactam (Figure 2).8,9
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Figure 2. A mechanism for nucleophile-catalyzed Staudinger reactions: A "ketene-first" pathway.
In the second mechanism, the nucleophilic catalyst first adds to the imine to generate
zwitterionic intermediate C, which can then add to a ketene to generate a subsequent zwitterionic
intermediate D. Finally, cyclization of D generates the desired P-lactam (Figure 3).
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Figure 3. A mechanism for nucleophile-catalyzed Staudinger reactions: An "imine-first" pathway
Taking into account the remarkable dependence of the cis/trans diastereoselectivity on
the choice of the N-sulfonyl group (eq 6), we began our investigation by examining the reactivity
of the catalyst (2) with a ketene in the absence of an imine, as well as with an imine in the
absence of a ketene. The 1H NMR spectrum of the reaction between catalyst (2) and phenyl
methyl ketene was inconclusive (i.e., no identifiable peaks were observed). Interestingly, while
there was no evidence by 1H NMR of a reaction between the catalyst and N-tosyl phenylimine
(eq 9), the catalyst reacted quantitatively with N-triflyl phenylimine to furnish 3 (eq 10).
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the differing electrophilicity of the two imines leads to divergent behavior in the
Moreover, we were able to obtain an X-ray crystal structure the product of a
reaction between 2 and N-triflyl phenylimine, complex 3 (Figure 4).
Interestingly, the absolute configuration of 3 is the opposite of what would be predicted for the
P3-lactam on the basis of Figure 3. We hypothesized that the diastereomer of 3 that was
crystallized was the more stable (or crystalline) adduct of (3), and less stable adduct of 3 was the
actual complex that was participating in the reaction that generated the trans P-lactam (i.e.,
Curtin-Hammett conditions). 20 Moreover, it was determined that when 3 was allowed to react
with a stoichiometric amount of phenyl methyl ketene, trans-3-methyl-3,4-diphenyl-N-triflyl P3-
lactam was isolated as the predominant diasteromer (86:14 dr), thus establishing that 3 was a
chemically and kinetically competent potential intermediate in the reaction cycle.
02 2 
C 30
Figure 4. X-ray crystal structure of catalyst 2-N-triflyl phenylimine adduct, 3. Thermal elipsoids are at
30% probability.
Additionally, kinetic experiments provided further insight into the reaction mechanism.
The rate law for the coupling reaction of N-triflyl phenylimine with phenyl methyl ketene at -20
TC in CD 2C12 was zero order with respect to ketene (Chart 1) and imine (Chart 2), with the
overall reaction being first order with respect to catalyst only. This data correlated well with the
proposed "imine-first" pathway outline in Figure 3, and suggested that the rate-determining step
of the reaction would be the ring-closure from the 3-component adduct D in Figure 3.
Chart 1. Percent product vs. time plot for the reaction of N-triflyl phenylimine with phenyl
methylketene at -20 TC with respect to 1 and 2 equivalents of ketenea
a
a
. U
a
* 1 equiv of Ketene
* * 2 equiv of Ketene
U
U
U
U
U
25.00
20.00
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aAll data are the average of two experiments.
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Chart 2. Percent product vs. time plot for the reaction of N-triflyl phenylimine with phenyl
methylketene at -20 'C with respect to 1 and 2 equivalents of iminea
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aAll data are the average of two experiments.
Furthermore, 4 was observed independently via 'H NMR at -26 TC (eq 15). This
evidence strongly suggested that 4 was actually the resting state of the catalytic cycle rather than
(3) as we initially presumed.
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Subsequently, we were also able to detect relevant signals in the 'H NMR spectrum
corresponding to (4) and not (3) during the catalytic reaction between N-triflyl phenylimine and
phenyl methyl ketene, confirming 4 as the resting state of the catalytic cycle (Figure 5).
Additional 'H NMR studies on 4 provided some noteworthy results: the initial diastereomeric
ratio of 3 at -78 'C is approximately 10:1; however, after addition of phenyl methyl ketene, the
+
9
4 4
• I E
• • 1 equiv Imine
=9
ai g 2 equiv Imine
IU
*989
"9
CD2CI2
-26 °C
dr of 4 is approximately 1.3:1. After warming the sample to 22 °C, the desired 13-lactam is
formed in >95:5 dr (eq 16).
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Figure 5. 'H NMR spectra of independently generated adduct 3 and adduct 4, and that of the reaction described in
equation 15.
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In addition to our rate-law study, the 1H NMR results from a catalytic reaction (Figure 5)
are consistent with our hypothesis that each step in the catalytic cycle exists in rapid equilibrium
until the formation of 4, again confirming that 4 is the resting state of the catalytic cycle. The
hypothesis that the initial steps in the catalytic cycle are reversible offers an explanation as to
why the absolute configuration of (3) is not what one would have expected or the basis of the
stereochemistry of the major 3-lactam product.
Finally, the a-secondary kinetic isotope effect was determined via 1H NMR based on
reactions of protio-N-triflyl phenylimine with phenyl methyl ketene (Chart 3) and a-deutero N-
triflyl phenylimine with phenyl methyl ketene (Chart 4) in CD2C12 at -20 'C.
Chart 3. a-Secondary Kinetic Isotope Effect Study: Reaction of a-Protio-N-Triflyl
Phenylimine a
50 100 150 200 250 300 350
Time (min)
400
aAll data are the average of two experiments. Reactions were conducted in CD 2 C12 at -20 *C. The
average error was calculated to be 5% (based upon the mean error for each data point) for each data point.
Chart 4. a-Secondary Kinetic Isotope Effect Study: Reaction of a-Deuterated N-Triflyl
Phenylimine a
50 100 150 200 250 300 350
Time (min)
400
'All data are the average of two experiments. Reactions were conducted in CD 2C12 at -20 *C. The
average error was calculated to be 5% (based upon the mean error for each data point) for each data point.
A regression analysis was conducted for the data depicted in Charts 4 and 5. From the quadratic
equations that fit the data with R2 > 0.99, we were able to determine that there is a substantial
normal a-secondary kinetic isotope effect for reactions of undeuterated versus a-deuterated
imines (kH/kD=l. 8 9 ) (Chart 5). The kH/kD value was calculated based on the term x since the
value for x2 was negligible.
Chart 5. a-Secondary Kinetic Isotope Effect Study: Comparison of a-Deuterated and a-Non-
Deuterated N-Triflyl Phenylimine a
50 100 150 200
Time (min)
Although not definitive, the substantial normal a-secondary kinetic isotope effect we
observed was consistent with the hypothesis that in the transition state of the rate-determining
step, there was a hybridization change from sp3 to sp2:20 such hybridization change is not
expected for the "ketene-first" pathway. On the other hand, a normal a-secondary kinetic
isotope effect is expected for the "imine-first" pathway if the cyclization step is the turnover-
limiting. Therefore, we believe this evidence strongly supports the "imine-first" pathway over
the "ketene-first" pathway.
2.3.5. Determination ofAbsolute Configuration
The absolute configuration of the aryl alkyl substituted 3-lactams was established by x-
ray crystallography of a representative compound generated from phenyl methyl ketene and 2-
bromophenyl N-triflyl imine (Table 6, entry 8), which was crystallized from benzene/pentane
Y = -0.0002x2 + 0.1263x + 0.683
R2 = 0.9974
y = -9E-O5x 2 + 0.067x + 1.5085
R2 = 0.9916
250 300 350 400
(1:3) at -30 TC. The bis-alkyl substituted 3-lactam generated from isopropyl methyl ketene and
4-fluorophenyl N-triflyl imine (Table 4, entry 4) was crystallized from 2-propanol/pentane (1:3)
at ambient temperature, and its absolute configuration was also determined by x-ray
crystallography. Adduct A was crystallized from acetonitrile at -30 TC, and the absolute
configuration of this compound was determined by x-ray crystallography.
2.4 Conclusions
In summary, we have demonstrated that trans P-lactams can be generated via catalysis
with a planar-chiral derivative of PPY. A wide array of N-triflylimines with various mono- and
di-substituted alkyl and aryl ketenes react with good enantioselectivity and yield. We have also
presented mechanistic data supporting a novel mechanism, in which the N-triflylimine, rather
than the ketene, reacts with the catalyst, via the "imine-first" pathway outlined in Figure 3.
2.5 Experimental Procedures
2.5.1. General
All air- and moisture-sensitive manipulations were carried out with standard Schlenk
technique under nitrogen or in a glove box under nitrogen.
Toluene, CH2C12, and THF were purified by passing through a neutral alumina column
under argon prior to use. 2,3-Dimethylbutyric acid (Karl Industries), 3,3-dimethylbutyric acid
(Aldrich), 2-phenylpropionic acid (TCI), 2-bromobenzylamine (Aldrich), thionyl chloride (Alfa
Aesar), dimethyl ethylamine (Aldrich), N-propylamine (Aldrich), 1-bromo-2-methylpropane
(Aldrich), methyliodide (Aldrich), LiAlH 4 (1.0 M in THF, Aldrich), lithium wire (Alfa Aesar),
TiCl3 (Aldrich) were used as received. Zinc metal (Stream) was activated with hydrochloric
acid. N-Buthyllithium (2.89 M in THF, Alfa Aesar) was titrated prior to use.
4-Fluorobenzaldehyde, 4-(trifluoromethyl)-benzaldehyde, o-tolualdehyde, 2-
bromobenzaldehyde, p-anisaldehyde, and benzaldehyde were distilled prior to use.
2-Bromo-3,3-dimethylbutyryl bromide, 2-bromo-3-methylbutyryl bromide and 2-bromo-
2,3-dimethylbutyryl bromide were synthesized according to a literature procedure for a related
compound.21 Planar-chiral catalysts were prepared and resolved as previously reported.22
'H NMR spectra were recorded on either Varian Mercury 300 or INOVA500
spectrometer at ambient temperature. 13C NMR spectra were obtained with complete proton
decoupling on a Varian INOVA501 spectrometer (126 MHz) at ambient temperature. '9F NMR
spectra were obtained on a Varian Mercury 300 spectrometer (282 MHz) at ambient temperature
and the chemical shifts are referenced to external trifluoroacetic anhydride at -78 ppm.
'H NMR spectra for the mechanism investigation was recorded on Bruker 400
spectrometer (400 MHz) at temperatures ranging from -80 to -20 *C. The initial target
temperature was calibrated with methanol and equilibrated over 1.5 h.
Infrared spectra were recorded on a Perkin Elmer 1600 FT-IR spectrometer. Optical
rotations were measured on a Perkin Elmer Model 241 polarimeter. Melting points were
measured on a Thomas Hoover capillary melting point apparatus and are uncorrected. Yields are
not optimized.
2.5.2. Synthesis of Imines and Ketenes
1,1,1-Trifluoro-N-sulfinyl-methanesulfonamide (CF3SO2NSO) was synthesized according
to the literature procedure23 where 4 N HCI in dioxane (0.5 equiv) was incorporated as an
additive after 3 days of reflux in thionyl chloride.
NTf The general procedure was followed: benzaldehyde (900 mg, 4.61 mmol) and
H CF3SO2NSO (489 mg, 4.61 mmol) in 1,2-dichloroethane (5.0 mL). The reaction
mixture was concentrated to dryness, and the product was purified via distillation
(300 mtorr, distillation temp at 72-75 'C). Product: 785 mg (77%) as colorless oil, which
solidified upon standing.
'H NMR (500 MHz, CDCl3) 8 9.19 (s, 1H), 8.08 (dd, J = 7.0, J = 1.0 Hz, 2H), 7.80 (m,
1H), 7.62 (t, J = 7.5 Hz, 2H). 13C NMR (126 MHz, CDCl3) 8 180.1, 137.6 (x2), 132.9, 131.7,
129.9 (x2), 119.3 (q, 1JcF = 321.3). '9F NMR (282 MHz, C6D6) 8 -77.9. HRMS (EI, m/e) calcd
for C8H6F3NO 2S (M+) 237.0071, found 237.0055. FTIR (CH2C12) 3058, 1595, 1564, 1364, 1223,
739 cm-1.
NTf 4-Fluorobenzaldehyde (211 mg, 1.70 mmol, freshly distilled) and CF3SO2NSO
- H (332 mg, 2.56 mmol) were dissolved in anhydrous 1,2-dichloroethane (2.7 mL).
F The resulting solution was heated to reflux under a nitrogen atmosphere for
16 h. The solvent was then removed under vacuum, leaving a slightly tan solid. The crude solid
was dissolved in CH2CI2/pentane (1:1) and filtered through a pad of Celite. The filtrate was
concentrated and redissolved in pentane under reflux conditions. Clean product was crystallized
upon slow cooling, which was then isolated as a white, crystalline solid. Yield: 285 mg (75%).
'H NMR (500 MHz, CDCI3) 8 9.15 (s, 1H), 8.13 (m, 2H), 7.31 (m, 2H). 13C NMR (126
MHz, CDCl3) 8 178.4, 168.6 (d, 'JcF= 263.5 Hz), 135.7 (d, 3 JCF = 10.4 Hz) (x2), 128.2, 119.3 (q,
'JcF = 321.9 Hz), 117.6(d, 2 JcF = 22.4 Hz)(x2). '9F NMR (282 MHz, C6D6) 8 -77.9, -98.3.
HRMS (EI, m/e) calcd for C8H5F4NO2S (M+) 254.9977, found 254.9981. FTIR (CH 2Cl2) 3056,
1569, 1223, 740 cm-1'. M.p. 61-63 oC.
NTf The general procedure was followed: 4-(trifluoromethyl)-benzaldehydeNTf
/- H (890 mg, 5.12 mmol, freshly distilled) and CF3SO 2NSO (1.00 g, 5.12 mmol)
F3C in 1,2-dichloroethane (10 mL). Product: 967 mg (62%) as a white, crystallineFaC
solid.
1H NMR (500 MHz, CDCl3) 8 9.27 (s, 1H), 8.21 (d, J = 8.0 Hz, 2H), 7.88 (d, J = 8.5 Hz,
2H). 13C NMR (126 MHz, CDCI3) 8 178.6, 138.1 (q, 2JcF = 32.8 Hz), 134.4, 132.9 (x2), 126.8
(q, 3Jcv= 3.5 Hz) (x2), 123.2 (q, 1JcF= 272.9 Hz), 119.3 (q, 'JcF= 321.8 Hz), 19F NMR (282 MHz,
CDCl3) 8 -64.2, -77.0. HRMS (EI, m/e) calcd for C9HsF6NO 2S (M+) 304.9945, found 304.9938.
FTIR (CH2Cl2) 3056, 1604, 1266, 1226, 740 cm-1. M.p. 45-46 TC.
NTf The general procedure was followed: o-tolualdehyde (308 mg, 2.56 mmol, freshly
- H distilled) and CF3SO2NSO (500 mg, 2.56 mmol) in 1,2-dichloroethane (5.0 mL).
Me Product: 302 mg (47%) as a tan, crystalline solid.
'H NMR (500 MHz, CDCI3) 8 9.46 (s, 1H), 8.13 (dd, J = 7.0, J = 1.5 Hz, 1H), 7.65 (dt,
J = 6.0 J = 1.5 Hz, 1H), 7.39 (m, 2H), 2.70 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 178.6, 144.7,
137.3, 132.7, 132.4, 129.9, 127.4, 119.4 (q, JcF = 321.3 Hz), 20.2. 19F NMR (282 MHz, C6D6) 8
-77.5. HRMS (EI, m/e) calcd for C9H9F3NO2S (M+) 251.0228, found 251.0212. FTIR (CH2CI2)
3055, 1558, 1265, 738 cm -n. M.p. 63-65 oC.
NTf The general procedure was followed: p-anisaldehyde (717 mg, 5.27 mmol)
H and CF3SO2NSO (1.03 g, 5.27 mmol) in 1,2-dichloroethane (10 mL).
MeO Product: 1.00 g (71%) as a white crystalline solid.
1H NMR (500 MHz, CDCl3) 8 9.04 (s, 1H), 8.04 (d, J = 9.0 Hz, 2H), 7.07 (d, J = 6.5 Hz,
2H), 3.96 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 178.6, 167.8, 135.9 (x2), 124.7, 144.7, 119.4
(q, 1JcF = 321.2 Hz), 56.2. '9F NMR (282 MHz, CDCl3) 8 -77.6. HRMS (El, m/e) calcd for
CgHgF3NO3S (M+), found 267.0167. F'IR (CH2C12) 3057, 1551, 1220, 824, 740 cm-'. M.p.
78-79 OC.
NTf The general procedure was followed: 2-Bromobenzaldehyde (462 mg, 2.45
-H mmol) and CF3SO2NSO (478 mg, 2.45 mmol) in 1,2-dichloroethane (5.0 mL).
Br Product: 334 mg (44%) of slightly tan, crystalline solid.
1H NMR (500 MHz, CDC13) 6 9.63 (s, 1H), 8.30 (d, J = 8.0 Hz, 1H), 7.77 (d, J = 7.5 Hz,
1H), 7.61 (dt, J = 6.0, J = 1.5 Hz, 1H), 7.52 (t, J = 8.0 Hz, 1H). 13C NMR (126MHz, CDCl3)
179.1, 138.3, 134.6, 131.7, 131.0, 130.6, 128.7, 119.3 (q, JCF = 321.3 Hz). '9F NMR (282 MHz,
C6D6) 6 -77.5. HRMS (El, m/e) calcd for CqHqF3NO2S (M+) 314.9176, found 314.9169. FTIR
(CH2C12) 3055, 1582, 1266, 739 cm-'. M.p. 44-46 oC.
NTf The general procedure was followed: 2-Naphthaldehyde (155 mg, 0.992
N I H mmol) and CF3SO2NSO (194 mg, 0.992 mmol) in 1,2-dichloroethane (2.0
mL). Product: 220 mg (77%) as a pale-yellow, crystalline solid.
'H NMR (500 MHz, CDCl3) 8 9.33 (s, 1H), 8.52 (s, 1H), 8.14 (d, J = 8.5 Hz, 1H), 8.05
(d, J = 8.0 Hz, 1H), 8.00 (d, J = 9.0 Hz, 1H), 7.96 (d, J = 8.5 Hz, 1H), 7.76 (t, J = 7.0 Hz, 1H),
7.67 (t, J = 7.5 Hz, 1H). 13C NMR (126 MHz, CDC13) 6 180.0, 139.5, 137.8, 132.7, 131.2, 130.3,
130.0, 129.4, 128.5, 128.0, 124.1, 119.4 (q, 'JcF = 321.3). 19F NMR (282 MHz, C6D6) 8 -77.8.
HRMS (El, m/e) calcd for C,2H8F3NO2S (M+) 287.0228, found 287.0214. FTIR (CH2C12) 3055,
1563, 1266, 739 cm -'. M.p. 124-126 oC.
O Table 1, entry 4. A solution of 2-bromo-3,3-dimethylbutyryl bromide (0.0775
II
C mmol, 1.0 equiv) in THF (0.3 mL) was added to a sonicated slurry of zinc powder
tButyl H
(0.252 mmol, 3.2 equiv) in THF (0.1 mL). Then, a catalytic amount of iodine dissolved in THF
(0.1 mL) was added into the reaction mixture, and the slurry was stirred at 0 *C for 1 h. Vacuum
transfer yielded the desired ketene as a clear, colorless solution, which was immediately used in
the Staudinger reaction.
The yield of ketene was quantified by quenching the vacuum-transferred solution with
propylamine (2.0 equiv) at -78 °C and warming to room temperature. The resulting mixture was
concentrated to give a white residue (62% yield).
o Table 1, entry 5. Isopropyl methyl ketene was generated in 76% yield, using theC
- same procedure as for t-butyl ketene.
i-Pr Me
Phenyl methyl ketene, phenyl ethyl ketene, phenyl isobutyl ketene, and diphenyl ketene were
synthesized according to literature procedure24 with dimethyl ethylamine as a base. In the case
of phenyl methyl ketene, diethyl ether was used as a solvent instead of THF.
2.5.3. Catalytic Enantioselective Synthesis of Trans f3-Lactams
Method A:
In a nitrogen-filled glovebox, a solution of acid bromide (1.0 equiv) in THF was added to
a Schlenk tube containing a sonicated slurry of zinc powder (3.2 equiv) in THF. Then, iodine
crystals dissolved in THF (0.1 mL) were added into the reaction mixture, and the slurry was
stirred at 0 *C for 1 h. The resulting ketene was vacuum-transferred into a Schlenk tube
containing a stirred solution of (-)-2 (0.1 equiv) and N-triflyl imine (1.1 equiv) in toluene at -78
*C. The reaction mixture was then gradually warmed to room temperature overnight, and the
desired product was purified and isolated by flash silica-gel column chromatography. The
diastereomeric ratio was determined by NMR analysis of crude material obtained from diethyl
ether extraction and subsequent silica-gel plug filtration of the reaction mixture before
purification.
Method B:
In a nitrogen-filled glovebox, dissolved N-triflyl imine (1.0 equiv) and (-)-2 (0.1 equiv)
in either toluene or dichloromethane and was cooled to 0 *C in an ice bath under a nitrogen
atmosphere. To this, ketene (1.0 equiv) dissolved in toluene solution was added over
approximately 1 min, and the syringe was rinsed with toluene. The resulting solution was
allowed to warm to room temperature while stirring overnight. The desired product was purified
and isolated by flash silica-gel column chromatography.
Method C:
In a nitrogen filled glovebox, a solution of N-triflyl imine (1.0 equiv) and (-)-2 (0.1
equiv) in a mixture of toluene/dicholoromethane and was cooled to 0 °C in an ice bath under a
nitrogen atmosphere. To this, ketene (1.0 equiv) dissolved in toluene solution was added over
approximately 1 min, and the syringe was rinsed with dichloromethane. The resulting solution
was allowed to warm to room temperature while stirring overnight. The desired product was
purified and isolated by flash silica-gel column chromatography.
0 NTable 4, entry 1. General method A was followed. A solution of 2-bromo-
~ Tf
t-Bu)ý •  3,3-dimethylbutyryl bromide (120 mg, 0.47 mmol) in THF (1.9 mL) was
added to a sonicated slurry of zinc powder (97.3 mg, 1.49 mmol) in THF (0.6
mL). Then, iodine crystals (1.80 mg, 7.10 [imol), dissolved in THF (0.6 mL), were added into
the reaction mixture and the slurry was stirred at 0 TC for 1 h. The resulting ketene was vacuum-
transferred into a Schlenk tube containing a stirred solution of (-)-2 (10.8 mg, 28.8 pmol) and
1,1,1-trifluoro-N-(phenylmethylene)-methanesulfonamide (75.1 mg, 0.32 mmol) in CH2Cl2
(12 mL) at -78 TC. The reaction mixture was then gradually warmed to room temperature
overnight, and the desired product was purified and isolated by flash silica-gel column
chromatography (2.5% EtOAc/hexanes). Yield: 51.9 mg (54%) of a slightly yellowish oil. GC
analysis: 78% ee [CP-Chirasil-Dex CB column; 140 °C (5 min), 1.0 *C/min to 170 °C; 14.37 psi
He; retention times: 14.0 min (major), 13.7 min (minor)].
Second run (same scale): Yield: 48.3 mg (50%), 77% ee.
1H NMR (500 MHz, C6D6) 8 7.01 (m, 3H), 6.92 (m, 2H), 4.73 (d, J = 3.5 Hz, 1H), 2.76
(d, J = 4.0 Hz, 1H), 0.68 (s, 9H). 13C NMR (126 MHz, CDCl3) 8 165.5, 136.0, 129.8, 129.4
(x2), 126.8 (x2), 119.3 (q, JcF = 322.5), 72.2, 61.9, 33.1, 27.1 (x3). '9F NMR (282 MHz, C6D6) 8
-77.6. FTIR (NaC1) 1823, 1410, 1211, 1145, 739 cm-'. HRMS (ESI, m/e) calcd for
C14HI6F3NO3S (M+Na) 358.0803, found 358.0703. [a]20D -73.3 (c 0.002, CH2CI2, 77% ee).
0 N Table 4, entry 2. General method A was followed. A solution of 2-bromo-N-Tf
2,3-dimethylbutyryl bromide (80.0 mg, 0.31 mmol) in THF (1.2 mL) was
Me added to a sonicated slurry of zinc powder (97.3 mg, 1.49 mmol) in THF (0.4
mL). Then, iodine crystals (0.40 mg, 1.58 imol), dissolved in THF (0.4 mL), were added into
the reaction mixture, and the slurry was stirred at 0 'C for 1 h. The resulting ketene was
vacuum-transferred into a Schlenk tube containing a stirred solution of (-)-2 (8.80 mg, 23.5
[mol) and 1,1,1-trifluoro-N-(phenylmethylene)-methanesulfonamide (61.3 mg, 0.26 mmol) in
toluene (10.4 mL) at -78 °C. The product was purified by flash silica-gel column
chromatography (10% EtOAc/hexanes). Yield: 72.9 mg (92%) of colorless oil, which solidified
upon standing. HPLC analysis: 80% ee [Daicel CHIRALCEL OJ-H column; 0.5 mL/min;
solvent system: 0.3% isopropanol/hexanes; retention times: 33.6 min (major), 20.5 min (minor)].
Second run (same scale): Yield: 77.3 mg (98%), 81% ee.
'H NMR (500 MHz, C6DA) 8 6.99 (m, 3H), 6.90 (m, 2H), 4.82 (s, 1H), 1.68 (septet,
J = 7.0 Hz, 1H), 0.68 (d, J = 7.0 Hz, 3H), 0.64 (d, J = 7.0 Hz, 3H), 0.42 (s, 3H). 13C NMR (126
MHz, CDC13) 8 169.7, 133.4, 129.2, 129.0(x2), 127.0 (x2), 119. 5 (q, VJcF = 323.0), 71.6, 67.6,
33.9, 17.9, 17.6, 12.7. 19F NMR (282 MHz, C6D6)8 -76.8. FFIR (NaCl) 1820, 1411, 1212, 740
cm- 1. HRMS (ESI, m/e) calcd for C14H16F3NO3S (M+Na) 358.0803, found 358.0693. [aI] 20D -
141.1 (c 0.003, CH 2C12, 80% ee).
0 N Table 4, entry 3. General method A was followed. A solution of 2-
bromo-3-cyclopentyl-2-methylproyryl bromide (150 mg, 0.50 mmol) in
Me toluene (1.5 mL) was added to a sonicated slurry of zinc powder
(105 mg, 1.61 mmol) in THF (0.8 mL). Then, iodine crystals (0.80 mg, 3.15 imol), dissolved in
THF (0.8 mL), were added into the reaction mixture, and the slurry was stirred at room
temperature for 1 h. The resulting ketene was vacuum-transferred into a Schlenk tube containing
a stirred solution of (-)-2 (7.80 mg, 20.6 imol) and 1,1,1-trifluoro-N-(phenylmethylene)-
methanesulfonamide (53.8 mg, 0.23 mmol) in toluene (7.7 mL) at -78 OC. The product was
purified by flash silica-gel column chromatography (10% EtOAc/hexanes). Yield as a mixture
of two diastereomers: 65.9 mg (85%) of a colorless oil. The major diastereomer was separated
(2.5% EtOAc/hexanes) as colorless oil. Yield: 27.0 mg (34%). GC analysis: 54% ee [CP-
Chirasil-Dex CB column; 140 °C (1 min), 0.5 °C/min to 180 °C; 8.33 psi He; retention times:
62.6 min (major), 63.2 min (minor)].
Second run (200 mg scale): Yield: 80.9 mg (79%) of colorless oil. The major
diastereomer yield: 39.1 mg (38%), 51% ee.
1H NMR (500 MHz, C6D6) 8 7.01 (m, 3H), 6.95 (m, 2H), 4.88 (s, 1H), 1.59 (m, 4H), 1.47
(m, 3H), 1.33 (m, 2H), 0.85 (m, 2H), 0.52 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 170.1, 133.4,
129.4, 129.0 (x2), 127.0 (x2), 119.6 (q, 1JcF = 323.0), 69.6, 62.8, 42.8, 36.5, 34.4, 34.3, 25.3,
25.1, 16.2. '9F NMR (282 MHz, C6D6) 8 -76.4. FTIR (NaCl) 2955, 1824, 1411, 1207 cm-1.
HRMS (ESI, mle) calcd for C17H 20F3NO3S (M+Na) 398.1116, found 398.1016. [a]20D -59.4 (c
0.002, CH2Cl2, 54% ee).
Table 4, entry 4. General method A was followed. A solution of 2-
bromo-2,3-dimethylbutyryl bromide (84.5 mg, 0.33 mmol) in THF
(1.3 mL) was added to a sonicated slurry of zinc powder (68.6 mg,
1.05 mmol) in THF (0.4 mL). Then, iodine crystals (0.40 mg, 1.58 [tmol),
dissolved in THF (0.4 mL), was added into the reaction mixture and the slurry was stirred at 0 °C
for 1 h. The resulting ketene was vacuum-transferred into a Schlenk tube containing a stirred
solution of (-)-2 (9.40 mg, 24.9 pmol) and 1,1,1-trifluoro-N-(4-fluorophenylmethylene)-
methanesulfonamide (70.0 mg, 0.27 mmol) in toluene (11 mL) at -78 *C. The product was
purified by flash silica-gel column chromatography (2.5% EtOAc/hexanes). Yield as a mixture
of two diastereomers: 68.0 mg (77%) of a colorless oil. The major diastereomer was separated
(2% EtOAc/hexanes) as colorless oil. Yield: 44.0 mg (50%). HPLC analysis: 93% ee [Daicel
CHIRALCEL OJ-H column; 0.6 mL/min; solvent system: 0.3% isopropanol/hexanes; retention
times: 33.6 min (major), 20.5 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 68.3 mg (77%), 97%
ee. Yield of the major diastereomer: 33.6 mg (38%).
1H NMR (300 MHz, C6D6) 6 6.65 (m, 4H), 4.71 (s, 1H), 1.68 (septet, J = 6.6 Hz, 1H),
0.66 (d, J = 6.6 Hz, 3H), 0.61 (d, J=7.0, 3H), 0.36 (s, 3H). 13C NMR (126 MHz, CDCI3) 8 169.5,
163.1(d, 'JcF = 248.7), 129.3 (d, 4 JcF = 2.9), 128.8(d, 3 JCF = 8.6) (x2), 119.5 (q, 'JcF = 323.0),
116.2(d, 2JCF = 21.9) (x2), 67.0, 66.4, 33.9, 17.9, 17.6, 12.7. '9F NMR (282 MHz, C6D6) 8 -76.7,
-113.0. FTIR (NaCI) 1822, 1411, 1214, 741 cm -'. HRMS (ESI, m/e) calcd for Cl4H15F4NO3S
(M+Na) 376.0709, found 376.0595. [a]2 0D -152.7 (c 0.003, CH 2Cl2, 93% ee).
Table 4, entry 5. General method A was followed. A solution of 2-
bromo-2,3-dimethylbutyryl bromide (65.8 mg, 0.26 mmol) in THF (1.0
mL) was added to a sonicated slurry of zinc powder (53.4 mg, 0.82:Fz
mmol) in THF (0.3 mL). Then, iodine crystals (0.30 mg, 1.18 imol),
dissolved in THF (0.3 mL), were added into the reaction mixture, and the slurry was stirred at
0 TC for 1 h. The resulting ketene was vacuum-transferred into a Schlenk tube containing a
stirred solution of (-)-2 (7.30 mg, 19.4 gmol) and 1,1,1-trifluoro-N-(4-
trifluoromethylphenylmethylene)-methanesulfonamide (65.0 mg, 0.21 mmol) in toluene (8.6
mL) at -78 TC. The product was purified by flash silica-gel column chromatography (2%
EtOAc/hexanes). Yield as a mixture of two diastereomers: 68.6 mg (88%) of a colorless oil. The
major diastereomer was separated (2% EtOAc/hexanes) as colorless oil. Yield: 42.6 mg (54%).
GC analysis: 66% ee [CP-Chirasil-Dex CB column; 120 °C (2 min), 2.0 °C/min to 180 °C; 13.49
psi He; retention times: 19.4 min (major), 19.2 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 67.3 mg (86%), 67%
ee. Yield of the major diastereomer: 29.5 mg (38%).
'H NMR (300 MHz, C6D6) 8 7.23 (d, J = 8.1 Hz, 2H), 6.75 (d, J = 8.1 Hz, 2H) 4.72 (s,
1H), 1.65 (septet, J = 6.6 Hz, 1H), 0.65 (d, J = 6.9 Hz, 3H), 0.61 (d, J = 6.9 Hz, 3H), 0.28 (s, 3H).
13C NMR (126 MHz, CDCl3) 8 169.1, 137.6, 131.5 (q, 2JcF = 32.8), 127.4 (x2), 126.1 (q,
JcF= 3.4)(x2), 123.9 (q, 'JcF = 272.3), 119.5 (q, 1'JcF= 323.0), 66.8, 66.7, 33.9, 18.0, 17.6, 12.9.
'
9F NMR (282 MHz, C6D6) 8 -63.1, -76.6. FTIR (NaCl) 1824, 1413, 1266, 740 cm-'. HRMS
(ESI, m/e) calcd for C15H,5F6NO3S (M+Na) 426.0677, found 426.0580. [a]2D -112.2 (c 0.003,
CH2C12, 66% ee).
Table 4, entry 6. General method A was followed. A solution of -
bromo-2,3-dimethylbutyryl bromide (84.9 mg, 0.33 mmol) in THF (1.3
mL) was added to a sonicated slurry of zinc powder (68.8 mg, 1.05
mmol) in THF (0.3 mL). Then, iodine crystals (0.40 mg, 1.58 ýtmol),
dissolved in THF (0.4 mL), were added into the reaction mixture and the slurry was stirred at
0 'C for 1 h. The resulting ketene was vacuum-transferred into a Schlenk tube containing a
stirred solution of (-)-2 (9.40 mg, 25.0 [tmol) and 1,1,1-trifluoro-N-(4-
methoxyphenylmethylene)-methanesulfonamide (73.5 mg, 0.28 mmol) in toluene (11 mL) at
-78 TC. The product was purified by flash silica-gel column chromatography (2.4%
EtOAc/hexanes). Yield as a mixture of two diastereomers: 84.4 mg (92%) of a colorless oil.
HPLC analysis: 68% ee [Daicel CHIRALCEL AD-H column; 1.0 mL/min; solvent system: 1.0%
isopropanol/hexanes; retention times: 6.10 min (major), 5.61 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 83.0 mg (91%), 67%
ee.
1H NMR (500 MHz, C6D6) 8 6.84 (d, J = 9.0 Hz, 2H), 6.62 (d, J = 8.1 Hz, 2H) 4.83 (s,
1H), 3.32 (s, 3H), 1.70 (septet, J = 6.5 Hz, 1H), 0.71 (d, J=7.0 Hz, 3H), 0.65 (d, J = 6.5 Hz, 3H),
0.50 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 170.0, 160.3, 128.36 (x2), 125.2, 119.5 (q,
'JcF= 323.0), 114.4 (x2), 67.5, 66.2, 55.5, 33.9, 17.9, 17.6, 12.7. 19F NMR (282 MHz, C6D6) 8 -
76.8. FTIR (NaC1) 2970, 1819, 1410, 1266, 741 cmn-1. HRMS (ESI, m/e) calcd for
C15H18F3NO4 S (M+Na) 388.0909, found 388.0801. [a]20oD -117.9 (c 0.003, CH 2C12, 68% ee).
Table 4, entry 7. General method A was followed. A solution of 2-bromo-
2,3-dimethylbutyryl bromide (80.0 mg, 0.31 mmol) in THF (1.2 mL) was
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mL). Then, iodine crystals (0.40 mg, 1.58 [tmol), dissolved in THF (0.4 mL),
were added into the reaction mixture, and the slurry was stirred at 0 TC for 1 h. The resulting
ketene was vacuum-transferred into a Schlenk tube containing a stirred solution of (-)-2
(8.80 mg, 23.5 ltmol) and 1,1,1-trifluoro-N-(2-methylphenylmethylene)-methanesulfonamide
(65.0 mg, 0.26 mmol) in toluene (10.4 mL) at -78 TC. The product was purified by flash silica
column chromatography (10% EtOAc/hexanes). Yield as a mixture of two diastereomers: 76.8
mg (94%) of a colorless oil.
Second run (same scale): Yield as a mixture of two diastereomers: 80.0 mg (97%).
'H NMR (500 MHz, C6D6) 8 6.96 (m, 3H) 6.84 (m, 1H), 5.26 (s, 1H), 1.86 (s, 3H), 1.69
(septet, J = 6.5 Hz, 1H), 0.81 (d, J = 6.5 Hz, 3H), 0.76 (d, J = 11.2, 3H), 0.52 (s, 3H). 13C NMR
(126 MHz, CDC13) 8 169.5, 135.7, 131.3, 130.9, 129.1, 127.0, 126.4, 119.4 (q, 'Jc = 322.5),
67.6, 63.8, 34.4, 19.9, 18.5, 18.0, 13.7. 19F NMR (282 MHz, C6D6)8 -77.1. FTIR (NaCI) 1820,
1411, 1210, 1140, 1073 cm 1. HRMS (ESI, m/e) calcd for C15Hs18F3NO 3S (M+Na) 372.0959,
found 426.0580. [ct] 20 D -45.1 (c 0.003, CH2C12, 78% ee).
Table 4, entry 8. General method A was followed. A solution of 2-
bromo-2,3-dimethylbutyryl bromide (64.5 mg, 0.25 mmol) in THF
(1.0 mL) was added to a sonicated slurry of zinc powder (52.3 mg,
0.80 mmol) in THF (0.3 mL). Then, iodine crystals (0.30 mg, 1.18 p[mol),
dissolved in THF (0.3 mL), were added into the reaction mixture, and the slurry was stirred at 0
°C for 1 h. The resulting ketene was vacuum-transferred into a Schlenk tube containing a stirred
solution of (-)-2 (7.20 mg, 19.0 p[mol) and 1,1,1-trifluoro-N-(2-napthylmethylene)-
methanesulfonamide (60.0 mg, 0.21 mmol) in toluene (8.4 mL) at -78 *C. The product was
purified by flash silica column chromatography (10% EtOAc/hexanes). Yield as a mixture of
two diastereomers: 74.1mg (89%) of a colorless oil. The major diastereomer was separated (2%
EtOAc/hexanes) as colorless oil. Yield: 38.9 mg (49%). HPLC analysis: 77% ee [Daicel
CHIRALCEL AD-H column; 1.0 mL/min; solvent system: 1.0% isopropanol/hexanes; retention
times: 6.89 min (major), 6.41 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 67.8 mg (85%), 73%
ee. Yield of the major diastereomer: 53.7 mg (67%).
1H NMR (300 MHz, C6D6)8 7.54 (m, 2H), 7.49 (d, J=8.5 Hz, 1H), 7.46 (s, 1H), 7.24 (m,
2H), 7.07 (dd, J = 7.0, J = 1.5 Hz, 1H), 5.03 (s, 1H), 1.65 (septet, J = 7.0 Hz, 1H), 0.73 (d, J = 7.0
Hz, 3H), 0.72 (d, J = 7.0 Hz, 3H), 0.46 (s, 3H). 13C NMR (126 MHz, CDC13) 8 169.8, 133.6,
133.1, 130.9, 128.9, 128.2, 128.0, 127.1 (d, J = 2.6) (x2), 126.8, 123.9, 119.6 (q, 1•c = 323.0),
67.9, 66.6, 34.1, 18.0, 17.6, 12.7. 19F NMR (282 MHz, C6D6) 8 -76.3. FTIR (NaCI) 1820, 1411,
1266, 740 cm- . HRMS (ESI, m/e) calcd for C,8H, 8F3NO3S (M+Na) 408.0959, found 408.0857.
[a]20 D -123.9 (c 0.003, CH2C12, 94% ee).
O Ph Eq. 3. A THF (1.3 mL) solution of the |3-lactam from Table 4, entry
I NHTf 1 (39.0 mg, 0.12 mmol) was added to 2-bromobenzyl 
amine
t-Bu
2( 3 7 m 0 13 
mmol) The reaction 
mixture was 
st
d erri at 65 oC for
4 h and stirred overnight at ambient temperature. The resulting reaction mixture was
q
concentrated down to dryness and purified by flash chromatography (5-10% EtOAc/hexanes)
and yielded 57.0 mg (94%) of white solid.
HPLC analysis: 77% ee [Daicel CHIRALCEL AD-H column; 1.0 mL/min; solvent system: 5.0%
isopropanol/hexanes; retention times: 11.2 min (major), 23.1 min (minor)].
1H NMR (500 MHz, C6D6) 8 9.07 (d, J = 6.5 Hz, 1H), 7.22 (dd, J = 7.0, 1.0 Hz, 1H), 7.02
(m, 3H), 6.95 (m, 2H), 6.82 (m, 1H), 6.74 (dd, J = 6.0, J = 2.0 Hz, 1H), 6.66 (td, J = 6.0,
J = 1.5 Hz, 1H), 5.09 (d, J = 5.5 Hz, 1H), 4.64 (m, 1H), 4.16 (dd, J = 8.5, J = 6.5 Hz, 1H), 3.96
(dd, J = 9.5, J = 5.5 Hz, 1H), 1.43 (d, J = 2.5 Hz, 1H), 1.01 (s, 9H). 13C NMR (126 MHz,
CDCI3) 8 172.9, 140.9, 136.2, 132.9, 130.8, 129.6, 128.9 (x2), 127.9, 127.86, 125.7 (x2), 123.9,
119.2 (q, 'JcF = 320.8), 62.1, 57.3, 44.0, 34.3, 29.0 (x3). 19F NMR (282 MHz, CDC13) 8 -78.3.
FTIR (NaC1) 3413, 1650, 1416, 1371, 1215, 1198 cm-1. HRMS (ESI, mle) calcd for
C21H24BrF3N203S (M+Na) 543.0643 found 545.0503. [a]2D -19.9 (c 0.001, CH2C12, 77% ee).
M.p. 89-93 TC.
Eq. 4. The 13-lactam (50.0 mg, 0.20 mmol) from Table 4, entry 7 was
deprotected [TiCl3 (4.0 equiv) and Li metal (14.0 equiv) in THF (2.5 mL) at
40 °C for 4 h] to determine the enantiomeric excess. The reaction is
quenched with 5% K2CO3 (1.0 mL) in an ice bath. The mixture is diluted
with EtOAc/H20 (1:1) and filtered through a pad of Celite. The organic layer is washed with
saturated NaHCO3 and brine, dried over Na2SO4, and concentrated to obtain crude material.
Product was further purified via flash silica-gel chromatography (10-20% EtOAc/hexanes).
Yield: 25.7 mg (59%) of a white, waxy residue. GC analysis: 78% ee [Chiraldex G-TA; 140 TC
(5 min), 0.5 °C/min to 180 °C; 5.0 psi He; retention times: 21.0 min (major), 18.9 min (minor)].
Second run with P-lactam (30.0 mg, 0.120 mmol): 14.5 mg (56%), 77% ee.
'H NMR (500 MHz, C6D6) 8 7.25 (m, 1H), 7.05 (m, 2H) 6.94 (m, 1H), 6.29 (broad s,
1H), 4.29 (s, 1H), 1.90 (s, 3H), 1.80 (septet, J = 6.5 Hz, 1H), 1.06 (d, J = 11.0 Hz, 3H), 1.05 (d,
J = 10.5 Hz, 3H), 0.73 (s, 3H). 13C NMR (126 MHz, C6D6) 6 173.8, 137.8, 135.5, 130.8, 127.8,
127.0, 126.7, 65.2, 56.7, 33.6, 19.9, 19.2, 18.7, 14.6. FTIR (NaCL) 3401, 1758. 1266. 896, 740
cm-'. HRMS (ESI, m/e) calcd for C14HI9NO (M+H) 218.1467, found 218.1548. [a]2D -23.0 (c
0.002, CH2C12, 77% ee).
0 NP Table 6, entry 1. General method B was followed. 1,1,1-Trifluoro-N-NTf
: (phenylmethylene)-methanesulfonamide (56.4 mg, 0.24 mmol) and (-)-2
Et |" (8.90 mg, 23.8 lmol) were dissolved in toluene (11 mL) and cooled to
-78 °C under a nitrogen atmosphere. To this, a phenyl ethyl ketene (34.8 mg, 0.24 mmol),
dissolved in toluene (1.2 mL), was added over approximately 1 minute, and the syringe was
rinsed with toluene (0.3 mL). The resulting solution was allowed to warm to room temperature
while stirring overnight. The product was purified by flash silica column chromatography (5-
10% EtOAc/hexanes). Yield as a mixture of two diastereomers: 54.3 mg (60%) of colorless oil.
The major diastereomer was separated (2.5% EtOAc/hexanes) as colorless oil. Yield: 36.6 mg
(40%). HPLC analysis: 68% ee [Daicel CHIRALCEL AD-H column; 0.5 mL/min; solvent
system: 1.0% isopropanol/hexanes; retention times: 10.7 min (major), 9.92 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 54.0 mg (59%).
Yield of the major diastereomer: 33.0 mg (36%), 65% ee.
1H NMR (500 MHz, C6D6) 67.22 (m, 2H), 6.99-7.09 (m, 8H), 5.23 (s, 1H), 1.51 (qq, J =
7.0, J = 7.5 Hz, 1H), 0.99 (qq, J = 7.0, J = 8.0 Hz, 1H), 0.45 (t, J = 7.0 Hz, 3H). 13C NMR (126
MHz, CDCl3) 6 167.7, 137.1, 132.7, 129.7, 129.5 (x2), 129.1 (x2), 128.5, 127.3 (x2), 126.1 (x2),
119.5 (q, IJCF= 323.0), 71.2, 69.7, 27.4, 8.69. '9F NMR (282 MHz, C6D6) 6-76.1. FTIR (NaC1)
1818, 1413, 1266, 1212, 740 cm 1. HRMS (ESI, m/e) calcd for C18H16F3NO3S (M+Na)
406.0803, found 406.0682. [a]20D -104.0 (c 0.003, CH2C12, 68% ee).
NTf 
Table 
6, entry 
2. General 
method 
B was 
followed. 
1,1,1-Trifluoro-N-
1,, (phenylmethylene)-methanesulfonamide 
(47.4 mg, 0.20 mmol) and (-)-2
O
7( 50 mg 20.0 pmol) were dissolved in CH2 2 (10.2 mL) and was cooledto 0 'C under a nitrogen at osphere. To this, phenyl methyl ketene (26.4 mg, 0.20 mmol),
dissolved in CH2C12 (1.0 mL), was added over approximately 2 min, and the syringe was rinsed
with CH2C12 (0.3 mL). The product was purified by flash silica column chromatography (5-20%
EtOAc/hexanes). Yield: 60.9 mg (82%) of a milky oil. GC analysis: 79% ee [CP-Chirasil-Dex
CB column; 170 'C (10 min), 0.5 °C/min to 180 'C; 9.17 psi He; retention times: 27.0 min
(major), 27.4 min (minor)].
Second run (same scale): Yield: 62.3 mg (84%), 83% ee.
'H NMR (500 MHz, C6D6) 8 7.21-7.19 (m, 2H), 7.01-7.05 (m, 6H), 6.94 (m, 2H) 5.24 (s,
1H), 0.83 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 168.3, 139.2, 132.8, 129.7 (x2), 129.2 (x2),
128.6 (x2), 127.0 (x2), 125.4 (x2), 119.5 (q, 1 cCF = 323.5), 71.3, 65.9, 20.4. '9F NMR (282 MHz,
C6D6) 8 -76.2. FTIR (NaCI) 1821, 1413, 1213, 1146 cm-'. HRMS (ESI, m/e) calcd for
C17HI4F3NO3 S (M+Na) 392.0803, found 392.0525. [a]20D -99.7 (c 0.003, CH2CI2, 79% ee).
4Tf 
Table 
6, entry 
3. General 
method 
B was 
followed. 
1,1,1-Trifluoro-N-
,, (phenylmethylene)-methanesulfonamide (68.1 mg, 0.29 mmol) and (-)-2
O
8 .01< mg 28.7 pmol) were dissolved in CH (12.1 mL) and stirred atroom temperature under a nitrogen atm spher . To this, isobutyl phenyl ketene (50.0 mg, 0.29
mmol), dissolved in CH2Cl 2 (1.9 mL), was added over approximately 1 min, and the syringe was
rinsed with CH2C12 (1.1 mL). The product was purified by flash silica column chromatography
(2.5-10% EtOAc/hexanes). Yield: 87.8 mg (74%) of a colorless oil.
Second run (same scale): Yield: 83.0 mg (70%).
'H NMR (500 MHz, C6D6) 8 7.28 (m, 2H), 7.08-6.99 (m, 8H), 5.23 (s, 1H), 1.48 (dd, J =
7.5, J = 6.5 Hz, 1H), 1.28 (m, 1H), 1.17 (dd, J = 4.5, J = 10.0 Hz, 1H), 0.66 (d, J = 6.5 Hz, 3H),
0.22 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, C6D6) 8 167.6, 138.5, 133.4, 129.9 (x2), 129.8,
129.3 (x2), 128.7, 128.68, 127.9 (x2), 126.5 (x2), 72.1, 69.9, 42.7, 25.0, 24.2, 23.3. '9F NMR
(282 MHz, C6D6) 8 -75.9. FTIR (NaC1) 1816, 1413, 1266, 739 cm -1. HRMS (ESI, m/e) calcd
for C20H2oF3NO3S (M+Na) 434.1116, found 434.1016. [a]20D -65.3 (c 0.002, CH2C12).
The 13-lactam (46.5 mg, 0.11 mmol) was reduced to the alcohol [1.0 M LiAlH 4 (3.0
equiv) in THF] to determine the enantiomeric excess. Yield: 38.0 mg (81%) white, waxy
residue. HPLC analysis: 63% ee [Daicel CHIRALCEL AD-H column; 1.0 mL/min; solvent
system: 1.0% isopropanol/hexanes; retention times: 27.6 min (major), 25.4 min (minor)].
Second run: 63% ee.
Alcohol: 'H NMR (500 MHz, C6D6) 8 7.31 (d, J = 7.5 Hz, 2H), 7.25 (m, 4H), 7.16-7.08
(m, 4H), 4.99 (s, 1H), 3.61 (d, J = 11.0 Hz, 1H), 3.23 (d, J = 11.0 Hz, 1H), 1.42 (dd, J = 9.5, J =
4.5 Hz, 1H), 1.26 (broad s, 1H), 1.00 (m, 1H), 0.84 (dd, J = 8.0, J = 6.0 Hz, 1H), 0.42 (broad s,
1H), 0.38 (d, J = 6.5 Hz, 3H), 0.36 (d, J = 8.0 Hz, 3H). 13C NMR (126 MHz, CDC13) 8140.3,
138.0, 128.8 (x4), 128.4(x2), 128.3, 127.9 (x2), 127.3, 119.1 (q, 1JcF = 320.8), 67.9, 65.0, 50.2,
46.4, 25.0, 24.9, 24.5. 19F NMR (282 MHz, CDCl3) 8 -78.6. FTIR (NaC1) 3605, 1423, 1266,
1199, 1229, 740 cm -1. HRMS (ESI, m!e) calcd for C20H24F3NO3S (M+Na) 438.1429, found
438.1334. [a]20D -1.0 (c 0.003, CH 2Cl2 , 63% ee).
Table 6, entry 4. General method C was followed. 1,1,1-Trifluoro-
N-[(4-fluorophenyl)methylene]-methanesulfonamide (50.0 mg, 0.20
rmmol) and (-)-2 (7.40 mg, 19.6 ýtmol) were dissolved in a mixture
of CH2Cl2 (4.6 mL) and toluene (4.3 mL) and cooled to 0 oC under a
nitrogen atmosphere. To this, phenyl methyl ketene (25.9 mg, 0.20 mmol), dissolved in toluene
(1.0 mL), was added over approximately 1 min, and the syringe was rinsed with CH2C12 (0.7
mL). The product was purified by flash silica column chromatography (10% EtOAc/hexanes).
Yield: 63.2 mg (83%) of colorless oil. HPLC analysis: 87% ee [Daicel CHIRALCEL AD-H
column; 1.0 mL/min; solvent system: 1.0% isopropanol/hexanes; retention times: 7.68 min
(major), 6.72 min (minor)].
Second run (same scale): Yield: 64.0 mg (84%), 83% ee.
1H NMR (500 MHz, C6D6) 8 7.15 (m, 2H), 7.06 (m, 3H), 6.69 (m, 4H), 5.13 (s, 1H), 0.78
(s, 3H). 13C NMR (126 MHz, CDCl3) 8 168.1, 163.4(d, 'JcF = 250.0 Hz), 139.0 (x2), 129.8 (x2),
128.9(d, 3 JCF = 8.7 Hz) (x2), 128.7, 125.3 (x2), 119.5 (q, 'J = 323.7 Hz), 116.4(d, 2 CF = 21.9 Hz)
(x2), 70.7, 65.9, 20.4. 19F NMR (282 MHz, C6D6) 8 -76.2, -112.3. FTIR (NaCl) 1822, 1414,
1213 cm-'. HRMS (ESI, m/e) calcd for C17H13F4NO3S (M+Na) 410.0552, found 410.0460. [cx]20 D
-105.5 (c 0.003, CH2C12, 87% ee).
Table 6, entry 5. General method C was followed. 1,1,1-Trifluoro-
N-[(4-trifluoromethylphenyl)methylene]-methanesulfonamide (60.0
mg, 0.20 mmol) and (-)-2 (7.40 mg, 19.7 lmol) were dissolved in a
C F::3
mixture of CH 2CI2 (4.6 mL) and toluene (4.2 mL) and cooled to 0 'C
under a nitrogen atmosphere. To this, phenyl methyl ketene (26.0 mg, 0.20 mmol), dissolved in
toluene (1.0 mL), was added over approximately 1 min, and the syringe was rinsed with CHzCl 2
(0.6 mL). The product was purified by flash silica column chromatography (2.5%
EtOAc/hexanes). Yield: 70.8 mg (82%) of colorless oil. HPLC analysis: 68% ee [Daicel
CHIRALCEL AD-H column; 1.0 mL/min; solvent system: 1.0% isopropanol/hexanes; retention
times: 6.63 min (major), 6.06 min (minor)]. The enantiomeric excess can be further improved by
crystallization of the racemate from pentane where mother liquor is enriched with desired
product. Yield: 54.9 mg (64%), 89% ee.
Second run (same scale): Yield: 66.0 mg (77%), 70% ee. Further purification yields
56.2 mg (65%), 84% ee.
'H NMR (500 MHz, C6D6) 8 7.27 (d, J = 8.5 Hz, 2H), 7.13 (m, 2H), 7.06 (m, 3H), 6.78
(d, J = 8.0 Hz, 2H), 5.12 (s, 1H), 0.70 (s, 3H). 13C NMR (126 MHz, CDCl3) 6 167.7, 138.6,
136.9, 131.9(q, 2JcF = 32.8 Hz), 129.9 (x2), 128.9, 127.5 (x2), 126.3(q, 3jCF = 4.0 Hz) (x2), 125.3
(x2), 123.9 (q, 'JCF = 272.3 Hz), 119.5 (q, 1 cCF = 323.7 Hz), 70.5, 66.2, 20.3. '9F NMR (282
MHz, C6D6) 8 -63.1, -76.1. FI'IR (NaCl) 1825, 1420, 1266, 740 cm -'. HRMS (ESI, m/e) calcd
for Ca8HI3F6NO3 S (M+Na) 460.0520, found 460.0423. [a]20D -87.3 (c 0.003, CH2Cl2, 89% ee).
Table 6, entry 6. General method B was followed. 1,1,1-Trifluoro-
N-(4-methoxy-phenylmethylene)-methanesulfonamide (50.0 mg,
0.19 mmol) and (-)-2 (7.00 mg, 18.7 [tmol) were dissolved in
toluene (8.5 mL) and was cooled to 0 °C under a nitrogen
atmosphere. To this, phenyl methyl ketene (24.7 mg, 0.19 mmol), dissolved in toluene (0.9 mL),
was added over approximately 1 min, and the syringe was rinsed with toluene (0.4 mL). The
resulting solution was allowed to warm to room temperature while stirring overnight. The
product was purified by flash silica column chromatography (2.5% EtOAc/hexanes). Yield as a
mixture of two diastereomers: 56.0 mg (75%) of a pale yellow oil. HPLC analysis: 81% ee
[Daicel CHIRALCEL AS-H column; 0.5 mL/min; solvent system: 1.0% isopropanol/hexanes;
retention times: 16.8 min (major), 18.0 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 57.6 mg (77%), 83%
ee.
'H NMR (500 MHz, C6D6) 6 7.23 (m, 2H), 7.06 (m, 2H), 7.02 (m, 1H), 6.88 (m, 2H),
6.64 (m, 2H), 5.24 (s, 1H), 3.24 (s, 3H), 0.92 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 168.5,
160.6, 139.4, 129.7 (x2), 128.5, 128.5 (x2), 125.3 (x2), 124.5, 119.5 (q, 'JcF = 323.7), 114. 6
(x2), 71.3, 65.8, 55.5, 20.5. '9F NMR (282 MHz, C6D6) 8 -75.9. FTIR (NaCI) 3057, 1819, 1412,
1265, 740 cm-1. HRMS (ESI, m/e) calcd for C,8H,6F3NOS (M+Na) 406.0803, found 406.0681.
[a]20D -23 (c 0.003, CH2C12, 81% ee).
Table 6, entry 7. General method B was followed. 1,1,1-Trifluoro-N-(2-
methyl-phenylmethylene)-methanesulfonamide (55.8 mg, 0.22 mmol) and
(-)-2 (8.40 mg, 22.2 tmol) were dissolved in toluene (10 mL) and cooled
to 0 'C under a nitrogen atmosphere. To this, phenyl methyl ketene (29.3
mg, 0.22 mmol), dissolved in toluene (1.1 mL), was added over approximately 2 min, and the
syringe was rinsed with toluene (0.6 mL). The resulting solution was allowed to warm to room
temperature while stirring overnight. The product was purified by flash silica column
chromatography (5% EtOAc/hexanes). Yield as a mixture of two diastereomers: 75.7 mg (89%)
of a colorless oil. The major diastereomer was separated (2.5-5% EtOAc/hexanes) as colorless
oil. Yield: 52.1 mg (61%). HPLC analysis: >99% ee [Daicel CHIRALCEL AD-H column; 1.0
mL/min; solvent system: 1.0% isopropanol/hexanes; retention times: 13.7 min (major), 15.8 min
(minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 75.6 mg (89%).
Yield of the major diastereomer: 50.2 mg (59%), >99% ee.
'H NMR (500 MHz, C6D6) 8 7.32 (m, 1H), 7.19 (m, 2H), 6.94-7.05 (m, 5H), 6.79 (m,
1H), 5.58 (s, 1H), 1.64 (s, 3H), 0.88 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 169.0, 138.4, 135.9,
131.2 (x2), 129.7 (x2), 129.3, 128.9, 126.5, 126.4, 125.5 (x2), 119.6 (q, 1'JcF= 323.7), 69.5, 65.5,
19.9, 17.5. 19F NMR (282 MHz, C6D6) 8 -76.3. FTIR (NaC1) 1820, 1414, 1266, 740 cm -1.
HRMS (ESI, m/e) calcd for C18H16F3NO3S (M+Na) 406.0803, found 406.0681. [a]20D -135.0 (c
0.003, CH 2C12, >99% ee).
Table 6, entry 8. General method C was followed. 1,1,1-Trifluoro-N-[(2-
bromophenyl)methylene]-methanesulfonamide (50.0 mg, 0.16 mmol) and
(-)-2 (5.90 mg, 15.8 ýtmol) were dissolved in a mixture of CH2CI2 (3.7
mL) and toluene (3.4 mL) and cooled to 0 'C under a nitrogen atmosphere.
To this, phenyl methyl ketene (20.9 mg, 0.16 mmol), dissolved in toluene (0.8 mL), was added
over approximately 2 min, and the syringe was rinsed with CH2C12 (0.5 mL). The product was
purified by flash silica column chromatography (2.5% EtOAc/hexanes). Yield as a mixture of
two diastereomers: 53.6 mg (76%) of colorless oil. The major diastereomer was separated (2.5-
5% EtOAc/hexanes) as colorless oil. Yield: 22.8 mg (32%). GC analysis: 85% ee [CP-Chirasil-
Dex CB column; 175 TC (5 min), 0.25 °C/min to 195 *C; 9.31 psi He; retention times: 39.8 min
(major), 40.3 min (minor)].
Second run (same scale): Yield as a mixture of two diastereomers: 58.1 mg (82%), 83%
ee. Yield of the major diastereomer: 20.6 mg (29%).
'H NMR (500 MHz, C6D6) 8 7.45 (m, 2H), 7.23 (dd, J = 6.0, J = 1.5 Hz, 1H), 7.11 (m,
3H), 7.03 (m, 1H), 6.81 (m, 1H), 6.58 (td, J = 6.5, J = 1.5 Hz, 1H) (m, 4H), 5.95 (s, 1H), 0.90 (s,
3H). 13C NMR (126 MHz, CDCl3) 8 168.5, 137.9, 133.8, 133.1, 130.9, 129.3 (x2), 128.9, 128.4,
128.0, 126.1 (x2), 123.1, 119.6 (q, IJc= 323.0), 70.4, 66.5, 18.1. 19F NMR (282 MHz, C6D6) 8-
76.2. FTIR (NaCI) 1823, 1415, 1266, 740 cm-'1 . HRMS (ESI, m/e) calcd for C17H13 BrF3NO3S
(M+Na) 469.9752, found 469.9650. [a]20D -138.2 (c 0.003, CH2C12, 85% ee).
Table 6, entry 9. General method B was followed. 1,1,1-Trifluoro-N-
(2-napthylmethylene)-methanesulfonamide (50.0 mg, 0.17 mmol) and
(-)-2 (6.50 mg, 17.4 [tmol) were dissolved in CH2C12 (8.0 mL) and
cooled to 0 'C under a nitrogen atmosphere. To this, phenyl methyl
ketene (23.0 mg, 0.17 mmol) dissolved in CH2C12 (0.9 mL) was added over approximately 2 min,
and the syringe was rinsed with CH2C12 (0.3 mL). The resulting solution was allowed to warm to
room temperature while stirring overnight. The product was purified by flash silica column
chromatography (10% EtOAc/hexanes). Yield: 56.0 mg (77%) of colorless oil. HPLC analysis:
93% ee [Daicel CHIRALCEL OD-H column; 0.5 mL/min; solvent system: 1.0%
isopropanol/hexanes; retention times: 15.0 min (major), 21.0 min (minor)].
Second run (same scale): Yield: 54.3 mg (74%), 94% ee.
'H NMR (500 MHz, C6D6) 8 7.59-7.49 (m, 4H), 7.27-7.24 (m, 3H), 7.13-7.04 (m, 5H),
5.44 (s, 1H), 0.88 (s, 3H). 13C NMR (126 MHz, CDCl3) 8 168.3, 139.3, 133.8, 133.2, 130.2,
129.8 (x2), 129.2, 128.7, 128.3, 128.1, 127.3, 127.28, 126.9, 125.4 (x2), 123.8, 119.6 (q, IJcF=
323.0), 71.5, 66.1, 20.4. 19F NMR (282 MHz, C6D6) 8 -76.2. FTIR (NaCI) 1821, 1413, 1215,
739 cm -1. HRMS (ESI, mle) calcd for C2,H, 6F3NO3S (M+Na) 442.0803, found 442.0692. [a]20D
-68.8 (c 0.003, CH2C 2, 93% ee).
Table 6, entry 10. General method B was followed. 1,1,1-Trifluoro-N-
(phenylmethylene)-methanesulfonamide (56.7 mg, 0.24 mmol) and (-)-2
(9.00 mg, 23.9 [tmol) were dissolved in CH2C12 (11 mL) and cooled to 0 *C under a nitrogen
atmosphere. To this, diphenyl ketene (46.4 mg, 0.24 mmol) dissolved in CH2C12 (1.2 mL) was
added over approximately 3 min, and the syringe was rinsed with CH2C12 (0.4 mL). The product
was purified by flash silica column chromatography (10% EtOAc/hexanes). Yield: 60 mg (60%)
of milky oil. HPLC analysis: >99% ee [Daicel CHIRALCEL OD column; 1.0 mL/min; solvent
system: 5.0% isopropanol/hexanes; retention times: 4.90 min (major), 5.74 min (minor)].
Second run (same scale): Yield: 65.0 mg (63%), 97% ee.
1H NMR (500 MHz, C6DA) 6 7.46 (m, 2H), 7.02 (m, 2H), 6.96 (m, 1H) 6.88-6.80 (m,
7H), 6.68 (m, 3H), 5.95 (s, 1H). 13C NMR (126 MHz, CDCl3) 8 166.4, 138.4, 135.4, 132.9,
129.5 (x3), 128.7, 128.6 (x2), 128.58(x2), 128.01 (x2), 127.97, 127.8 (x2), 126.9 (x2), 119. 3 (q,
JcF =323.0), 74.9, 70.7. '9F NMR (282 MHz, C6D6) 8 -76.4. FTIR (NaCl) 1814, 1414, 1266,
739 cm -'. HRMS (ESI, m/e) calcd for C22HI6F3NO3S (M+Na) 454.0803, found 454.0692. [t]20D
-25.9 (c 0.003, CH2Cl2, >99% ee).
F Eq 5. A solution of LiAlH4 (1.0 M in THF; 0.16 mL; 3.0 equiv) was added to
a solution of the 3-lactam (20.0 mg, 51.5 mmol; 87% ee) in THF (0.7 mL).
The resulting mixture was heated to 50 'C for 3 h. Then, it was then cooled to
HO NTf 0 °C, and the reaction was quenched by the addition of 1 N NaOH (200 mL).
Ph Me H
The resulting slurry was dried over MgSO 4 and filtered. The filtrate was
concentrated, and the residue was purified by column chromatography (40% Et20/hexanes),
which furnished the alcohol as a colorless film (15.9 mg, 79%).
The ee of the product was determined by trifluoroacetylating (trifluoroacetic anhydride)
the alcohol. GC analysis: 88% ee [CP-Chirasil-Dex CB column; 175 oC (5 min), 0.25 °C/min to
195 ooC; 9.31 psi He; retention times: 23.0 min (major), 22.7 min (minor)].
Second run (same scale): Yield: 15.0 mg (74%), 88% ee.
'H NMR (500 MHz, CDCl3) 8 7.49 (m, 2H), 7.43 (m, 2H), 7.34 (m, 1H), 7.26 (m, 2H),
7.05 (m, 1H), 6.77 (d, J = 8.0 Hz, 1H), 5.01 (d, J = 8.0 Hz, 1H), 4.15 (dd, J = 8.0, J = 3.0 Hz,
1H), 3.79 (dd, J = 8.0, J = 2.5 Hz, 1H), 2.01 (s, 1H), 1.26 (s, 1H), 1.16 (s, 3H). 13C NMR (126
MHz, CDCl3) 8 162.6 (d, 1JCF = 247 Hz), 141.8, 130.0 (d, 3 JcF = 8.1 Hz), 129.1, 128.5, 127.7,
127.1, 119.3 (q, 'JcF = 321 Hz), 115.4 (d, 2 JcF = 21.9 Hz), 67.2, 66.3, 46.7, 23.7. FTIR (NaC1)
3608, 3055, 1266, 742 cm'1. HRMS (ESI, m/e) calcd for C17H17F4NNaO3S (M+Na) 414.0757,
found 414.0757. [a]20D-1.45 (c 0.75, CH2Cl2, 88% ee).
F Eq 6. A 1 N solution of KOH (374 mL, 0.38 mmol) was added to a solution
of the P-lactam (72.4 mg, 0.19 mmol; 79% ee) in ethanol (1.5 mL). The
O resulting mixture was heated to reflux for 2 h and then stirred at room
HO . NTf temperature overnight. It was then cooled to 0 *C, and the reaction was
Ph Me H
quenched by the addition of a solution of 1 N HCI (400 mL). The product
was extracted with MTBE, and the organic layer was washed with saturated NaHCO3 and brine,
dried over Na2SO4, and concentrated, furnishing a waxy, white solid (68.4 mg, 90%).
The ee of the product was determined by reducing the acid to the alcohol (excess 1.0 M
LiAlH 4 in THF at room temperature), and then trifluoroacetylating the alcohol (trifluoroacetic
anhydride). GC analysis: 80% ee [CP-Chirasil-Dex CB column; 175 *C (5 min), 0.25 *C/min to
195 'C; 9.31 psi He; retention times: 23.0 min (major), 22.7 min (minor)].
Second run (P-lactam: 30.0 mg, 78% ee): Yield: 28.8 mg (92%), 79% ee.
'H NMR (500 MHz, C6D6) 87.60 (m, 4H), 7.38 (m, 2H), 7.28 (m, 1H), 7.10 (m, 2H11),
4.97 (broad s, 1H), 3.27 (s, 1H), 1.25 (s, 3H). 13C NMR (126 MHz, CDCI3) 8 172.0, 162.3 (d,
1JcF = 248 Hz), 142.0, 133.3, 129.6, 128.6, 127.6, 127.0, 119.2 (q, ' JcF = 322 Hz), 114.9 (d, 2 JcF
= 22.4 Hz), 65.6, 56.4, 21.3. 19F NMR (282 MHz, CD3OD) 8 -80.2, -117.2. FTIR (NaCl) 3574,
1607, 1397, 1369, 1266, 1228, 1203, 740 cm -'. HRMS (ESI, m/e) calcd for C17Hs15F4NNaO4S
(M+Na) 428.0658, found 428.0550. [a]20D +42 (c 0.25, CH2Cl2, 79% ee).
S Eq 7. A solution of the P-lactam (21.0 mg, 56.9 mmol; 79% ee) in
NTf THF (0.7 mL) was added to 2-bromobenzylamine (11.6 mg, 62.5
H
mmol). The reaction mixture was stirred at 40 C for 4 h and then at
room temperature overnight. The resulting mixture was concentrated and purified by flash
chromatography (5-10% EtOAc/hexanes), which furnished 31.0 mg (98%) of a white solid.
HPLC analysis: 79% ee [Daicel CHIRALCEL AD-H column; 1.0 mL/min; solvent system:
10.0% isopropanol/hexanes; 
retention times: 6.68 min (major), 10.7 min (minor)].
Second run (same scale; 0-lactam: 83% ee): Yield: 28.8 mg (91%), 83% ee.
'H NMR (500 MHz, CDC13) 8 8.53 (d, J = 8.5 Hz, 1H), 7.54 (dd, J = 7.5, J = 1.0 Hz, 1H),
7.41-7.20 (m, 11H), 6.35 (m, 1H), 4.75 (d, J = 8.5 Hz, 1H), 4.63 (dd, J = 8.5, J = 6.0 Hz, 1H),
4.49 (dd, J = 9.0, J = 6.0 Hz, 1H), 1.41 (s, 3H). 13C NMR (126 MHz, CDC13) 8 175.0, 141.4,
137.7, 136.3, 133.1, 131.1, 129.8, 129.1, 128.6, 128.55, 128.48, 128.0, 127.9, 126.6, 124.0, 119.1
(q, IJcv = 321 Hz), 67.4, 54.1, 44.5, 25.0. FTIR (NaC1) 3456, 3054, 1649, 1421, 1265, 739 cm - '.
HRMS (ESI, m/e) caled for C24H22BrF3N2NaO 3S (M+Na) 577.0379, found 577.0346. [a]2 0 D -
7.1 (c 0.19, CH2Cl2, 79% ee). M.p. 166-167 'C.
• NH Eq 8. Lithium metal (4.40 mg, 0.640 mmol) was combined with TiCl3
PhI. (14.1 mg, 91.4 mmol) in THF (1.2 mL) in a Schlenk tube, and the
Me resulting mixture was heated to reflux for 30 min. The solution was
CF3 allowed to cool, and then a solution of the P-lactam (20.0 mg, 45.7 mmol;
89% ee) in THF (0.6 mL) was added slowly. The resulting mixture was heated at 40 'C for 3 h
and then at room temperature for 12 h. The mixture was then cooled in an ice bath and quenched
with 5% K2CO3 (1.0 mL). A 1:1 mixture of Et2O/H20 (1.0 mL) was added, and then the reaction
mixture was filtered through a pad of Celite. The organic layer was separated, washed with
saturated NaHCO3 and brine, dried over Na2 SO 4 , and concentrated. The product was purified by
flash chromatography (20-50% Et20/hexanes). Yield: 11.9 mg (85%) of cloudy oil.
HPLC analysis: 90% ee [Daicel CHIRALCEL AD-H column; 1.0 mL/min; solvent system: 10%
isopropanol/hexanes; retention times: 10.5 min (major), 8.85 min (minor)].
Second run (same scale; P-lactam: 89% ee): Yield: 11.3 mg (81%), 90% ee.
'H NMR (500 MHz, C6D6) 8 7.48 (m, 2H), 7.33 (d, J = 8.5 Hz, 2H), 7.20 (m, 2H), 7.10
(m, 1H), 6.73 (d, J = 8.5 Hz, 2H), 5.08 (broad s, 1H), 4.23 (s, 1H), 0.91 (s, 3H). 13 C NMR (126
MHz, CDCl3) 6 172.4, 141.6, 141.3, 130.7 (q, 2JCF = 32.8 Hz), 129.2, 127.7, 127.0, 126.02,
125.98 (q, 3 JCF = 4.0 Hz), 123.3 (q, JCF = 328 Hz), 64.7, 63.4, 20.0. FTIR (NaC1) 3251, 2927,
1762. 1326. 740 cm-'. HRMS (ESI, m/e) calcd for Cl7H14F3NNaO (M+Na) 328.0920, found
328.0911. [a] 20D -9.2 (c 0.21, CD2C12, 90% ee).
ONTf  Eq 14. N-Benzylidene-1,1,1-trifluoromethanesulfonamide (3.20 mg, 13.3 mmol)
H Ph and (-)-2 (5.00 mg, 13.3 mmol) were dissolved in CDzCl2 (0.5 mL).
Ocatalyst
3
1H NMR (400 MHz, CD2C12, -27 OC) 8 9.11 (d, J = 7.4 Hz, 1H), 7.18 (m, 5H), 6.42 (s, 1H), 5.91
(d, J = 7.4 Hz, 1H), 4.55 (d, J = 2.3 Hz, 1H), 4.35 (d, J = 2.2 Hz, 1H), 3.99 (dd, J = 5.8, J = 2.9
Hz, 1H), 3.82 (m, 2H), 3.68 (m, 1H), 3.54 (m, 1H), 2.19 (m, 1H), 2.12 (m, 3H), 1.67 (s, 15H).
13C NMR (126 MHz, CD 2C12, r.t.) 6 128.9, 128.3, 126.7, 119.6 (q, 'Jc = 327 Hz), 93.7, 81.4,
79.4, 77.2, 66.3, 64.6, 51.4, 26.7, 25.0, 10.1, 1.3. 19F NMR (282 MHz, CD2Cl2) 8 -79.4.
Chart 1 and 2. Kinetics Experiment
Standard Condition: Reaction with 1 equivalent of ketene and 1 equivalent of imine
N-Benzylidene-1,1,1-trifluoromethanesulfonamide (4.74 mg, 20.0 mmol) and (-)-2 (750 [g, 2.00
jimol) in CD 2C12 (1.0 mL) were combined at -20 *C. After 15 min at -20 °C, phenyl methyl
ketene (2.64 mg, 20.0 mmol) in CD2C12 (0.1 mL) was added while maintaining the temperature
at -20 0C. The reaction was monitored over 6 h at -20 °C, taking data points every 15 min.
Reaction with 2 equivalent of ketene and 1 equivalent of imine
Standard conditions were used except with phenyl methyl ketene (5.29 mg, 40.0 mmol), which
was added as a solution in CD 2Cl2 (0.1 mL).
Reaction with 1 equivalent of ketene and 2 equivalent of imine
N-Benzylidene-1,1,1-trifluoromethanesulfonamide (9.48 mg, 40.0 mmol) was used.
Chart 4. a-Secondary Kinetic Isotope Effects
a-Deuterated N-benzylidene-1,1,1-trifluoromethanesulfonamide (4.74 mg, 20.0 mmol) and (-)-2
(750 tg, 2.00 [mol) in CD2Cl2 (1.0 mL) were combined at -20 °C. After 15 min at -20 °C,
phenyl methyl ketene (2.64 mg, 20.0 mmol) was added as a solution in CD2C12 (0.1 mL) while
maintaining -20 *C. Reaction was monitored over 6 h at -20 "C, taking data points every 15
mm.
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Chapter 3
Asymmetric Synthesis of Tertiary a-Chloroesters Catalyzed by a Planar-
Chiral Nucleophilic Catalyst
109
3.1 Introduction
There has been rejuvenation in the use of chiral a-chlorocarbonyl containing compounds
as building blocks in organic synthesis in recent years. This motif is attractive as subsequent
derivatizations can yield a wide variety of chiral, carbonyl-containing targets.' Studies on
developing novel methods to access compounds such as these via asymmetric catalysis have
focused on three main areas: a) the at-halogenation of readily enolizable carbonyl compounds
mediated by a chiral Lewis acid,2 b) the a-halogenation of chiral zwitterionic enolates obtained
from a nucleophile and a ketene, 3 c) organocatalytic a-halogenation via a chiral enamine
intermediate.4
While these reports provide methods that allow access to various secondary a-
chlorocarbonyl compounds, syntheses of tertiary a-chlorocarbonyl compounds are noticeably
rare.' Tertiary a-chlorocarbonyl compounds are not only used as key intermediates in medicinal
chemistry,6 but are also found in potent pharmaceutical compounds.7
Previous examples of constructing tertiary a-chlorocarbonyl compound include a
benzoylquinine (BQ) catalyzed method developed by Bartoli9 where trichloroquinolinone is used
as a chlorinating reagent (eq 1). However, this method is limited to diketones and ketoesters.
O.Oo
MeO0 0 N(BQ) 0 0
R R" (N R' (1)
I , Cl  44-90 % yields51-96 % ee
Cl
Another method that generates tertiary a-chloro P-ketoesters uses a Ti catalyst, developed by
Togni (eq 2).2a Again this method is limited to a ketoester backbone, and only moderate
stereochemical purity is observed.
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O 0 Ti(TADDOL*)CI2pyridine
R OR" Cl-I-_Cl
R' I
Ar
0 0
R OR"
CI R'
37-83 % yields
10-71 % ee
Yamamoto 2c developed a Zr-mediated reaction that yields cyclic a-chloroketones. This method
utilizes a novel chiral chlorinating reagent; however, a stoichiometric amount of the chiral
chlorinating agent is used and superstoichimetric Zr is required and the method is limited to
cyclic silyl enol ethers (eq 3).
OSiR3  ZrCl 4  0Ph .Ph >90 % yieldsCl-source 'CI 31-87 % ee
0 0
Cl-source = 
`o"
Ar I CI Ar
Ar = 1-naphthalyl
Analogous to our strategy, Lectka3 has used ketene chemistry to install the chloro-
substituent at the a-position of carbonyl-containing compounds in the presence of a chiral
nucleophile (eq 4). This method uses perchlorinated quinone as a chlorinating agent and
produces secondary a-chloroesters in good yields (40-81%) and excellent ee (80-99%).
MeO
0 O (BQ)
R Cl Base
R C-O
H
BQ
0
40-81 % yields (4)
80-99 % ee
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Due to the limited existing methods for accessing tertiary a-chlorocarbonyl compounds,
our aim was to create a general catalytic method for the synthesis of tertiary cc-chlorocarbonyl
compounds using chiral nucleophilic catalysis (eq 5).
chiral
nucleophilic 0
-c R + Cl-R catalyst R1 R (5)= R ( )
Ar CI Ar
3.2 Results and Discussion
3.2.1. Reaction Optimization
The initial reaction screening was performed by Dr. Kevin McCauley. In our early
studies on the synthesis of a-chlorocarbonyl compounds via the reaction of a ketene and
electrophilic chlorinating reagent, we examined the reaction of phenyl ethyl ketene with various
chlorinating agents under a range of conditions (entries 1-4 of Table 1).8 In the presence of
PPY*, the use of reagents such as N-chlorosuccinimide, 4b 2,9 and 33a provided the product in poor
yield and/or ee (entries 1 and 2). On the other hand, the reaction of phenyl ethyl ketene with
hexachloroacetone1 ° cleanly furnished the desired enol ester with promising enantioselectivity
(57% ee; entry 3). Hexachloroacetone is an inexpensive and commercially available chlorinating
reagent that is relatively underutilized as an electrophilic chlorinating reagent. 1a,b We
hypothesized that using a similar chlorinating agent to hexachloroacetone, but with more rigidity
built into the backbone, might improve the enantioselectively. This proved to be the case as
demonstrated by the reaction of phenyl ethyl ketene with 2,2,6,6-tetrachlorocyclohexanone1 I
catalyzed by PPY* (86% yield and 94% ee; entry 4). To the best of our knowledge, this is the
first example of the use of 2,2,6,6-tetrachlorocyclohexanone as a chlorinating reagent in
asymmetric catalysis.
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Table 1. Effect of Reaction Parameters on the Catalytic Asymmetric Synthesis of Tertiary a-
Chloroesters.
0'IO C Et
Ph
5% (-)-PPY*
toluene
-7Q or' t r +
o .L.1.2 equiv -I!•VL L1.2 equiv "standard conditions"
I
entry change from the "standard conditions"
1 N-chlorosuccinimide or 2, instead of 1
2 3, instead of 1
3 hexachloroacetone, instead of 1
4 none
5 (-)-4, instead of (-)-PPY*
6 benzoylquinine, instead of (-)-PPY*
7 r.t., instead of -78 °C to r.t.
8 CH2C 2, instead of toluene
9 THF, instead of toluene
O
o Et
Cl CIl Ph
1:t Cl
yield (%)
<5
40
96
86
46
<5
45
17
<5
ee (%)
8
57
88
26
11
All data are the average of two runs.
Ph Fe Ph
Ph Phh
Ph
(-)-4
Me Fe Me
Me Me
Me
(-)-PPY*
Other attempts to improve the yield and enantioselectivity included the use of (-)-4,
which possesses a bulkier bottom ring relative to PPY*. However, in a reaction that utilized (-)-
4, a lower yield and enantioselectivity were obtained (entry 5). Additionally, the use of
benzoylquinine12 afforded essentially none of the desired product (entry 6). Upon conducting the
chlorinations at higher temperature (entry 7) or in other solvents (entries 8 and 9), poor yields
and ee were observed. In the absence of a catalyst, no reaction between phenyl ethyl ketene and
2,2,6,6-tetrachlorocyclohexanone was observed.
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3.2.2. Asymmetric Synthesis of Tertiary a-Chloroesters Catalyzed by (-)-PPY*
After determining the best reaction conditions for the chlorination of phenyl ethyl ketene,
we next examined the scope of this method, and we determined that the best enantioselectivities
were obtained when the ketene substituents are unhindered (Table 2). It was found that a lower
catalyst loading (3 mol%) could be employed relative to the initial screening conditions (5
mol%). Additionally, the reaction rate was rapid: most reactions were complete within 3 hours
at -78 *C. It was also determined that the catalyst can be recovered during the purification step
in approximately 60% yield.
Thus, reactions of phenyl alkyl ketenes in which the alkyl group was Me, Et, or i-Bu
proceeded with good enantiomeric excess (entries 1-2, 4), whereas modest ee was observed in
the case of a-branched alkyl substituents (entry 3 and 5). Similarly, if the aryl group was ortho-
substituted, the chlorination occurred with only moderate enantioselectivity (entry 8). On the
other hand, reactions of meta- and para-substituted aryl ketenes (entries 7, 9 and 10) and of a
heteroaryl ketene (entry 6) as well as naphthalyl ketene (entry 11) generally proceeded with
acceptable levels of asymmetric induction in the ranges of 72-95% ee.
Table 2. Catalytic Asymmetric Synthesis of Tertiary a-Chlorocarbonyl Compounds
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3.0% (-)-PPY*
toluene and/or Et20
-78 °C
0
OR
CI CICArCl l lI
1:t Cl
entry Ar R ee (%) yield (%)
1 Ph Me 91 74
2 Ph Et 94 86
3 Ph i-Pr 47 83
4 Ph i-Bu 85 76
5c  Ph Cyp 65 79
6 3-thiophenyl i-Bu 83 62
7 4-CIC 6H5  Et 82 82
8 o-tolyl Et 67 90
9 m-tolyl Et 95 88
10 3-OMeC 6H5  Et 86 82
11b 6-OMe-2-Naphthyl Me 72 63
a All data are the average of two experiements. b 7.5% (-)-PPY* was used.
c Reaction conducted at -78 C.
The 4-chloro derivative (entry 7) can potentially be further functionalized by a cross-coupling
reaction of the aryl chloride. In a similar fashion, the anisole derivatives (entries 10 and 11) can
be functionalized by deprotection to the phenol and subsequently used as nucleophiles.
Fully aware that subsequent functionalization of these chlorinated enol esters was of
importance, we explored transesterification conditions that would allow access to a more
common and useful ester, e.g., a methyl ester. Numerous conditions were examined, including
the use of R3SnOMe reagents that are known to induce transesterification with enol esters. 13
However, use of these types of reagents proved to be ineffective for our hindered enol esters.
We have also investigated acid catalyzed transesterification mediated either by Lewis or protic
acids, base catalyzed hydrolysis, or reduction conditions without any success. Subsequently,
mild conditions were found that allowed for the transesterification to the methyl ester by use of
methanol with K2C0 3. Unfortunately, the long reaction time (3.5 days) and moderate yield
(48%) prompted us to investigate other alternatives. Our next strategy was to oxidize the enol
alkene to generate a more reactive ester (i.e., a hemiacetalate). However, numerous oxidizing
conditions were attempted (OsO4/NMO, 03, DDQ etc.) without any success. Gratifyingly, an
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0
A IC
ArAR
1.2 equiv
acyl transfer reaction with the sterically demanding enol ester was accomplished through
activation by bromine. Thus, treatment with Br 2 and then a nucleophile furnished a methyl ester
or an alcohol (eq 6). Both reactions occurred without any erosion in stereochemical purity.
O0
Et
C,_ CII•cPh
C•
1) Br2, CH2C12  O
0OC 00- Et
MeO -2) DMAP, MeOH Ci Ph
r.t. 78%
1) Br2, CH2C12
0 o c HOC Et
2) LiBH 4, THF CI Ph
60 0C 79%
3.2.3. Mechanistic Discussion
A variety of mechanisms, two of which are illustrated in Figure 1, can be envisioned for
the PPY*-catalyzed coupling of ketenes with 2,2,6,6-tetrachlorocyclohexanone to afford tertiary
cc-chlorocarbonyl compounds. In the top pathway, the key intermediate is a chiral chlorinating
agent (N-chlorinated PPY*; ion pair A), which is formed by reaction of the catalyst with 2,2,6,6-
tetrachlorocyclohexanone. 14 Subsequently, a new ion pair (B) is produced via addition of RO- to
the ketene. Finally, Cl transfer occurs from the chiral N-chlorinated PPY* to the achiral enolate
to furnish a new stereocenter with concurrent regeneration of the catalyst.15
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RO N R2 CI-PPY* CI-PPY* C
DR B A
,ICl
III
RO
O
RR
1
- 0
+ R2PPY* R + * R2
D R1  PPY R
CD R1RI C
RO
0OCI, ],,Cl
CIC C
Figure 1. Two of the possible mechanisms for asymmetric chlorinations catalyzed by PPY*: Top: via a
chiral chlorinating agent; Bottom: via a chiral enolate.
In an alternative mechanism (bottom of Figure 1), PPY* adds to the ketene to afford a chiral
enolate (C), which then reacts with the achiral chlorinating agent to furnish a new stereocenter
(ion pair D). Acyl transfer can then occur to produce the tertiary a-chloroester with concurrent
regeneration of the catalyst. 6",7
Several observations have been made that may be relevant to understanding the
mechanism. First, the 'H NMR spectrum of the reaction between phenyl cyclopentyl ketene and
2,2,6,6-tetrachlorocyclohexanone catalyzed by PPY* at -80 'C in toluene-d8 shows that the
resting state of the catalyst during the reaction is the unbound catalyst (i.e., not N-chlorinated or
N-acylated PPY*) (Figure 2).
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Catalytic Reaction
toluene-d8
PPY* Product
, . A
DCM
ref. std
Ketene ppy,I
~J. ,;~ A~ A A.'
9 8 7 6 5 4 3 1
Co 0O0 0 C0 -0 ,( ) N KO00r
Figure 2. 1H NMR spectrum to determine the resting-state of the catalyst. The reaction was performed
as a reaction between phenyl cyclopentyl ketene, 2,2,6,6-tetrachlorocyclohexanone, and (-)-PPY* (10
mol%) at -80 to -82 °C in toluene-d8 with DCM as a reference standard.
Second, when (-)-PPY* was mixed with 2,2,6,6-tetrachlorocyclohexanone at -78 'C or at room
temperature (in the absence of a ketene), no reaction was observed by 1H NMR spectroscopy.
Third, all attempts to trap the proposed enolate of the ion pair A failed: No reaction was
observed upon addition of MeOTf, TMSOTf, TMSC1, isopropanol, or water during the
stoichiometric reaction between PPY* and 2,2,6,6-tetrachlorocyclohexanone in toluene-d. at
various different temperatures. Fourth, the enantioselectivity of the product correlated linearly
with catalyst ee, which was consistent with the presence of one catalyst molecule in the
stereochemistry-determining step of the reaction (Chart 1).18
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Chart 1. Catalyst% ee vs Product% eea
100
90
80
70
60
50
40
0 10 20 30 40 50 60
% ee of Catalyst
70 80 90 100
a This reaction was followed using m-tolyl ethyl ketene in Table 2, entry 9.
However, due to the rapid reaction rate, attempts to determine the rate law proved to be
difficult either by 'H NMR or React-IR.
Although we have not ruled out reaction via a chiral chlorinating agent (top of Figure 1),
on the basis of circumstantial evidence such as the stereochemical outcome and the reactivity
profile, the chiral-enolate pathway is currently favored (bottom of Figure 1). Specifically, (1)
The absolute stereochemistry at the a-center is the opposite of that predicted for a Bronsted acid
catalyzed reactions."5 (2) Unlike in reactions that involve Bronsted acid catalysis by protonated
PPY*, the hindered ketenes are not useful substrates for our catalytic asymmetric chlorinations.
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3.2.4. Determination of Absolute Configuration
The absolute configuration of the reaction product was established by x-ray
crystallography of a representative compound (Table 2, entry 11) that was crystallized from
ethanol at 0 °C.
3.3 Conclusions
We have developed a catalytic asymmetric method for the synthesis of tertiary a-
chloroesters that complements recent progress in the generation of secondary a-halocarbonyl
compounds. Additionally, we have demonstrated that commercially available 2,2,6,6-
tetrachlorocyclohexanone is an efficient chlorinating reagent in our reaction conditions. It has
been shown that the tertiary a-chloro enolesters are surprisingly robust; however, they can be
derivatized into useful intermediates such as methyl esters and alcohols without erosion of
enantioselectivity.
3.4 Experimental Procedures
3.4.1. General
All air- or moisture-sensitive manipulations were carried out under nitrogen with
standard syringe/Schlenk techniques or in a glovebox.
Prior to use, toluene, CH2Cl2, and Et2O were purified by passage through a neutral
alumina column under argon. 2,2,6,6-Tetrachlorocyclohexanone (Aldrich) was recrystallized
from pentane/CH 2CI2. Bromine (Alfa Aesar), methanol (anhydrous; Aldrich), lithium
borohydride (Aldrich), and DMAP (Aldrich) were used as received. PPY* was prepared and
resolved as previously reported. 9 The ketenes were prepared according to literature procedures.20
1H NMR spectra were recorded on either Varian Mercury 300 or INOVA 500
spectrometer (300 or 500 MHz) at ambient temperature. 13C NMR spectra were obtained with
complete proton decoupling on a Varian INOVA 501 spectrometer (126 MHz) at ambient
temperature.
Infrared spectra were recorded on a Perkin Elmer 1600 FT-IR spectrometer. Optical
rotations were measured on a Perkin Elmer Model 241 polarimeter.
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3.4.2. Catalytic Asymmetric Synthesis of Tertiary a-Chloroesters
General. Three solutions were prepared in a glovebox: the ketene (1.0 equiv) in a flask, (+)-
PPY* (3 mol%) in a vial, and 2,2,6,6-tetrachlorocyclohexanone (1.2 equiv) in a vial. All other
manipulations were conducted outside of a glovebox. Two solvent systems were employed:
toluene only (entries 2, 9, 10, and 11) and ~17:1 Et2O:toluene (entries 1, 3-8).
Table 2, entry 1. A solution of phenyl methyl ketene (50.0 mg, 0.38 mmol)
in Et2O (8.0 mL) was cooled to -78 oC. A solution of 2,2,6,6-
tetrachlorocyclohexanone (107 mg, 0.45 mmol) in Et2O (1.0 mL) was added
in one portion, followed by the rapid (~15 seconds) dropwise addition of a
solution of (+)-PPY* (4.3 mg, 11 [tmol) in a 1:1 mixture of Et2O and toluene (1.0 mL). The
reaction mixture was stirred at -78 TC for 45 min, and then the solvent was removed, and the
desired product was isolated by flash chromatography (5% EtOAc/hexanes). Yield: 105 mg
(76%) of a colorless oil. HPLC analysis: 90% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min;
solvent system: 15% iso-propanol/hexanes; retention times: 29.4 min (minor), 47.0 min (major)].
Second run with (-)-PPY* (same scale as above). Yield: 100 mg (72%), 91% ee.
1H NMR (500 MHz, CDCl3) 8 7.70-7.69 (m, 2H), 7.43-7.34 (m, 3H), 2.72-2.70 (m, 2H),
2.59 (t, J=6.0 Hz, 2H), 2.31 (s, 3H), 2.01-1.96 (m, 2H).
13C NMR (76 MHz, CDCl3) 8 166.6, 140.5, 139.6, 128.9, 128.8, 128.5(x2), 126.7(x2), 83.9, 69.6,
45.5, 32.8, 29.7, 20.4. FTIR (NaCl) 3063, 2942, 1772, 1447, 1130, 756, 695 cm-'. HRMS (ESI,
mle) calcd for C15H14C 4NaO2 (M+Na) 388.9640, found 388.9650. [a] 2 0D +22 (c 0.0040, CH2C12;
91% ee from (-)-PPY*).
Table 2, entry 2. A solution of phenyl ethyl ketene (70.0 mg, 0.48 mmol) in
toluene (23 mL) was cooled to 
-78 oC. A solution of 2,2,6,6-
tetrachlorocyclohexanone (136 mg, 0.58 mmol) in toluene (2.0 mL) was
da ded in one portion followed by the rapid (~15 seconds) dro 
wise addition
of a solution of (+)-PPY* (5.4 mg, 14 tmol) in toluene (2.0 mL). The reaction mixture was
121
CI,
CI1
stirred at -78 'C for 45 min, and then the solvent was removed, and the desired product was
isolated by flash chromatography (5% EtOAc/hexanes). Yield: 160 mg (87%) of a colorless oil.
HPLC analysis: 94% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-
propanol/hexanes; retention times: 27.9 min (major), 50.6 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 156 mg (85%), 94% ee.
'H NMR (500 MHz, CDCl3) 8 7.69-7.67 (m, 2H), 7.42-7.38 (m, 2H), 7.36-7.33 (m, 1H),
2.73-2.64 (m, 2H), 2.59 (t, J=6.0 Hz, 2H), 2.52 (qq, J=7.0, 7.5 Hz, 2H), 2.04-1.92 (m, 2H), 1.10
(t, J=7.0 Hz, 3H). 13C NMR (76 MHz, CDCl3) 8 166.2, 140.4, 138.1, 128.8, 128.6, 128.4(x2),
127.1(x2), 83.9, 75.4, 45.6, 34.4, 32.9, 20.4, 9.3. FTIR (NaCl) 3029, 2942, 1772, 1657, 1448,
1161,696 cm'. HRMS (ESI, m/e) calcd for Cl6Hl6C14NaO2 (M+Na) 402.9797, found 402.9806.
[a]20D -36 (c 0.0027, CH2C12 ; 94% ee from (+)-PPY*).
O Table 2, entry 3. phenyl isopropyl ketene (50.0 mg, 0.38 mmol) was
•i-Pr
O i-Pr dissolved in Et20 (8.0 mL) and tetrachlorocyclohexanone (106 mg, 0.45
CI PhCII Ph Cl mmol) was in Et2O (1.0 mL). (+)-PPY* (4.30 mg, 11.3 Rmol) was
C1
dissolved in a 1:1 mixture of Et2O and toluene (1.0 mL). The reaction
mixture was stirred at -78 TC to room temperature over 20 hrs. The desired product was purified
and isolated by flash silica column chromatography (5.0% EtOAc / hexanes). Yield: 120 mg
(81%) of a colorless oil. HPLC analysis: 45% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min;
solvent system: 15% iso-propanol/hexanes; retention times: 20.8 min (minor), 34.5 min (major)].
Second run with (-)-PPY*: same scale as above. Yield: 125 mg (84%), 49% ee.
'H NMR (500 MHz, CDCI3) 8 7.75 (m, 2H), 7.38 (m, 2H), 7.32 (m, 1H), 3.17 (septet,
J=6.5 Hz, 1H) 2.68 (m, 2H), 2.54 (m, 2H), 1.97 (m, 2H), 1.27 (d, J=8.0 Hz, 3H), 0.89 (d, J=6.5
Hz, 3H). 13C NMR (76 MHz, CDCl3) 6 166.2, 140.5, 137.3, 128.7, 128.6, 128.3(x2), 127.7(x2),
83.9, 81.4, 45.7, 36.9, 33.0, 20.5, 19.1, 17.3. FTIR (NaCl) 3061, 2942, 1771, 1655, 1447, 1158,
697 cm-'. HRMS (ESI, m/e) calcd for C,7HI8C140 2 (M+Na) 416.9961, found 416.9954. [a]20D -
20.8 (c 0.0041, CH 2C12, 44% ee with (+)-PPY*).
O Table 2, entry 4. A solution of phenyl isobutyl ketene (60.0 mg, 0.34
~i-Bu mmol) in Et2O (7.1 mL) was cooled to -78 oC. A solution of 2,2,6,6-
Cl I PhCl tetrachlorocyclohexanone (97.4 mg, 0.41 mmol) in Et2O (1.0 mL) was
Cl
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added in one portion, followed by the rapid (~15 seconds) dropwise addition of a solution of (+)-
PPY* (3.9 mg, 10 Itmol) in a 1:1 mixture of Et2O and toluene (1.0 mL). The reaction mixture
was stirred at -78 °C for 2 h, and then the solvent was removed, and the desired product was
isolated by flash chromatography (5% EtOAc/hexanes). Yield: 110 mg (78%) of a colorless oil.
HPLC analysis: 84% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-
propanol/hexanes; retention times: 7.10 min (major), 10.3 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 105 mg (74%), 85% ee.
'H NMR (500 MHz, CDC13) 8 7.70-7.69 (m, 2H), 7.41-7.32 (m, 3H), 2.74-2.64 (m, 2H),
2.62-2.56 (m, 2H), 2.55 (dd, J=5.0, 10.0 Hz, 1H), 2.42 (dd, J=5.5, 9.5 Hz, 1H), 2.10-1.94 (m,
2H), 1.87 (septet, J=5.0 Hz, 1H), 0.99 (d, J=7.0 Hz, 3H), 0.78 (d, J=6.5 Hz, 3H). 13C NMR (126
MHz, CDCl3) 8 166.5, 140.5, 138.3, 128.7, 128.5, 128.3(x2), 127.2(x2), 83.9, 74.4, 49.5, 45.7,
33.0, 25.5,24.6, 24.4,20.5. FTIR (NaCI) 3029,2958, 1770, 1699, 1447, 1182,697 cm 1. HRMS
(ESI, m/e) calcd for C18sH2Cl4NaO2 (M+Na) 431.0115, found 431.0131. [a]2D -12 (c 0.0045,
CH2Cl2; 84% ee from (+)-PPY*).
Table 2, entry 5. A solution of phenyl cyclopentyl ketene (60.0 mg,
0.32 mmol) in Et2O (6.5 mL) was cooled to -78 TC. A solution of
2,2,6,6-tetrachlorocyclohexanone (91.2 mg, 0.39 mmol) in Et20 (1.0
mL) was added in one ortion, followed by the rapid (~15 seconds)
dropwise addition of a solution of (+)-PPY* (6.1 mg, 16 pmol) in a 1:1 mixture of Et20 and
toluene (1.0 mL). The reaction mixture was allowed to slowly warm to r.t. overnight (total
reaction time: 20 h). The solvent was removed, and the desired product was isolated by flash
chromatography (5% EtOAc/hexanes). Yield: 111 mg (82%) of a colorless oil. HPLC analysis:
68% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-
propanol/hexanes; retention times: 15.6 min (major), 29.7 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 104 mg (76%), 62% ee.
1H NMR (500 MHz, CDCl3) 8 7.75-7.73 (m, 2H), 7.39-7.35 (m, 2H), 7.34-7.30 (m, 1H),
3.40 (q, J=8.0 Hz, 1H), 2.73-2.63 (m, 2H), 2.55 (t, J=6.0 Hz, 2H), 2.14-2.09 (m, 1H), 2.01-1.93
(m, 2H), 1.92-1.83 (m, 1H), 1.75-1.44 (m, 6H). 13C NMR (126 MHz, CDC13) 8 166.2, 140.5,
138.4, 128.7, 128.5, 128.3(x2), 127.6(x2), 83.9, 80.2, 47.8, 45.6, 32.9, 29.4, 28.5, 26.6, 26.3,
20.5. FTIR (NaCI) 2960, 2870, 1770, 1657, 1447, 1155, 699 cm1-'. HRMS (ESI, mle) calcd for
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C19H20C14NaO2 (M+Na) 443.0115, found 443.0129. [a] 20 D +23 (c 0.0042, CH2C12; 62% ee from
(-)-PPY*).
O Table 2, entry 6. A solution of 3-thienyl isobutyl ketene (50.0
O r-Bu mg, 0.28 mmol) in Et2O (5.2 mL) was cooled to -78 *C. A
CI CI solution of 2,2,6,6-tetrachlorocyclohexanone (78.0 mg, 0.33
CI Ar = 3-thienyl
mmol) in Et2O (1.0 mL) was added in one portion, followed by
the rapid (~15 seconds) dropwise addition of a solution of (+)-PPY* (3.1 mg, 8.3 L.tmol) in a 1:1
mixture of Et2O and toluene (1.0 mL). The reaction mixture was stirred at -78 *C for 2 h, and
then the solvent was removed, and the desired product was isolated by flash chromatography
(5% EtOAc/hexanes). Yield: 70 mg (61%) of a colorless oil. HPLC analysis: 84% ee [Daicel
CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-propanol/hexanes; retention
times: 12.8 min (major), 17.3 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 72 mg (63%), 81% ee.
1H NMR (500 MHz, CDCl3) 8 7.56 (dd, J=0.5, 1.5 Hz, 1H), 7.31 (dd, J=3.0, 2.0 Hz, 1H),
7.26 (dd, J=0.5, 4.0 Hz, 1H), 2.73-2.70 (m, 2H), 2.59 (t, J=6.0 Hz, 2H), 2.55 (dd, J=5.5, 9.5 Hz,
1H), 2.40 (dd, J=6.0, 9.0 Hz, 1H), 2.02-1.98 (m, 2H), 1.96-1.91 (m, 1H), 1.00 (d, J=7.0 Hz, 3H),
0.88 (d, J=6.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) 6 165.9, 140.5, 140.1, 128.7, 127.3, 126.0,
124.2, 83.9, 71.5, 49.3, 45.6, 33.0, 25.8, 24.4, 24.3, 20.5. FTIR (NaCI) 3116, 2958, 1772, 1658,
1440 1160, 743 cm 1'. HRMS (ESI, m/e) calcd for C,6H18Cl4NaO 2S (M+Na) 436.9782, found
436.9674. [a] 20D -15 (c 0.0025, CH 2C12; 84% ee from (+)-PPY*).
O Table 2, entry 7. A solution of 4-chlorophenyl ethyl ketene
0 1Et  (60.0 mg, 0.33 mmol) in Et2O (7.3 mL) was cooled to -78 0C.
CI CI A solution of 2,2,6,6-tetrachlorocyclohexanone (94.0 mg, 0.40
CI Ar = 4-CIC6 H4
mmol) in Et2O (1.0 mL) was added in one portion, followed by
the rapid (~15 seconds) dropwise addition of a solution of (+)-PPY* (3.7 mg, 10 p[mol) in a 1:1
mixture of Et2O and toluene (1.0 mL). The reaction mixture was stirred at -78 °C for 2 h, and
then the solvent was removed, and the desired product was isolated by flash chromatography
(5% EtOAc/hexanes). Yield: 110 mg (80%) of a colorless oil. HPLC analysis: 82% ee [Daicel
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CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-propanol/hexanes; retention
times: 15.1 min (major), 49.6 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 115 mg (83%), 82% ee.
'H NMR (500 MHz, CDCl3) 6 7.63-7.60 (m, 2H), 7.38-7.36 (m, 2H), 2.75-2.58 (m, 3H),
2.60 (t, J=6.5 Hz, 2H), 2.47 (qq, J=7.5, 7.0 Hz, 1H), 2.03-1.94 (m, 2H), 1.08 (t, J=7.5 Hz, 3H).
13C NMR (126 MHz, CDCl3) 8 165.8, 140.4, 136.8, 134.7, 128.9, 128.7(x2), 128.6(x2), 83.9,
74.7, 45.6, 34.3, 32.9, 20.4, 9.2. FTIR (NaCI) 2941, 1773, 1658, 1491, 1161, 750 cm'. HRMS
(ESI, m/e) calcd for C16HI5ClsNaO2 (M+Na) 436.9407, found 436.9427. [a]'D -27 (c 0.0039,
CH2C12; 82% ee from (+)-PPY*).
O Table 2, entry 8. A solution of o-tolyl ethyl ketene (50.0 mg, 0.31 mmol)
Oi% Et in Et2O (6.7 mL) was cooled to -78 °C. A solution of 2,2,6,6-
C1 CI' o-tolylCGl 1'l  tetrachlorocyclohexanone (88.0 mg, 0.38 mmol) in Et2O (1.0 mL) was
CI
added in one portion, followed by a solution of (+)-PPY* (3.5 mg, 9.4
[mol) in a 1:1 mixture of Et2O and toluene (1.0 mL). The reaction mixture was stirred at -78 oC
for 3 h, and then the solvent was removed, and the desired product was isolated by flash
chromatography (5% EtOAc/hexanes). Yield: 110 mg (89%) of a colorless oil. HPLC analysis:
68% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-
propanol/hexanes; retention times: 19.7 min (major), 37.7 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 112 mg (90%), 65% ee.
1H NMR (500 MHz, CDCl3) 67.73-7.71 (m, 1H), 7.27-7.20 (m, 3H), 2.80-2.63 (m, 4H),
2.57 (t, J=6.5 Hz, 2H), 2.52 (s, 3H), 2.06-1.94 (m, 2H), 1.11 (t, J=7.0 Hz, 3H).
13C NMR (126 MHz, CDC13) 8 166.1, 140.3, 137.1, 136.0, 132.5, 128.7, 127.5, 125.9(x2), 84.1,
75.6, 45.9, 33.2, 33.1, 22.2, 20.3, 9.35. FTIR (NaC1) 2942, 1771, 1656, 1453, 1127, 740 cmx.
HRMS (ESI, mle) calcd for C17H,8C140 2 (M+Na) 416.9959, found 416.9961. [a]"D +30 (c
0.0033, CH2C12; 65% ee from (-)-PPY*).
Table 2, entry 9. A solution of m-tolyl ethyl ketene (50.0 mg, 0.31
mmol) in toluene (13.4 mL) was cooled to -78 OC. A solution of
Ar = mrn-tolyl
Cl
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2,2,6,6-tetrachlorocyclohexanone (88.0 mg, 0.38 mmol) in toluene (2.0 mL) was added in one
portion, followed by the rapid (~15 seconds) dropwise addition of a solution of (+)-PPY* (3.5
mg, 9.4 [tmol) in toluene (2.0 mL). The reaction mixture was stirred at -78 °C for 3 h, and then
the solvent was removed, and the desired product was isolated by flash chromatography (5%
EtOAc/hexanes). Yield: 113 mg (91%) of a colorless oil. HPLC analysis: 95% ee [Daicel
CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-propanol/hexanes; retention
times: 14.3 min (major), 23.0 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 105 mg (85%), 94% ee.
'H NMR (500 MHz, CDCl3) 8 7.49-7.45 (m, 2H), 7.29-7.25 (m, 1H), 7.16-7.14 (m, 1H),
2.75-2.64 (m, 3H), 2.58 (t, J=6.0 Hz, 2H), 2.48 (qq, J=7.0, 7.5 Hz, 1H), 2.37 (s, 3H), 2.03-1.94
(m, 2H), 1.09 (t, J=7.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) 8 166.3, 140.4, 138.0, 129.3,
128.8, 128.2, 127.9(x2), 124.1, 84.0, 75.5, 45.7, 34.5, 33.0, 21.7, 20.5, 9.3. FTIR (NaC1) 3055,
2944, 1771, 1440, 1265, 1161, 739 cm'. HRMS (ESI, m/e) calcd for C,7H,8Cl4NaO2 (M+Na)
416.9954, found 416.9971. [a]2 0D -35 (c 0.0011, CH2C12; 95% ee from (+)-PPY*).
Table 2, entry 10. A solution of m-methoxyphenyl ethyl
ketene (50.0 mg, 0.28 mmol) in toluene (11.7 mL) was
cooled to -78 TC. A solution of 2,2,6,6-
Ar = 3-(MeO)C 6H4
tetrachlorocvclohexanone (80.0 mg, 0.34 mmol) in toluene
(2.0 mL) was added in one portion, followed by the rapid (~15 seconds) dropwise addition of a
solution of (+)-PPY* (3.2 mg, 8.5 [mol) in toluene (2.0 mL). The reaction mixture was stirred
at -78 TC for 3 h, and then the solvent was removed, and the desired product was isolated by
flash chromatography (5% EtOAc/hexanes). Yield: 96 mg (82%) of a colorless oil. HPLC
analysis: 87% ee [Daicel CHIRALCEL OJ column; 0.9 mL/min; solvent system: 15% iso-
propanol/hexanes; retention times: 24.8 min (major), 48.7 min (minor)].
Second run with (-)-PPY* (same scale as above). Yield: 95 mg (81%), 85% ee.
'H NMR (300 MHz, CDCl3) 8 7.30-7.22 (m, 3H), 6.89-6.87 (m, 1H), 3.83 (s, 3H), 2.73-
2.64 (m, 3H), 2.58 (t, J=6.3 Hz, 2H), 2.53-2.47 (m, 1H), 2.20-1.94 (m, 2H), 1.09 (t, J=7.2 Hz,
3H). 13C NMR (126 MHz, CDCl3) 8 166.2, 159.6, 140.4, 139.6, 129.4, 128.8, 119.4, 114.2,
113.2, 83.9, 75.2, 55.6, 45.6, 34.5, 33.0, 20.4, 9.3. FTIR (NaC1) 2942, 1771, 1601, 1433, 1161,
126
CI.
697 cm-'. HRMS (ESI, m/e) calcd for C17H18Cl4NaO3 (M+Na) 432.9908, found 432.9917. [af]D
+20 (c 0.0025, CH2C12; 85% ee from (-)-PPY*).
Table 2, entry 11. 6-methoxy-2-naphthyl methyl
ketene (60.0 mg, 0.28 mmol) was dissolved in toluene
Ar = 6-OMe-2-naphthyl (11.7 mL) and tetrachlorocyclohexanone (80.0 mg,
Ar = 6-OM-2-naphthyl0.34 mmol) was in toluene (2.0 m. (+)-PPY* (8.000.  L). )-P~P
mg, 21.2 [tmol) was dissolved in toluene (2.0 mL). The reaction mixture was stirred at -78 'C to
room temperature over 20 hrs. The desired product was purified and isolated by flash silica
column chromatography (100% CH2C12). Yield: 81 mg (64%) of colorless oil. HPLC analysis:
73% ee [Daicel CHIRALCEL AS-H column; 1.0 mL/min; solvent system: 1% iso-
propanol/hexanes; retention times: 12.9 min (major), 19.1 min (minor)].
Second run with (-)-PPY*: same scale as above. Yield: 78 mg (61%), 70% ee.
'H NMR (500 MHz, CDCI3) 8 8.07 (d, J=2.0 Hz, 1H), 7.79-7.72 (m, 3H), 7.18 (dd, J=2.5,
J=6.5 Hz, 1H), 7.14 (d, J=2.5 Hz, 1H), 3.84 (s, 3H), 2.70 (m, 2H), 2.59 (m, 2H), 2.41 (s, 3H),
1.99 (m, 2H). 13C NMR (126 MHz, CDCl3) 8 166.7, 158.6, 140.6, 134.8, 134.5, 130.2, 128.9,
128.3, 127.2, 125.5, 125.4, 119.5, 105.7, 83.9, 70.0, 55.6, 45.6, 32.9, 29.6, 20.5. FTIR (NaCI)
3055, 2987, 1712, 1266, 896, 742 cmn '. HRMS (ESI, m/e) calcd for C20H18C140 3 (M+Na)
468.9902, found 468.9896. [a]20D -7.2 (c 0.00050, CH 2Cl 2, 70% ee (-)-PPY*).
O Eq 5, transesterification. The enol ester (39.0 mg, 0.10 mmol; 94% ee) was
MeO) Et dissolved in CH2Cl2 (2.0 mL), and the resulting solution was cooled to 0 *C.
Cl Ph
Bromine (5.2 [lL, 0.10 mmol) was added, and the reaction mixture was stirred at
0 'C for 2 h. The solvent was removed, and then the residue was dissolved in MeOH (1.5 mL).
DMAP (37.0 mg, 0.31 mmol) was added, and the mixture was stirred for 20 h at r.t. The desired
product was purified by flash chromatography (10% EtOAc/hexanes). Yield: 17 mg (78%) of a
colorless oil. GC analysis: 93% ee [CP-Chirasil-Dex CB column; 100 *C (2 min), 1.0 °C/min to
120 'C; 12.62 psi He; retention times: 20.2 min (major), 20.5 min (minor)].
Second run: same scale as above. Yield: 17 mg (78%), 94% ee.
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1H NMR (300 MHz, CDCJ3) 8 7.51-7.48 (m, 2H), 7.48-7.36 (m, 3H), 3.78 (s, 3H), 2.51
(sextet, J=6.9 Hz, 1H), 2.39 (sextet, J=6.9 Hz, 1H), 0.99 (t, J=7.5 Hz, 3H). 13C NMR (126 MHz,
CDCl3) 8 171.3, 139.6, 128.6(x2), 128.5, 126.4(x2), 75.8, 53.6, 34.9, 9.4. FTIR (NaCI) 2953,
1738, 1447, 1248, 697 cm -1. HRMS (ESI, m/e) calcd for C1,H13CINaO 2 (M+Na) 235.0496,
found 235.0504. [a]20D -23 (c 0.00050, CH2C12; 93% ee).
HO/- •Et Eq. 5, reduction. The enol ester (50.0 mg, 0.13 mmol; 93% ee) was dissolved in
C( Ph CH 2C12 (2.5 mL), and the resulting solution was cooled to 0 TC. Bromine (6.7 [LL,
0.13 mmol) was added, and the reaction mixture was stirred at 0 TC for 2 h. The solvent was
removed, and then the residue was dissolved in THF (2.5 mL). LiBH4 (29.0 mg, 1.31 mmol) was
added, and the mixture was stirred for 5 h at 60 *C. The reaction mixture was cooled to 0 °C,
and then water (1 mL) was added. The product was extracted with EtOAc (3 x 30 mL), and the
combined extracts were dried over MgSO4. The desired product was isolated by flash
chromatography (25% EtOAc/hexanes). Yield: 19 mg (79%) of a colorless oil. HPLC analysis:
92% ee [Daicel CHIRALCEL OD-H column; 1.0 mL/min; solvent system: 1% hexanes/hexanes;
retention times: 17.0 min (minor), 18.8 min (major)].
Second run: same scale as above. Yield: 19 mg (79%), 94% ee.
1H NMR (300 MHz, C6D6) 8 7.38-7.35 (m, 2H), 7.11-6.99 (m, 3H), 3.70 (dd, J=6.0, 5.7
Hz, 1H), 3.61 (dd, J=6.0, 7.2 Hz, 1H), 2.09 (sextet, J=7.2 Hz, 1H), 1.97 (sextet, J=7.2 Hz, 1H),
1.52 (t, J=6.6 Hz, 1H), 0.79 (t, J=7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) 8 140.3, 128.6(x2),
128.0, 127.1(x2), 71.4, 66.1, 33.2, 9.1. FTIR (NaC1) 3398, 2974, 1494, 1445, 1055, 698 cm-'.
HRMS (ESI, m/e) calcd for Co10H13CINaO (M+Na) 207.0547, found 207.0554. [a]20D -7.1 (c
0.0015, CH2C12; 92% ee).
Chart 1. Product% ee vs Catalyst% ee.
The procedure was followed for m-tolyl ethyl ketene. Catalyst with 26% ee furnished a-
chloroester with 26% ee (85% yield). Catalyst with 55% ee furnished a-chloroester with 53% ee
(81% yield). Catalyst with 75% ee furnished a-chloroester with 70% ee (87% yield).
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3.6. 1H NMR for Selected Compounds
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Chapter 4
Catalytic Asymmetric Synthesis of a-Aminoesters via Copper-Catalyzed
N-H Insertion Reactions
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4.1 Introduction
Developing efficient methods for the synthesis of optically active a-amino carboxylic
acid derivatives is of considerable importance in organic chemistry and biology. Optically active
phenylglycine and its derivatives are not only versatile chiral building blocks in organic
synthesis, but they are also fundamental to peptide and protein synthesis. Moreover, optically
active unnatural a-amino acids are now routinely incorporated into protein synthesis to
understand the mechanism of biological processes. 2 As a result, a great deal of effort has been
devoted to the preparation of a- and 3-amino acids in enantiomerically pure form of either
configuration. 3
In recent decades, metal-mediated carbenoid reactions have gained wide application in
synthetic organic chemistry. Many of these studies focused on cyclopropanation reactions, X-H
(X= C, N, O, Si, S) insertion reactions, and ylide formation followed by subsequent
rearrangement reactions to afford a diverse set of products.4 Although remarkable advances have
been made in the area of asymmetric C-H insertion reactions, 5 relatively few advances have been
made in the area of asymmetric insertion into N-H bonds.6
Following the first report on the catalytic N-H insertion reaction in the presence of copper
by Yates,7 a diasteroselective copper-catalyzed N-H insertion reaction has been reported.6a The
first example of a catalytic asymmetric N-H insertion catalyzed by copper was reported by
Jorgensen (eq 1 ),6f where in the presence of ethyl a-diazoester and aniline, the product was
generated in moderate yield (75%) and poor ee (26%). This method lacks generality since only
one example (i.e., ethyl a-diazoester and aniline) was reported.
-PhN2  .NH2 10 mol% CuPF 6  HN'PhOEt . OEt (1)Me
O
Me
75% yield
26% ee
R=2,4-dimethylphenyl
More recently, a significant improvement of this method was demonstrated by Zhou (eq
2 ).6g In this report, a diverse set of aniline derivatives were inserted into ethyl a-diazoester,
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catalyzed by a copper/chiral bisoxazoline complex. Products were generated in good yield (51-
96%) and excellent ee (8-98%, where most of the examples were >90% ee).
5.0 mol% CuCI HN,Ar
N2  6.0 mol% NaBARF HN
MeW OEt Ar-NH 2 -- Me OEt (2)
0 o
51-96% yield
8-98% ee
20 examples
6.0 mol%
In addition, diastereoselective N-H insertion reactions using rhodium have also been
documented. 6b-e Finally, Jorgensen reported a silver-catalyzed asymmetric N-H insertion reaction
(eq 3 ).6f This method afforded product in poor yield (5%) and moderate ee (48%). Again, a
single example was described.
N2 PhMe2OEt K rNH2 10 mol% AgOTf H..N.•.OEt (3)MeAY) OEt (3II Me
O0
5% yield
S 48% ee
10 mol%
Although these examples show a tremendous advance toward the synthesis of optically
active a-amino carbonyl containing compounds, these methodologies are limited to aniline based
amine insertions. Hence, obtaining free a-amino carbonyl compounds from these sets of
products is challenging.8
More recently, our laboratory has developed the first effective method for catalytic
enantioselective insertion into O-H bonds using a copper/(+)-BISAF catalyst (eq 4).9 This
reaction afforded products in high yield (88-98%) and good ee (21-98%). Furthermore, the
insertion product was deprotected to provide the a-hydroxy ester in high yield without
racemization.
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N2
Ar _)<OMe R10-H
O R'1 = CH2CH2TMS
2.0% Cu(OTf)23.8% (+)-BISAF
4.0% H20
CICH2CH2CI
r.t.
OR,
Ar _ OMe
0
21-98% ee
88-98% yield
OHBF3*OEt 2  OHCH2 0I2  Ar OMe (4)CH2Cl2 A
r.t. O
98% yield
Ar = Ph
Our aim was to develop a general catalytic system for the synthesis of a-amino carbonyl
compounds using an ca-diazoester and a protected amine source (that can readily be deprotected)
in the presence of a metal and a chiral ligand (eq 5).
N2
Ar R
0
M/L*
R'(H)N-H MD.
RI = protecting group
for an amine
N(H)R1
Ar R
O
4.2 Results and Discussion
4.2.1. Reaction Optimization
Initially, we examined several reaction parameters including various metals, chiral
ligands and different protected amines. These parameters were varied simultaneously in order to
determine the optimal conditions for the reaction of a protected amine with a diazoester species.
We chose methyl a-diazo-a-phenyl-ester and tert-butyl carbamate (BocNH2) as model substrates
for the optimization screening (eq 6). The choice of methyl a-diazo-a-phenyl-ester is based
upon the fact that it lacks a 3-proton, which is known to lead to unwanted side products in
certain metal-catalyzed processes.6f BocNH 2 was chosen for its ability to be readily cleaved with
acid to afford free a-amino acids.
N2
N OMe
141
BocNH 2
4.0 mol% M
6.0 mol% L*
DCE
0.08 M
r.t.
NHBoc
OMe (6)
or0
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We began our investigation by screening metal/chiral ligand systems such as Cu, Ag, and
Rh in combination with chiral ligands such as diphosphines, diamines, diimines, amino alcohols,
Pybox, P-N ligands, semicorrins and bisoxazoline ligands.
Me Me
Me Me Me Me
Me Me Me Me
Me[ Me MeFeFe i:e
I I
Me Fe Me Me Fe Me
Me Me (-)-BISAF Me , Me (-)-Bpy*
Me Me
Figure 1. Planar-chiral ligands used in the synthesis of a-aminoesters.
In the presence of rhodium(I) and a variety of different ligands, acceptable yields of
product (>70%) were observed; however, enantioselectivities were <5%. After screening
various copper and ligand combinations, an initial promising result (Table 1) was obtained with
CuPF6(CH3CN)4 and a planar-chiral bisazaferrocene ligand (BISAF, Figure 1), where 67% ee
was observed (entry 1). Additionally, the effect of copper(I) counter anion appeared to play an
important role in this reaction. Copper complexes that contained strongly coordinating anions
yielded inferior enantioselectivities (entries 2-6); however, the use of CuPF6/(-)-BISAF provided
product in 67% ee. Interestingly, (-)-BISAF was also compatible with silver(I) salts, generating
the product in 73% ee (entries 7-9). As indicated before, there is only a single example in the
literature of a catalytic asymmetric N-H insertion reaction that is mediated by silver, and the
product was generated in moderate ee (48%) and poor yield (5 %).6f We decided to screen copper
salts with other non-coordinating anions. The use of CuCI or CuCl2 in conjunction with AgSbF 6
gave an improvement in ee to 79% (entries 11-12). However, further optimization of this
reaction proved to be difficult. In most cases, the reaction seemed to be extremely rapid at room
temperature, i.e., the reaction was completed in <30 min.
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Table
N2
OMe
S0
1. Initial Screening of Metals with (-)-BISAF
4.0 mol% M NHBoc
6.0 mol% (-)-BISAF
BocNH 2  _ OMe
DCE
0.08 M 0
r.t.
entry M ee (%)
1 CuPF6(CH3CN) 4  67
2 Cu(OTf) 2  11
3 CuOTf*benzene 5
4 CuOAc -
5 CuCI 0
6 CuCl2  0
7 AgSbF6  69
8 AgPF6  73
9 AgAsF6  70
10 AgCl -
al 1 CuCl2/AgSbF 6  79bl 2  CuCI/AgSbF 6  73
a Cu/Ag ratio was 1:2. b Cu/Ag ratio
was 1:1.
Subsequently, we postulated that the use of a more rigid ligand would help in improving
enantioselectivity. Hence, the use of a 2,2'-bipyridyl based planar-chiral ligand (Bpy*, Figure 1)
under the same reaction conditions as described in Table 1, entry 12 provided desired product in
80% ee and 75% yield. Again, we examined several metal sources (CuCl, CuBr, or Cul in
conjunction with AgSbF6, AgAsF6, or AgPF6) along with the (-)-Bpy* ligand and determined
that the combination of CuBr and AgSbF6 with (-)-Bpy* as the ligand provided the most
consistent results.
In order to improve upon the yield and ee of our preliminary lead, we examined the
dependence of the insertion reaction on the steric nature of the diazoester (Table 2). A general
increase in stereoselectivity was observed when the ester group was increased in size (Table 2,
entries 2-4), with the tert-butyl ester furnishing the highest yield and ee. In addition, 1.5
equivalents of diazoester was necessary to generate the products in acceptable yield (>70%).
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Table 2. Copper-Catalytic N-H Insertions: Reaction Parameters.
7.0% CuBr
N2  6.0% AgSbF6  BocHN
A OR' 8.0% (-)-Bpy* A
Boc-NH2  ArAr CICH 2CH2CI0 r.t., 30 min
1.5 equiv
R1= t-Bu
1, H OR1
0
entry change from standard condition yield (%)ab ee (%)a
1 none 74 94
2 R1 = Me instead of t-Bu 70 70
3 R'1 = i-Pr instead of t-Bu 69 84
4 R'1 = Bn instead of t-Bu 81 77
5 no BPy* 72 0
6 7.0% CuBr alone instead of NR -
7 7.0% AgSbF6 alone instead of 15 86
8 7.0% CuPF6(CH3CN) 4 alone intead of 51 39
9 6.0% AgOTf instead of AgSbF6  78 87
10 8.0% of 1 instead of BPy* 72 0
11 8.0% of BISAF instead of BPy* 63 <6
12 0 OC o/n instead of r.t. 46 76
13 THF instead of CICH 2CH2CI 59 69
14 Benzene instead of CICH 2CH2CI NR -
a Average of two experiments. b Isolated yields.
The effect of further modification of the reaction parameters on the yield and ee for the
copper catalyzed coupling of BocNH2 with tert-butyl a-diazo-a-phenyl-ester were investigated
(Table 2). In the absence of the (-)-Bpy* ligand, we observed a significant background reaction,
in which 0% ee was observed (entry 5). Under the standard reaction conditions, but in the
absence of AgSbF6 (i.e., reaction catalyzed only by CuBr and (-)-Bpy* ligand), there was no
product formation (entry 6). Finally, in the absence of CuBr (i.e., reaction catalyzed only by
AgSbF6 and (-)-Bpy* ligand), a significant decrease in yield (15%), yet a high ee (86%) was
observed (entry 7). These results highlight the importance of the use of two metals in our
optimized reaction condition. It is our hypothesis that the actual metal species that is catalyzing
the reaction is the "CuSbF6". In contrast, when CuPF6(CH3CN)4 was used instead of the CuBr
and AgSbF6 combination, an unsatisfactory yield and ee were observed (entry 8). In the
presence of CuBr and AgOTf, product was obtained with inferior stereoselectivity, and no
stereoselectivity was observed by the use of chiral bisoxazoline (1) or (-)-BISAF ligands (entries
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10-11). Insertion reactions that were conducted either at lower temperature (entry 12) or in other
solvents, i.e., THF or benzene, afforded either low ee or no product (entries 13-14).
4.2.2. Copper/(-)-Bpy*-Catalyzed Asymmetric Synthesis of a-Aminoesters
Copper/(-)-Bpy*-catalyzed insertions into the N-H bond of BocNH2 proceeded in good
yield (48-89%) and ee (80-95%) with range of tert-butyl at-diazoesters (Table 3).
Table 3. Copper-Cata
N2
Boc-NH 2  Ar 1  OtBu
0
1.5 equiv
entry Ar
1 Ph
2 (2-Me
3 (3-Me
4 (4-0M
5 (4-Br)
6 (4-CF
7 2-nap
8 0
lyzed N-H Insertions:
7.0% CuBr
6.0% AgSbF 6
8.0% (-)-Bpy*
CICH2CH2CI
r.t., 30 min
.)C6H4
)C6H4
e3)C6 H4CAH4y
3)C6H4
hthyl
9 3-thienyl
yield (%)a,b
75
71
75
61
86
89
73
74
48
Reaction Scope
BocHN H
ArX Ot-Bu
0
ee (%)a
94
81
88
95
85
85
91
90
80
a Average of two experiments. b Isolated yield.
Thus, substitution on the aromatic ring was tolerated at the ortho, meta, and para positions
(entries 2-6). Additionally, the aromatic ring of the diazoester can be electronically diverse
(entries 4-6), while still providing high ee's of product (> 85%). Furthermore, bicyclic
substituents also reacted well to generate product in good ee (entries 7-8) and a thiophene
derivative reacted to afford 80% ee with a modest yield (48%, entry 9).
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In addition to the use of BocNH2, we were able to demonstrate that another carbamate
derivative was tolerated using our reaction conditions. Specifically, we were able to show that
benzyl carbamate (CbzNH2) is also an effective coupling partner. Thus, this method now
provides direct access to highly useful Cbz-protected a-aminoesters. Several examples of the
reaction of CbzNH 2 with tert-butyl-a-diazoesters are included in Figure 2. Electron-rich, -poor,
and -neutral diazoesters generated products in good ee (82-95%) and yield (49-78%).
CbzHN, H
: Ot-Bu
CbzHN, H
Me N Ot-Bu
MeO 0
2 3 4
95% ee, 76%y 90% ee, 49%y 82% ee, 78%y
Figure 2. The scope of the N-H insertion reaction involving CbzNH2 with Cul(-)-Bpy*.
4.2.3. Determination of Absolute Configuration
The absolute stereochemistry of tert-butyl a-(tert-butoxycarbonylamino)-a-diazoesters
(5) was determined by correlation with (R)-tert-butyl a-(tert-butoxycarbonylamino)-a-diazoester
reported in the literature.1 o (R)-tert-Butyl a-amino-a-phenyl-ester (7) was prepared as shown in
Scheme 1. All relevant data were consistent with the reported values.1 o
Scheme 1.
7.0% CuBr
N2  6.0% AgSbF6)~~Ot.BLI 8.0% (+)-bpy
Boc-NH2 Ph' O t-Bu  8.0% (+)-bpy 10CICH 2CH 2CI
O r.t., 30 min
1.5 equiv
BocHN HPhI O t
-Bu
0
5
4.0 M HCI Dioxane/EtOAc
2.0 h, r.t.
99% yield
HCI
H2N H B 10% K2C03
Ph Ot Bu 85%
0
6
H 2N _ -BH
Ph Ot-Bu
0
7
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4.3 Conclusions
We have developed an efficient method for catalytic enantioselective insertion into N-H
bonds. Thus, a copper/Bpy* catalyst system is effective in coupling carbamates such as BocNH2
and CbzNH 2 with ct-aryl-a-diazoesters in good yield (48-89%) and ee (81-95%), after which the
Boc- or Cbz-group can be cleaved to generate a free a-amino-a-diazoester.
4.4 Experimental Procedures
4.4.1. General
All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen.
BocNH 2 was recrystallized from dichloromethane and pentane. All other chemicals were
purchased from commercial suppliers and used as received, unless noted otherwise.
Dichloroethane (anhydrous; Fluka), CuBr (Strem), AgSbF6 (Strem), CbzNH2 (Aldrich) were
used as received. Bpy* ligand was prepared and resolved as previously reported.1"
HPLC analyses were carried out on an Agilent 1100 series system with Daicel Chiralpak®
columns in hexane/isopropanol mixtures. GC analysis were carried out on an Agilent 6850
series system with CP-Chirasil-Dex CB column; 140 'C (5 min), 1.0 °C/min to 160 'C; 14.37 psi
He or Astec G-TA column; 140 'C (1 min), 1.0 °C/min to 180 'C; 14.89 psi He
Melting points were measured on a Hoover melting point apparatus and are uncorrected.
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4.4.2. Preparation of Diazo Compounds
GP 1. All of the a-diazoesters were prepared via direct diazo transfer as previously reported
using either tosyl azide or p-ABSA.9
The following diazo compounds have been previously reported: tert-butyl a-diazo-a-phenyl-
ester (CAS 72410-67-4) and tert-butyl a-diazo-a-4-methoxyphenyl-ester (CAS 76530-00-2).
N2  tert-Butyl a-diazo-act-2-naphthalenyl-ester. The compound was
Ot
-
Bu prepared according to GP 1 using tert-butyl 2-naphthalenyl-ester (843
mg, 3.48 mmol), MeCN (14 mL), DBU (0.78 mL, 5.22 mmol), and
tosyl azide (870 mg, 4.52 mmol). Product: 695 mg (74%); orange solid.
H NMR (CDC13, 300 MHz) 8 8.04 (s, 1H), 7.86-7.79 (m, 3H), 7.52-7.43 (m, 3H), 1.60 (s, 9H);
13C NMR (CDC13, 75.5 MHz) 8 164.9, 133.8, 131.5, 128.7, 127.8, 127.7, 126.7, 125.8, 123.5,
122.6, 122.1, 82.4, 28.6 (x3), the resonance of the carbon that bears the diazo group was not
detected;
IR (film) cm- 1 3055, 2987, 2306, 2088, 1696, 1422, 1266, 1148, 896,739,705.
In 1 1.
ret t- uty a-d azo-a-o-tolyl-ester. The compound was
perp ared
IBu according to GP 1 using tert-butyl o-tolyl-ester (3.10 g, 15.0 mmol), MeCN
(53 mL), DBU (4.50 mL, 30.0 mmol), and p-ABSA (5.40 g, 22.5 mmol).
Product: 1.02 g (29%); orange oil.
1H NMR (CDCl3, 300 MHz) 8 7.51-7.47 (m, 1H), 7.37-7.32 (m, 3H), 2.47 (s, 3H), 1.63 (s, 9H);
13C NMR (CDCJ3, 75.5 MHz) 8 165.5, 137.6, 130.9, 130.88, 128.7, 126.5, 124.8, 81.9, 28.6
(x3), 20.2, the resonance of the carbon that bears the diazo group was not detected;
IR (film) cm- 1 2979, 2932, 2084, 1699, 1491, 1368, 1295, 1253, 1149, 1006,.
N2  tert-Butyl a-diazo-a-m-tolyl-ester. The compound was prepared
Me . OtBu according to GP 1 using tert-butyl m-tolyl-ester (2.44 g, 11.8 mmol),
MeCN (42 mL), DBU (2.70 mL, 17.8 mmol), and p-ABSA (3.70 g, 15.4
mmol). Product: 1.33 g (47%); orange oil.
1H NMR (CDCl3, 300 MHz) 8 7.38-7.34 (m, 1H), 7.29-7.27 (m, 2H), 7.02-6.99 (m, 1H), 2.38 (s,
3H), 1.58 (s, 9H);
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13C NMR (CDCl3, 75.5 MHz) 6 164.9, 138.8, 128.9, 126.6, 126.1, 124.8, 121.2, 82.1, 28.6 (x3),
21.8, the resonance of the carbon that bears the diazo group was not detected;
IR (film) cm - 1 2979, 2931, 2084, 1701, 1605, 1492, 1369, 1344, 1290, 1249, 1143, 1055, 779.
N2
BrOtBu
Br. 0
tert-Butyl a-diazo-a-4-bromophenyl-ester. The compound was
prepared according to GP 1 using tert-butyl 4-bromophenyl-ester (1.67 g,
6.15 mmol), MeCN (28 mL), DBU (1.38 mL, 9.23 mmol), and tosyl
azide (1.54 g, 8.00 mmol). Product: 1.40 g (77%); orange solid.
1H NMR (CDCl3, 300 MHz) 8 7.48 (d, J = 9.0 Hz, 2H), 7.35 (d, J = 8.7 Hz, 2H), 1.55 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 6 164.3, 132.1 (x2), 125.5 (x2), 125.5, 119.2, 82.6, 28.6 (x3), the
resonance of the carbon that bears the diazo group was not detected;
IR (film) cm - 1 3055, 2984, 2088, 1696, 1491, 1347, 1266, 1148, 1003, 740, 705.
N2  tert-Butyl a-diazo-a-4-trifluoromethylphenyl-ester. The
OtBu compound was prepared according to GP 1 using tert-butyl 4-
F3c  0 trifluoromethylphenyl-ester (3.46 g, 13.3 mmol), MeCN (60 mL), DBU
(2.90 mL, 20.0 mmol), and p-ABSA (4.20 g, 17.3 mmol). Product: 1.45 g (38%); orange solid.
1H NMR (CDCl3, 300 MHz) 8 7.60 (s, 4H), 1.55 (s, 9H);
13C NMR (CDC13, 75.5 MHz) 6 163.9, 130.9, 127.4 (q, 2JCF= 33.0 Hz), 125.9 (q, 3JCF= 3.8 Hz),
123.6, 122.5, 82.9, 28.5 (x3), the resonance of the carbon that bears the diazo group was not
detected;
IR (film) cm-1 3055, 2987, 2094, 1699,1422, 1328, 1266, 1148, 896, 740, 705.
N2
0 -,I OtBu
and tosyl azide (1.73 g,0
and tosyl azide (1.73 g,
tert-Butyl a-diazo-a-1,3-dioxol-5-yl-phenyl-ester. The compound
was prepared according to GP 1 using tert-butyl 1,3-dioxol-5-yl-phenyl-
ester (1.64 g, 6.94 mmol), MeCN (28 mL), DBU (1.56 mL, 10.4 mmol),
9.02 mmol). Product: 489 mg (27%); orange solid.
1H NMR (CDC13, 300 MHz) 8 7.06-7.05 (m, 1H), 6.85-6.83 (m, 2H), 5.96 (s, 2H), 1.54 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 6 165.1, 148.5, 146.0, 127.8, 117.9, 109.0, 105.9, 101.4, 82.2,
28.5 (x3), the resonance of the carbon that bears the diazo group was not detected;
IR (film) cm - 1 3055, 2984, 2087, 1694, 1505, 1493, 1370, 1266, 1235, 1041, 740, 705.
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N2  tert-Butyl a-diazo-a-3-thiophenyl-ester. The compound was prepared
& orOtBu according to GP 1 using tert-butyl 3-thiophenyl-ester (4.34 g, 21.9 mmol),
MeCN (69 mL), DBU (4.90 mL, 32.8 mmol), and tosyl azide (6.80 g, 28.5
mmol). Product: 829 mg (17%); orange solid.
H NMR (CDCl3, 300 MHz) 8 7.40-7.36 (m, 2H), 7.03-7.01 (m, 1H), 5.96 (s, 2H), 1.56 (s, 9H);
13C NMR (CDCI3, 75.5 MHz) 8 165.0, 126.4, 124.6, 123.9, 117.6, 82.3, 28.6 (x3), the resonance
of the carbon that bears the diazo group was not detected;
IR (film) cm-1 3055, 2986, 2306, 2085, 1695, 1422, 1318, 1266, 1139, 896, 740, 705.
4.4.3. Preparation of a-Aryl-a-diazoesters
GP 2: Table 1 and 2
All enantioselectivities and isolated yields that are reported in Table 1 are the average of two
runs, with (+)-Bpy*.
All enantioselectivities and isolated yields that are reported in Table 2 are the average of two
runs, first one with (-)-Bpy* and second one with the other enantiomer.
General Procedure A
In a glovebox, the catalyst was prepared by mixing CuBr (1.23 mg, 8.54 mmoles), (-)-Bpy*
(6.30 mg, 9.76 mmoles), AgSbF 6 (2.52 mg, 7.32 mmoles) and dichloroethane (1.1 mL) in an
amber vial. The resulting mixture was stirred for 45 min. In a separate vial, tert-butyl a-diazo-
a-phenyl-ester (49.1 mg, 0.183 mmoles) and BocNH2 (14.3 mg, 0.122 mmoles) were dissolved
in dichloroethane (0.8 mL) and added into a vial containing the catalyst mixture via syringe over
3 min and rinsed vial with dichloroethane (0.1 mL). The reaction mixture was stirred at room
temperature for 30 min, concentrated to dryness and purified via flash column chromatography.
General Procedure B
In a glovebox, the catalyst was prepared by mixing CuBr (1.02 mg, 7.14 mmoles), (-)-Bpy*
(5.20 mg, 8.16 mmoles), AgSbF6 (2.10 mg, 6.12 mmoles) and dichloroethane (2.8 mL) in an
amber vial. The resulting mixture was stirred for 45 min. From this mixture, 0.90 mL was
withdrawn and reserved in a separate amber vial. In another separate vial, tert-butyl a-diazo-
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a-phenyl-ester (22.3 mg, 0.102 mmoles) and CbzNH2 (16.0 mg, 0.102 mmoles) were dissolved
in dichloroethane (0.56 mL) and added into a vial containing the catalyst mixture via syringe
over 3 min. Dichloroethane (0.10 mL) was used to rinse the vial. This reaction mixture was
allowed to stir for 5 min, and then the reserved catalyst mixture was added all at once.
Subsequently, phenyl diazo tert-butylester (11.1 mg, 0.051 mmoles) in dichloroethane (0.56 mL)
was added dropwise over 30 sec, and rinsed the vial with dichloroethane (0.10 mL). The
reaction mixture was stirred at room temperature for 30 min, concentrated to dryness and
purified via flash column chromatography.
BocHN, H Ot-Bu Table 3, entry 1. The compound was prepared according to GP A with (-)-
0 Bpy* from 154 mg tert-butyl ct-diazo-ct-phenyl-ester (0.704 mmol) and
55.0 mg BocNH 2 (0.469 mmol). After chromatography on silica gel (1%
ethylether in CH 2C12), the title compound was isolated as a white solid: run 1, 105 mg (73%,
93% ee); run 2, 110 mg (76%, 95% ee). The ee was determined on a CP-Chirasil-Dex CB
column with tr(major) 21.6 min., tr(minor) 22.0 min.
MP: 0 C;
[a]20D = -120 (c = 0.950, CH2C12), 95% ee, with (+)-Bpy*;
1H NMR (CDCl3, 500 MHz) 8 7.29-7.21 (m, 5H), 5.53 (d, J = 6.5 Hz, 1H), 5.13 (d, J = 7.5 Hz,
1H), 1.36 (s, 9H), 1.31 (s, 9H);
13C NMR (CDCl3, 126 MHz) 8 170.4, 155.0, 137.0, 128.8, 128.2(x2), 127.1(x2), 82.5, 78.0,
58.2, 28.5(x3), 27.9(x3);
IR (film) cm - 1 3055, 2987, 2306, 1422, 1266, 896,740, 705;
HRMS (ESI) calcd for C17H25NO4 (M + Na ) 330.1676, found 330.1679.
BocHN, H Ot-Bu Table 3, entry 2. The compound was prepared according to GP A with (-)-
0 Bpy* from 119 mg tert-Butyl a-diazo-ca-o-tolyl-ester (0.512 mmol) and
Me 40.0 mg BocNH 2 (0.341 mmol). After chromatography on silica gel (1%
ethylether in CH2Cl2), the title compound was isolated as a colorless oil: run 1, 74.0 mg (68%,
77% ee); run 2, 81.0 mg (74%, 81% ee). The ee was determined on a Astec G-TA column with
tr(major) 37.1 min., tr(minor) 37.6 min.
[a]20D = +85.6 (c = 1.25, CH2Cl2), 77% ee, with (-)-Bpy*;
158
H NMR (CDC13, 500 MHz) 8 7.27-7.16 (m, 4H), 5.52 (d, J = 7.0 Hz, 1H), 5.44 (d, J = 7.5 Hz,
1H), 1.43 (s, 9H), 1.37 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 8 170.9, 155.1, 136.8, 136.5, 130.9, 128.1, 126.4, 126.1, 82.3,
79.9, 54.7, 28.5(x3), 28.0(x3), 19.7;
IR (film) cm - 1 3055, 2985, 2306, 1712, 1492, 1369, 1266, 1154, 896,740, 705;
HRMS (ESI) calcd for C18H27NO4 (M + Na + ) 344.1832, found 344.1838.
BocHN,, H
Me BocHN, H Ot-Bu Table 3, entry 3. The compound was prepared according to GP A with
0 (-)-Bpy* from 163 mg tert-Butyl a-diazo-a-m-tolyl-ester (0.704
mmol) and 55.0 mg BocNH 2 (0.469 mmol). After chromatography on
silica gel (1% ethylether in CH2Cl2), the title compound was isolated as a colorless oil: run 1, 114
mg (76%, 88% ee); run 2 with BocNH2 (0.427 mmol), 100 mg (73%, 87% ee). The ee was
determined on AD-H column (hexanes/iso-propanol 90:10, flow 1.0 mL/min.) with tr(minor)
6.53 min., tr(major) 10.4 min.
[a]20D = +87.5 (c =1.50, CH2C 2), 88% ee, with (-)-Bpy*;
1H NMR (CDCl3, 500 MHz) 8 7.22 (dd, J = 15, 7.5 Hz, 1H), 7.16-7.09 (m, 3H), 5.55 (d, J = 7.5
Hz, 1H), 5.16 (d, J= 7.5 Hz, 1H), 2.34 (s, 3H), 1.44 (s, 9H), 1.40 (s, 9H);
13C NMR (CDCI3, 126 MHz) 8 170.5, 155.0, 138.5, 137.7 129.0, 128.7, 127.9, 124.1, 82.4,
80.0, 58.2, 28.5(x3), 28.0(x3), 21.6;
IR (film) cm- 1 3055, 2984, 2306, 1712, 1494, 1266, 1155, 1052, 740, 705;
HRMS (ESI) calcd for CzsH 27NO4 (M + Na+ ) 344.1832, found 344.1833.
MI
Ot-Bu Table 3, entry 4. The compound was prepared according to GP A
with (-)-Bpy* from 159 mng tert-Butyl a-diazo-ca-4-methoxyphenyl-
atr ts (0 640 mw-~' l)n dA 50 0 e B~T (H 0427 l~ri Af
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chromatography on silica gel (1% ethylether in CH2C12), the title compound was isolated as a
colorless oil: run 1, 89.0 mg (62%, 94% ee); run 2, 86.0 mg (60%, 95% ee). The ee was
determined on AD-H column (hexanes/iso-propanol 90:10, flow 1.0 mL/min.) with tr(minor)
9.40 min., tr(major) 11.1min.
[a]20D = +106 (c = 1.20, CH2Cl2), 94% ee, with (-)-Bpy*;
1H NMR (CDCl3, 500 MHz) 8 7.28 (d, J = 8.0 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 5.56 (d, J = 7.0
Hz, 1H), 5.14 (d, J= 7.5 Hz, 1H), 3.78 (s, 3H), 2.34 (s, 3H), 1.44 (s, 9H), 1.40 (s, 9H);
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13C NMR (CDCl3, 126 MHz) 8 170.6, 159.4, 154.9, 130.0, 128.3(x2), 114.3(x2), 82.3, 79.9,
57.6, 55.3, 28.5(x3), 27.9(x3);
IR (film) cm - 1 3055, 2987, 2306, 1422, 1266, 896,740, 705;
HRMS (ESI) calcd for C18H27NO5 (M + Na ) 360.1781, found 360.1772.
BocHN,, H Ot-Bu Table 3, entry 5. The compound was prepared according to GP A with
Br 0 (-)-Bpy* from 152 mg tert-Butyl c-diazo-ca-4-bromophenyl-ester
(0.512 mmol) and 40.0 mg BocNH2 (0.341 mmol). After
chromatography on silica gel (2% ethylether in CH2C 2), the title compound was isolated as a
colorless oil: run 1, 113 mg (86%, 85% ee); run 2, 113 mg (86%, 85% ee). The ee was
determined on AD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(minor) 25.1
min., tr(major) 26.7 min.
[a]20D = +72.2 (c = 1.65, CH2C12), 85% ee, with (-)-Bpy*;
H NMR (CDCl3, 300 MHz) 8 7.46 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 5.65 (d, J = 6.9
Hz, 1H), 5.15 (d, J = 7.2 Hz, 1H), 1.42 (s, 9H), 1.38 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 8 169.8, 154.9, 137.2, 131.9(x2), 128.8(x2), 122.2, 83.0, 80.3,
57.7, 28.5(x3), 27.9(x3);
IR (film) cm - 1 3055, 2987, 2306, 1712, 1422, 1266, 1156, 896, 706, 736;
HRMS (ESI) calcd for C17H24BrNO4 (M + Na + ) 408.0781, found 408.0789.
BocHN,H
BocN, H Ot-Bu Table 3, entry 6. The compound was prepared according to GP A
1 with (-)-Bpy* from 146 mg tert-Butyl a-diazo-c-4-
F3 C trifluoromethylphenyl-ester (0.512 mmol) and 40.0 mg BocNH2 (0.341
mmol). After chromatography on silica gel (1% ethylether in CH2Cl2), the title compound was
isolated as a colorless oil: run 1, 113 mg (88%, 85% ee); run 2, 115 mg (90%, 84% ee). The ee
was determined on AD-H column (hexanes/iso-propanol 99:1, flow 1.0 mL/min.) with tr(major)
17.2 min., tr(minor) 19.1 min.
[a]20D = +77.2 (c = 1.25, CH2C12), 85% ee, with (-)-Bpy*);
1H NMR (CDCl3, 500 MHz) 8 7.60 (d, J = 8.0 Hz, 2H), 7.49 (d, J = 8.0 Hz, 2H), 5.76 (d, J = 7.0
Hz, 1H), 5.26 (d, J = 7.0 Hz, 1H), 1.42 (s, 9H), 1.39 (s, 9H);
13C NMR (CDCl3, 126 MHz) 8 169.5, 154.9, 142.2, 130.4 (q, 2JCF= 32.2 Hz), 127.4(x2), 125.8
(q, 3JCF= 3.4 Hz), 125.77, 124.2 (q, JCF= 272 Hz), 83.2, 80.4, 57.9, 28.5(x3), 27.9(x3);
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IR (film) cm - 1 3055, 2987, 2306, 1713, 1422, 1326, 1266, 1156, 896, 736, 706;
HRMS (ESI) calcd for CI8H24F 3NO4 (M + Na+ ) 398.1550, found 398.1559.
BocHN,, H Ot-Bu Table 3, entry 7. The compound was prepared according to GP A
0 with (-)-Bpy* from 155 mg tert-Butyl a-diazo-ct-2-naphthalenyl-
ester (0.578 mmol) and 45.1 mg BocNH 2 (0.385 mmol). After
chromatography on silica gel (1% ethylether in CH2C12), the title compound was isolated as a
white solid: run 1, 96.0 mg (70%, 89% ee); run 2, 103 mg (75%, 92% ee). The ee was
determined on AD-H column (hexanes/iso-propanol 90:10, flow 1.0 mL/min.) with tr(minor)
7.43 min., tr(major) 10.3 min.
MP: oC;
[a]20D = +106 (c = 1.20, CH2CI2), 89% ee, with (-)-Bpy*;
H NMR (CDCl3, 500 MHz) 8 7.85-7.83 (m, 4H), 7.50-7.47 (m, 3H), 5.73 (d, J = 7.0 Hz, 1H),
5.38 (d, J = 7.5 Hz, 1H), 1.45 (s, 9H), 1.39 (s, 9H);
13C NMR (CDCl3, 126 MHz) 6 170.4, 155.0, 135.4, 133.5, 133.2, 128.7, 128.3, 127.9(x2),
126.4(x2), 124.9, 82.7, 80.1, 58.4, 28.5(x3), 28.0(x3);
IR (film) cm- 1 3055, 2986, 2306, 1712, 1422, 1266, 1155, 896, 739, 705;
HRMS (ESI) calcd for C21H27NO4 (M + Na+ ) 380.1832, found 380.1831.
SBocHN,, H Ot-Bu Table 3, entry 8. The compound was prepared according to GP A with
o< o (-)-Bpy* from 120 mg tert-Butyl ca-diazo-a-1,3-dioxol-5-yl-phenyl-
ester (0.458 mmol) and 35.7 mg BocNH2 (0.305 mmol). After
chromatography on silica gel (2% ethylether in CH 2C12), the title compound was isolated as a
colorless oil: run 1, 80.0 mg (75%, 89% ee); run 2, 77.0 mg (72%, 91% ee). The ee was
determined on AD-H column (hexanes/iso-propanol 90:10, flow 1.0 mL/min.) with tr(minor)
9.17 min., tr(major) 13.2 min.
[a]20D = +79.6 (c = 1.80, CH 2C 2), 89% ee, with (-)-Bpy*;
1H NMR (CDCl3, 300 MHz) 6 6.83-6.75 (m, 3H), 5.95 (s, 2H), 5.56 (d, J = 6.6 Hz, 1H), 5.09 (d,
J = 7.5 Hz, 1H), 1.43 (s, 9H), 1.40 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 8 170.4, 154.9, 148.0, 147.6, 131.8, 120.7, 108.6, 107.6, 101.3,
82.6, 80.1, 57.9, 28.5(x3), 27.9(x3);
IR (film) cm - 1 3055, 2987, 2306, 1715, 1422, 1266, 1155, 896, 740, 705;
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HRMS (ESI) calcd for C18H25NO6 (M + Na + ) 374.1574, found 374.1572.
BocHN H Table 3, entry 9. The compound was prepared according to GP A with (-)-
'I- Ot-Bu/ O Bpy* from 172 mg tert-Butyl a-diazo-a-3-thiophenyl-ester (0.768 mmol)S 0
and 60.0 mg BocNH 2 (0.512 mmol). After chromatography on silica gel
(1% ethylether in CH2C12), the title compound was isolated as a yellow oil: run 1, 84.0 mg (51%,
82% ee); run 2, 77.0 mg (46%, 77% ee). The ee was determined on IA column (hexanes/iso-
propanol 95:5, flow 1.0 mL/min.) with tr(minor) 11.3 min., tr(major) 14.3 min.
[a]2 0D = -51.5 (c = 1.70, CH2C12), 82% ee, with (+)-Bpy*;
H NMR (CDCl3, 300 MHz) 8 7.31-7.28 (m, 1H), 7.24-7.23 (m, 1H), 7.08 (dd, J = 3.6, 1.2 Hz,
1H), 5.95 (s, 2H), 5.46 (d, J = 7.5 Hz, 1H), 5.32 (d, J = 8.4 Hz, 1H), 1.45 (s, 9H), 1.44 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 8 170.1, 153.6, 138.2, 126.5, 126.4, 122.5, 82.7, 80.2, 54.3,
28.5(x3), 28.1(x3);
IR (film) cm - 1 3430, 30054, 2983, 2306, 1714, 1493, 1369, 1265, 1154, 1055, 744, 705;
HRMS (ESI) calcd for C15H23NO4 (M + Na + ) 336.1240, found 336.1246.
CbzHNH
CbzHN,, H Ot-Bu 2. The compound was prepared according to GP B with (-)-Bpy* from 83.4
0 mg tert-Butyl cc-diazo-c-phenyl-ester (0.383 mmol) and 60.0 mg CbzNH2
(0.383 mmol) and 41.7 mg diazo tert-butylester (0.191 mmol) as a second
portion. After chromatography on silica gel (0.5% ethylether in CH2Cl2), the title compound was
isolated as a colorless oil: run 1, 100 mg (77%, 88% ee); run 2, 110 mg (77%, 94% ee). The ee
was determined on AD-H column (hexanes/iso-propanol 95:5, flow 1.0 mL/min.) with tr(minor)
19.5 min., tr(major) 25.5 min.
[a]20D = -70.6 (c = 2.35, CH 2C12), 94% ee, with (+)-Bpy*;
1H NMR (CDCl3, 300 MHz) 8 7.36 (broad s, 10H), 5.89 (d, J = 6.9 Hz, 1H), 5.28 (d, J = 7.5 Hz,
1H), 5.11 (dt, J = 8.7 Hz, 12 Hz, 2H), 1.40 (s, 9H);
13C NMR (CDCl3, 75.5 MHz) 8 175.7, 155.5, 137.5, 136.4, 128.9(x2), 128.7(x2), 128.4(x2),
128.3 (x2), 127.1(x2), 82.8, 67.1, 58.5, 27.9(x3);
IR (film) cm - 1 3424,3055,2984,2306,1722,1498,1266,1153,1051,739,704;
HRMS (ESI) calcd for C20H23NO4 (M + Na + ) 364.1519, found 364.1520.
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3. The compound was prepared according to GP B with (-)-Bpy* from
86.9 mg tert-Butyl a-diazo-a-4-methoxyphenyl-ester 
(0.350 mmol)
d na 55 0 mg CbzNH (0 350 mmol) and 43 4 mg diazo tert-butylester
(0.175 mmol) as a second portion. After chromatography on silica gel (100% CH 2C12), the title
compound was isolated as colorless oil: run 1, 62 mg (48%, 90% ee); run 2, 110 mg (49%, 90%
ee). The ee was determined on AD-H column (hexanes/iso-propanol 90:10, flow 1.0 mL/min.)
with tr(minor) 22.1 min., tr(major) 24.5 min.
[a]20D = -92.4 (c = 1.30, CH 2C12), 90% ee, with (+)-Bpy*;
1H NMR (CDCl3, 300 MHz) 8 7.27 (broad s, 5H), 7.21 (d, J = 8.7 Hz, 2H), 6.79 (d, J = 8.7 Hz,
2H), 5.76 (d, J = 7.2 Hz, 1H), 5.12 (d, J = 7.5 Hz, 1H), 5.02 (dt, J = 7.8 Hz, 12 Hz, 2H), 3.72 (s,
3H), 1.32 (s, 9H);
13C NMR (CDCI3, 75.5 MHz) 8 170.2, 159.6, 155.5, 136.4, 129.7, 128.7(x2), 128.4(x5), 114.3
(x2), 82.6, 67.1, 58.0, 55.4, 28.0(x3);
IR (film) cm- 1 3055, 2987, 2306, 1719, 1512, 1421, 1266, 1154, 896, 740, 705;
HRMS (ESI) calcd for C21H25NO5 (M + Na + ) 394.1625, found 394.1619.
4. The compound was prepared according to GP B with (-)-Bpy* from
91.0 mg tert-Butyl a-diazo-a-4-trifluoromethylphenyl-ester (0.318
mmol) and 50.0 mg CbzNH (0.318 mmol) and 500 mg diazo tert-
butylester (0.159 mmol) as a second portion. After chromatography on silica gel (1.0%
ethylether in CH 2Cl2), the title compound was isolated as white residue: run 1, 105 mg (81%,
81% ee); run 2, 96.0 mg (74%, 83% ee). The ee was determined on AD-H column (hexanesliso-
propanol 95:5, flow 1.0 mL/min.) with tr(minor) 16.2 min., tr(major) 18.0 min.
[a]20D = - 92.7 (c = 1.20, CH2Cl2), 83% ee, with (+)-Bpy*;
H NMR (CDCl3, 300 MHz) 8 7.62 (d, J = 8.1 Hz, 2H), 7.51 (d, J = 8.1 Hz, 2H), 7.36 (broad s,
5H), 6.06 (d, J = 6.6 Hz, 1H), 5.33 (d, J = 6.9 Hz, 1H), 5.10 (dt, J = 11.4 Hz, 12.3 Hz, 2H), 1.40
(s, 9H);
13C NMR (CDCl3, 75.5 MHz) 8 169.1, 155.5, 141.7, 136.2, 130.6 (q, 2JcF= 32.5 Hz), 128.7 (x2),
128.5, 128.4, 127.5(x2), 125.9 (q, 3JcF= 3.9 Hz), 122.3, 83.6, 67.3, 58.2, 27.9(x3);
IR (film) cm- 1 3055, 2987, 2306, 1719, 1422, 1266, 1167, 896, 740, 705;
HRMS (ESI) calcd for C21H22F3NO4 (M + Na + ) 432.1393, found 432.1397.
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4.4.4. Determination of Absolute Configuration
HCI4M HCI DioxaneN I H2NBocHN H EMHCtDoxane H2 N ,,H 10% K2CO 3  ~ Ot-Bu
Ph>ý Ot-Bu EtOAc Ph Ot-Bu 10%K2CO Ph 
Ot-Bu
2.0 h, r.t. 8P 5%
0 quant. yield 6 7567
Into a vial containing tert-butyl a-(tert-butoxycarbonylamino)-a-diazoesters (5) (53.0 mg, 0.172
mmol) in ethyl acetate (0.5 mL) was added 4.0 M dioxane (0.2 mL) at room temperature.
Resulting mixture was stirred for 2 hrs and evaporated down to dryness to obtain 6. Resulting
white residue was stirred in diethyl ether (2.0 mL) and 10% K 2CO 3 (1.0 mL) until all the solids
dissolved. Separation of layers, extraction of the product with diethyl ether (1.0 mL x2)
followed by brine wash, and dried over MgSO4. After chromatography on silica gel (5% MeOH
in EtOAc), (7) was isolated as crystalline residue (30.3mg, 85%y).
[ct]2 D = - 97.5 (c = 1.61, CHCl3), from 5 (94% ee, with (+)-Bpy*) compared to the literature
reported value of [a]2 0D = - 108 (c = 1.61, CHCl3) for 7;
1H NMR (CDCl3, 500 MHz) 8 7.38-7.27 (m, 5H), 4.49 (s, 1H), 1.92 (s, 2H), 1.40 (s, 9H);
13C NMR (CDCl3 , 126 MHz) 8 173.4, 141.1, 128.8, 127.9, 126.8, 81.7, 59.5, 29.9, 28.1.
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4.6 'H NMR for Selected Compounds
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Appendix A. X-ray Crystal Structure Data
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X-ray Crystal Structure of Adduct 3 from Chapter 2, Eq 14.
ENTf
H Ph
atalyst 2
Crystals suitable for X-ray structural analysis were obtained by crystallizing
adduct 3 from acetonitrile at -30 'C.
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Table 1. Crystal data and structure refinement for 3.
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 22.49'
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
C33H38.5F3FeN4.502S
675.09
100(2) K
0.71073 A
Monoclinic
P2(1)
a = 12.9446(11) A a= 90.
b = 13.3261(12) A 3= 94.617(3)*.
c = 18.8459(16) A y = 90*.
3240.4(5) A3
1.384 Mg/m 3
0.584 mm-1
1412
0.10 x 0.10 x 0.03 mm3
1.58 to 22.490.
-13<=h<=13, -14<=k<=14, 0<=1<=20
34504
8451 [R(int) = 0.0992]
100.0%
Semi-empirical from equivalents
0.9827 and 0.9439
Full-matrix least-squares on F2
8451 / 1 / 815
1.033
R1 = 0.0485, wR2 = 0.0835
R1 = 0.0721, wR2 = 0.0923
0.014(17)
0.419 and -0.266 e.A -3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x
103) for 3. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq)
Fe(1) -1138(1) -8011(1) -3462(1) 20(1)
S(1) -5338(1) -9437(1) -4163(1) 27(1)
F(1) -6715(3) -10864(3) -3984(2) 46(1)
F(2) -7008(3) -9486(3) -3462(2) 71(1)
F(3) -5795(3) -10454(3) -3031(2) 51(1)
0(1) -5982(3) -9237(3) -4802(2) 47(1)
0(2) -4537(3) -10179(3) -4199(2) 37(1)
N(1) -3495(3) -7595(3) -3393(2) 17(1)
N(2) -1560(3) -5145(3) -3810(2) 19(1)
N(3) -5044(3) -8465(3) -3778(2) 25(1)
C(1) -2481(4) -7537(4) -3054(3) 20(1)
C(2) -1978(4) -8244(4) -2589(3) 21(1)
C(3) -993(4) -7831(4) -2370(3) 22(1)
C(4) -878(4) -6905(4) -2709(3) 18(1)
C(5) -1805(4) -6698(4) -3156(3) 16(1)
C(6) -2149(4) -5919(4) -3660(3) 16(1)
C(7) -3164(4) -6042(4) -3991(3) 21(1)
C(8) -3775(4) -6849(4) -3848(3) 18(1)
C(9) -457(4) -4998(4) -3555(3) 22(1)
C(10) -90(4) -4200(4) -4052(3) 27(2)
C(11) -1058(4) -3568(4) -4224(3) 26(2)
C(12) -1917(4) -4353(4) -4311(3) 27(2)
C(13) -4170(4) -8465(4) -3246(3) 22(1)
C(14) -4519(4) -8414(4) -2492(3) 19(1)
C(15) -4200(4) -9159(5) -2003(3) 33(2)
C(16) -4517(5) -9127(6) -1322(3) 42(2)
C(17) -5168(5) -8373(6) -1123(3) 43(2)
C(18) -5504(5) -7652(5) -1617(3) 39(2)
C(19) -5175(4) -7660(5) -2296(3) 27(2)
C(20) -6251(5) -10085(5) -3636(4) 38(2)
C(21) -1101(4) -9360(4) -3981(3) 26(2)
C(22) -1470(4) -8604(4) -4461(3) 23(2)
C(23) -690(4) -7849(4) -4482(3) 24(2)
C(24) 169(4) -8140(5) -4001(3) 24(1)
C(25) -84(4) -9082(5) -3694(3) 25(2)
C(26) -1648(5) -10331(5) -3824(3) 39(2)
C(27) -2489(4) -8592(5) -4922(3) 35(2)
C(28) -748(5) -6924(4) -4950(3) 31(2)
C(29) 1193(4) -7598(5) -3845(3) 29(2)
C(30) 587(4) -9696(5) -3177(3) 35(2)
Fe(2) -3227(1) -4738(1) -1139(1) 22(1)
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S(101)696(1) -3023(1) -176(1) 28(1)
F(101) 2715(2) -3297(3) -228(2) 48(1)
F(102) 1893(3) -4596(3) 112(2) 43(1)
F(103) 2185(2) -3348(3) 830(2) 46(1)
O(101)26(3) -3370(3) 345(2) 31(1)
O(102)961(3) -1976(3) -158(2) 32(1)
N(101)-1051(3) -4097(3) -1582(2) 22(1)
N(102)-3651(3) -3475(3) -3001(2) 22(1)
N(103)449(4) -3371(3) -945(2) 26(1)
C(101)-1854(4) -4795(5) -1645(3) 22(1)
C(102)-2001(4) -5686(4) -1273(3) 21(1)
C(103)-2932(4) -6132(4) -1556(3) 22(1)
C(104)-3408(4) -5496(4) -2083(3) 23(2)
C(105)-2755(4) -4642(4) -2154(3) 18(1)
C(106)-2833(4) -3723(4) -2553(3) 21(1)
C(107)-1977(4) -3056(5) -2447(3) 26(1)
C(108)-1136(4) -3266(4) -1979(3) 25(2)
C(109) -4642(4) -4045(4) -3092(3) 29(2)
C(110)-.5392(5) -3279(4) -3448(3) 39(2)
C(111)-4719(5) -2659(5) -3891(3) 38(2)
C(112)-3729(5) -2526(5) -3406(3) 33(2)
C(113)-94(4) -4309(4) -1074(3) 23(1)
C(114)579(4) -5085(4) -1400(3) 23(2)
C(115)1140(4) -4825(5) -1982(3) 27(2)
C(116)1791(4) -5521(5) -2266(3) 32(2)
C(117)1869(5) -6483(5) -1983(3) 33(2)
C(118)1332(5) -6738(5) -1411(3) 32(2)
C(119)679(4) -6048(4) -1121(3) 24(2)
C(120)1934(5) -3595(5) 148(3) 33(2)
C(121)-3214(4) -3516(4) -477(3) 25(2)
C(122)-3161(4) -4409(4) -74(3) 23(1)
C(123)-4057(5) -5005(4) -282(3) 29(2)
C(124)-4679(4) -4456(5) -807(3) 31(2)
C(125)-4159(4) -3538(5) -942(3) 27(2)
C(126)-2470(5) -2646(4) -429(3) 31(2)
C(127)-2322(4) -4686(5) 495(3) 35(2)
C(128)-4292(5) -6005(5) 34(3) 47(2)
C(129)-5721(4) -4773(6) -1160(3) 46(2)
C(130)-4544(4) -2701(5) -1426(3) 36(2)
N(1S) 983(6) -12262(5) -2878(4) 74(2)
C(1S) 1615(6) -12158(5) -2436(4) 55(2)
C(2S) 2368(6) -12018(6) -1839(4) 64(2)
N(2S) -6420(4) -5717(5) -3484(3) 51(2)
C(3S) -6521(5) -6128(5) -4021(4) 35(2)
C(4S) -6611(5) -6644(5) -4705(3) 39(2)
N(3S) -2049(5) -10695(4) -1949(3) 56(2)
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C(5S) -1255(7) -10604(5) -1636(4) 50(2)
C(6S) -223(6) -10463(6) -1270(3) 61(2)
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Table 3. Bond lengths [A] and angles [0] for 3.
Fe(1)-C(25) 2.045(6)
Fe(1)-C(21) 2.049(6)
Fe(1)-C(24) 2.049(5)
Fe(1)-C(22) 2.054(5)
Fe(1)-C(5) 2.055(5)
Fe(1)-C(4) 2.056(5)
Fe(1)-C(1) 2.058(6)
Fe(1)-C(23) 2.062(5)
Fe(1)-C(3) 2.066(5)
Fe(1)-C(2) 2.068(5)
S(1)-O(1) 1.434(4)
S(1)-O(2) 1.439(4)
S(1)-N(3) 1.517(5)
S(1)-C(20) 1.822(7)
F(1)-C(20) 1.343(7)
F(2)-C(20) 1.325(7)
F(3)-C(20) 1.336(7)
N(1)-C(8) 1.344(6)
N(1)-C(1) 1.415(6)
N(1)-C(13) 1.491(7)
N(2)-C(6) 1.326(6)
N(2)-C(12) 1.466(6)
N(2)-C(9) 1.482(6)
N(3)-C(13) 1.451(6)
C(1)-C(2) 1.410(7)
C(1)-C(5) 1.443(7)
C(2)-C(3) 1.419(7)
C(3)-C(4) 1.403(7)
C(4)-C(5) 1.437(7)
C(5)-C(6) 1.452(7)
C(6)-C(7) 1.418(7)
C(7)-C(8) 1.374(7)
C(9)-C(10) 1.518(7)
C(10)-C(11) 1.523(7)
C(11)-C(12) 1.527(7)
C(13)-C(14) 1.527(7)
C(14)-C(19) 1.384(7)
C(14)-C(15) 1.394(7)
C(15)-C(16) 1.380(8)
C(16)-C(17) 1.382(9)
C(17)-C(18) 1.383(8)
C(18)-C(19) 1.382(8)
C(21)-C(22) 1.410(8)
C(21)-C(25) 1.432(7)
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C(21)-C(26) 1.516(8)
C(22)-C(23) 1.428(8)
C(22)-C(27) 1.520(7)
C(23)-C(24) 1.431(7)
C(23)-C(28) 1.515(8)
C(24)-C(25) 1.431(8)
C(24)-C(29) 1.517(7)
C(25)-C(30) 1.495(7)
Fe(2)-C(123) 2.042(5)
Fe(2)-C(104) 2.043(6)
Fe(2)-C(122) 2.048(5)
Fe(2)-C(121) 2.051(6)
Fe(2)-C(125) 2.055(6)
Fe(2)-C(105) 2.059(5)
Fe(2)-C(102) 2.060(6)
Fe(2)-C(124) 2.062(6)
Fe(2)-C(103) 2.065(6)
Fe(2)-C(101) 2.085(5)
S(101)-O(102) 1.437(4)
S(101)-O(101) 1.438(4)
S(101)-N(103) 1.531(4)
S(101)-C(120) 1.834(6)
F(101)-C(120) 1.340(7)
F(102)-C(120) 1.336(7)
F(103)-C(120) 1.341(6)
N(101)-C(108) 1.336(7)
N(101)-C(101) 1.394(7)
N(101)-C(113) 1.529(6)
N(102)-C(106) 1.341(6)
N(102)-C(112) 1.477(7)
N(102)-C(109) 1.488(7)
N(103)-C(113) 1.445(7)
C(101)-C(102) 1.398(8)
C(101)-C(105) 1.463(7)
C(102)-C(103) 1.410(7)
C(103)-C(104) 1.408(7)
C(104)-C(105) 1.431(8)
C(105)-C(106) 1.437(7)
C(106)-C(107) 1.423(7)
C(107)-C(108) 1.374(7)
C(109)-C(110) 1.526(7)
C(110)-C(111) 1.502(8)
C(111)-C(112) 1.523(7)
C(113)-C(114) 1.513(8)
C(114)-C(119) 1.389(7)
C(114)-C(115) 1.407(7)
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C(1 15)-C(116)
C(1 16)-C(1 17)
C(1 17)-C(1 18)
C(1 18)-C(119)
C(121)-C(122)
C(121)-C(125)
C(121)-C(126)
C(122)-C(123)
C(122)-C(127)
C(123)-C(124)
C(123)-C(128)
C(124)-C(125)
C(124)-C(129)
C(125)-C(130)
N(1S)-C(1S)
C(1S)-C(2S)
N(2S)-C(3S)
C(3S)-C(4S)
N(3S)-C(5S)
C(5S)-C(6S)
C(25)-Fe(1)-C(21)
C(25)-Fe(1)-C(24)
C(21)-Fe(1)-C(24)
C(25)-Fe(1)-C(22)
C(21)-Fe(1)-C(22)
C(24)-Fe(1)-C(22)
C(25)-Fe(1)-C(5)
C(21)-Fe(1)-C(5)
C(24)-Fe(1)-C(5)
C(22)-Fe(1)-C(5)
C(25)-Fe(1)-C(4)
C(21)-Fe(1)-C(4)
C(24)-Fe(1)-C(4)
C(22)-Fe(1)-C(4)
C(5)-Fe(1)-C(4)
C(25)-Fe(1)-C(1)
C(21)-Fe(1)-C(1)
C(24)-Fe(1)-C(1)
C(22)-Fe(1)-C(1)
C(5)-Fe(1)-C(1)
C(4)-Fe(1)-C(1)
C(25)-Fe(1)-C(23)
C(21)-Fe(1)-C(23)
C(24)-Fe(1)-C(23)
C(22)-Fe(1)-C(23)
1.389(8)
1.389(8)
1.372(8)
1.390(8)
1.410(8)
1.446(8)
1.505(8)
1.434(8)
1.509(7)
1.425(8)
1.501(8)
1.429(8)
1.516(8)
1.500(8)
1.129(8)
1.441(9)
1.150(8)
1.456(9)
1.150(8)
1.465(10)
40.9(2)
40.9(2)
68.8(2)
68.3(2)
40.2(2)
68.6(2)
163.1(2)
155.2(2)
126.4(2)
121.5(2)
125.0(2)
161.9(2)
107.9(2)
156.8(2)
40.91(19)
153.2(2)
120.0(2)
165.4(2)
109.9(2)
41.1(2)
67.5(2)
68.4(2)
68.2(2)
40.7(2)
40.6(2)
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C(5)-Fe(1)-C(23)
C(4)-Fe(1)-C(23)
C(1)-Fe(1)-C(23)
C(25)-Fe(1)-C(3)
C(21)-Fe(1)-C(3)
C(24)-Fe(1)-C(3)
C(22)-Fe(1)-C(3)
C(5)-Fe(1)-C(3)
C(4)-Fe(1)-C(3)
C(1)-Fe(1)-C(3)
C(23)-Fe(1)-C(3)
C(25)-Fe(1)-C(2)
C(21)-Fe(1)-C(2)
C(24)-Fe(1)-C(2)
C(22)-Fe(1)-C(2)
C(5)-Fe(1)-C(2)
C(4)-Fe(1)-C(2)
C(1)-Fe(1)-C(2)
C(23)-Fe(1)-C(2)
C(3)-Fe(1)-C(2)
O(1)-S(1)-O(2)
O(1)-S(1)-N(3)
O(2)-S(1)-N(3)
O(1)-S(1)-C(20)
O(2)-S(1)-C(20)
N(3)-S(1)-C(20)
C(8)-N(1)-C(1)
C(8)-N(1)-C(13)
C(1)-N(1)-C(13)
C(6)-N(2)-C(12)
C(6)-N(2)-C(9)
C(12)-N(2)-C(9)
C(13)-N(3)-S(1)
C(2)-C(1)-N(1)
C(2)-C(1)-C(5)
N(1)-C(1)-C(5)
C(2)-C(1)-Fe(1)
N(1)-C(1)-Fe(1)
C(5)-C(1)-Fe(1)
C(1)-C(2)-C(3)
C(1)-C(2)-Fe(1)
C(3)-C(2)-Fe(1)
C(4)-C(3)-C(2)
C(4)-C(3)-Fe(1)
C(2)-C(3)-Fe(1)
C(3)-C(4)-C(5)
109.2(2)
121.7(2)
128.7(2)
106.6(2)
125.0(2)
119.4(2)
162.3(2)
68.1(2)
39.8(2)
66.6(2)
155.0(2)
117.9(2)
106.4(2)
152.8(2)
125.9(2)
69.2(2)
68.0(2)
40.0(2)
164.2(2)
40.16(19)
117.5(3)
110.4(3)
117.1(2)
100.8(3)
101.6(3)
107.0(3)
116.1(5)
124.2(4)
119.7(4)
122.7(4)
126.0(4)
111.1(4)
118.8(4)
127.5(5)
110.3(5)
122.2(5)
70.4(3)
126.5(4)
69.4(3)
106.3(5)
69.6(3)
69.8(3)
109.6(5)
69.7(3)
70.0(3)
108.7(5)
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C(3)-C(4)-Fe(1) 70.5(3)
C(5)-C(4)-Fe(1) 69.5(3)
C(4)-C(5)-C(1) 105.1(5)
C(4)-C(5)-C(6) 135.9(5)
C(1)-C(5)-C(6) 118.9(5)
C(4)-C(5)-Fe(1) 69.6(3)
C(1)-C(5)-Fe(1) 69.6(3)
C(6)-C(5)-Fe(1) 122.6(4)
N(2)-C(6)-C(7) 121.6(5)
N(2)-C(6)-C(5) 123.0(5)
C(7)-C(6)-C(5) 115.4(5)
C(8)-C(7)-C(6) 122.2(5)
N(1)-C(8)-C(7) 125.0(5)
N(2)-C(9)-C(10) 103.5(4)
C(9)-C(10)-C(11) 103.1(4)
C(10)-C(11)-C(12) 102.9(5)
N(2)-C(12)-C(11) 103.6(4)
N(3)-C(13)-N(1) 107.9(4)
N(3)-C(13)-C(14) 111.8(4)
N(1)-C(13)-C(14) 111.1(4)
C(19)-C(14)-C(15) 119.8(5)
C(19)-C(14)-C(13) 120.9(5)
C(15)-C(14)-C(13) 119.3(5)
C(16)-C(15)-C(14) 119.9(6)
C(15)-C(16)-C(17) 120.5(6)
C(16)-C(17)-C(18) 119.3(6)
C(19)-C(18)-C(17) 120.9(6)
C(18)-C(19)-C(1,4) 119.6(6)
F(2)-C(20)-F(3) 107.2(6)
F(2)-C(20)-F(1) 106.0(5)
F(3)-C(20)-F(1) 106.4(5)
F(2)-C(20)-S(1) 112.0(5)
F(3)-C(20)-S(1) 112.2(4)
F(1)-C(20)-S(1) 112.6(5)
C(22)-C(21)-C(25) 108.2(5)
C(22)-C(21)-C(26) 126.6(5)
C(25)-C(21)-C(26) 125.2(5)
C(22)-C(21)-Fe(1) 70.1(3)
C(25)-C(21)-Fe(1) 69.4(3)
C(26)-C(21)-Fe(1) 128.8(4)
C(21)-C(22)-C(23) 108.5(5)
C(21)-C(22)-C(27) 127.4(6)
C(23)-C(22)-C(27) 124.1(5)
C(21)-C(22)-Fe(1) 69.7(3)
C(23)-C(22)-Fe(1) 70.0(3)
C(27)-C(22)-Fe(1) 128.9(4)
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C(22)-C(23)-C(24) 107.9(5)
C(22)-C(23)-C(28) 126.0(5)
C(24)-C(23)-C(28) 126.1(5)
C(22)-C(23)-Fe(1) 69.4(3)
C(24)-C(23)-Fe(1) 69.1(3)
C(28)-C(23)-Fe(1) 128.6(4)
C(23)-C(24)-C(25) 107.6(5)
C(23)-C(24)-C(29) 128.0(6)
C(25)-C(24)-C(29) 124.4(5)
C(23)-C(24)-Fe(1) 70.1(3)
C(25)-C(24)-Fe(1) 69.4(3)
C(29)-C(24)-Fe(1) 127.4(4)
C(24)-C(25)-C(21) 107.9(5)
C(24)-C(25)-C(30) 127.1(5)
C(21)-C(25)-C(30) 125.0(5)
C(24)-C(25)-Fe(1) 69.7(3)
C(21)-C(25)-Fe(1) 69.7(3)
C(30)-C(25)-Fe(1) 127.3(4)
C(123)-Fe(2)-C(104) 124.9(2)
C(123)-Fe(2)-C(122) 41.1(2)
C(104)-Fe(2)-C(122) 162.1(2)
C(123)-Fe(2)-C(121) 68.7(2)
C(104)-Fe(2)-C(121) 156.5(2)
C(122)-Fe(2)-C(121) 40.2(2)
C(123)-Fe(2)-C(125) 68.8(2)
C(104)-Fe(2)-C(125) 120.9(2)
C(122)-Fe(2)-C(125) 68.6(2)
C(121)-Fe(2)-C(125) 41.3(2)
C(123)-Fe(2)-C(105) 163.8(2)
C(104)-Fe(2)-C(105) 40.8(2)
C(122)-Fe(2)-C(105) 154.8(2)
C(121)-Fe(2)-C(105) 121.8(2)
C(125)-Fe(2)-C(105) 110.0(2)
C(123)-Fe(2)-C(102) 116.8(2)
C(104)-Fe(2)-C(102) 68.0(2)
C(122)-Fe(2)-C(102) 106.2(2)
C(121)-Fe(2)-C(102) 126.4(2)
C(125)-Fe(2)-C(102) 165.6(2)
C(105)-Fe(2)-C(102) 68.5(2)
C(123)-Fe(2)-C(124) 40.6(2)
C(104)-Fe(2)-C(124) 108.1(2)
C(122)-Fe(2)-C(124) 68.4(2)
C(121)-Fe(2)-C(124) 68.5(2)
C(125)-Fe(2)-C(124) 40.6(2)
C(105)-Fe(2)-C(124) 128.1(2)
C(102)-Fe(2)-C(124) 151.5(2)
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C(123)-Fe(2)-C(103)
C(104)-Fe(2)-C(103)
C(122)-Fe(2)-C(103)
C(121)-Fe(2)-C(103)
C(125)-Fe(2)-C(103)
C(105)-Fe(2)-C(103)
C(102)-Fe(2)-C(103)
C(124)-Fe(2)-C(103)
C(123)-Fe(2)-C(101)
C(104)-Fe(2)-C( 101)
C(122)-Fe(2)-C(101)
C(121)-Fe(2)-C(101)
C(125)-Fe(2)-C(101)
C(105)-Fe(2)-C(101)
C(102)-Fe(2)-C(101)
C(124)-Fe(2)-C(101)
C(103)-Fe(2)-C(101)
O(102)-S(101)-O(101)
O(102)-S(101)-N(103)
O(101)-S(101)-N(103)
O(102)-S(101)-C(120)
O(101)-S(101)-C(120)
N(103)-S(101)-C(120)
C(108)-N(101)-C(101)
C(108)-N(101)-C(113)
C(101)-N(101)-C(113)
C(106)-N(102)-C(112)
C(106)-N(102)-C(109)
C( 112)-N(102)-C(109)
C(113)-N(103)-S(101)
N(101)-C(101)-C(102)
N(101)-C(101)-C(105)
C(102)-C(101)-C(105)
N(101)-C(101)-Fe(2)
C(102)-C(101)-Fe(2)
C(105)-C(101)-Fe(2)
C(101)-C(102)-C(103)
C(101)-C(102)-Fe(2)
C(103)-C(102)-Fe(2)
C(104)-C(103)-C(102)
C(104)-C(103)-Fe(2)
C(102)-C(103)-Fe(2)
C(103)-C(104)-C(105)
C(103)-C(104)-Fe(2)
C(105)-C(104)-Fe(2)
C(104)-C(105)-C(106)
105.7(2)
40.1(2)
124.9(2)
162.5(2)
153.9(2)
67.9(2)
40.0(2)
118.7(2)
151.4(2)
68.0(2)
119.1(2)
110.0(2)
130.2(2)
41.34(19)
39.4(2)
167.6(2)
66.5(2)
116.9(2)
110.3(2)
117.2(2)
101.3(3)
101.5(3)
107.4(3)
118.6(5)
122.0(5)
119.4(5)
123.6(5)
125.2(5)
110.8(4)
118.9(4)
130.9(5)
120.8(5)
108.3(5)
126.4(4)
69.3(3)
68.4(3)
108.3(5)
71.2(3)
70.2(3)
109.0(5)
69.1(3)
69.8(3)
108.4(5)
70.8(3)
70.2(3)
135.2(5)
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C(104)-C(105)-C(101) 105.9(5)
C(106)-C(105)-C(101) 118.8(5)
C(104)-C(105)-Fe(2) 69.0(3)
C(106)-C(105)-Fe(2) 121.7(4)
C(101)-C(105)-Fe(2) 70.3(3)
N(102)-C(106)-C(107) 120.1(5)
N(102)-C(106)-C(105) 124.0(5)
C(107)-C(106)-C(105) 116.0(5)
C(108)-C(107)-C(106) 122.1(6)
N(101)-C(108)-C(107) 123.6(5)
N(102)-C(109)-C(110) 102.8(5)
C(111)-C(110)-C(109) 103.6(5)
C(110)-C(111)-C(112) 103.3(5)
N(102)-C(112)-C(111) 103.3(5)
N(103)-C(113)-C(114) 111.7(4)
N(103)-C(113)-N(101) 107.7(4)
C(114)-C(113)-N(101) 109.7(4)
C(119)-C(114)-C(115) 118.9(6)
C(119)-C(114)-C(113) 121.2(5)
C(115)-C(114)-C(113) 119.9(5)
C(116)-C(115)-C(114) 120.2(6)
C(117)-C(116)-C(115) 119.7(6)
C(118)-C(117)-C(116) 120.3(6)
C(117)-C(118)-C(119) 120.5(6)
C(114)-C(119)-C(118) 120.3(6)
F(102)-C(120)-F(101) 107.3(5)
F(102)-C(120)-F(103) 107.4(5)
F(101)-C(120)-F(103) 107.4(5)
F(102)-C(120)-S(101) 111.6(4)
F(101)-C(120)-S(101) 112.1(4)
F(103)-C(120)-S(101) 110.7(4)
C(122)-C(121)-C(125) 108.1(5)
C(122)-C(121)-C(126) 127.9(5)
C(125)-C(121)-C(126) 123.9(5)
C(122)-C(121)-Fe(2) 69.8(3)
C(125)-C(121)-Fe(2) 69.5(3)
C(126)-C(121)-Fe(2) 128.5(4)
C(121)-C(122)-C(123) 108.5(5)
C(121)-C(122)-C(127) 126.2(5)
C(123)-C(122)-C(127) 125.3(5)
C(121)-C(122)-Fe(2) 70.0(3)
C(123)-C(122)-Fe(2) 69.2(3)
C(127)-C(122)-Fe(2) 127.9(4)
C(124)-C(123)-C(122) 107.7(5)
C(124)-C(123)-C(128) 127.6(6)
C(122)-C(123)-C(128) 124.7(5)
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C(124)-C(123)-Fe(2) 70.5(3)
C(122)-C(123)-Fe(2) 69.7(3)
C(128)-C(123)-Fe(2) 127.2(4)
C(123)-C(124)-C(125) 108.4(5)
C(123)-C(124)-C(129) 126.5(6)
C(125)-C(124)-C(129) 125.1(6)
C(123)-C(124)-Fe(2) 68.9(3)
C(125)-C(124)-Fe(2) 69.4(3)
C(129)-C(124)-Fe(2) 128.0(4)
C(124)-C(125)-C(121) 107.3(5)
C(124)-C(125)-C(130) 127.4(5)
C(121)-C(125)-C(130) 125.2(6)
C(124)-C(125)-Fe(2) 70.0(3)
C(121)-C(125)-Fe(2) 69.2(3)
C(130)-C(125)-Fe(2) 129.9(4)
N(1S)-C(1S)-C(2S) 176.1(9)
N(2S)-C(3S)-C(4S) 178.0(7)
N(3S)-C(5S)-C(6S) 177.0(8)
Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2x 103) for 3. The anisotropic displacement
factor exponent takes the form: -2_2[ h2 a*2 Ul l + ... +2 h k a* b* U 12
ull U22  U33  U23  U13  Ul2
Fe(1) 16(1) 22(1) 22(1) -2(1) 1(1) 1(1)
S(1) 24(1) 27(1) 29(1) -1(1) -1(1) -6(1)
F(1) 37(2) 34(2) 65(3) -1(2) -4(2) -17(2)
F(2) 33(2) 45(3) 139(4) -10(3) 41(2) -3(2)
F(3) 60(3) 51(3) 41(2) 9(2) 3(2) -21(2)
0(1) 58(3) 44(3) 34(3) 3(2) -23(2) -21(3)
0(2) 26(3) 31(3) 57(3) -20(2) 12(2) -2(2)
N(1) 9(3) 19(3) 21(2) 6(2) 2(2) 1(2)
N(2) 19(3) 19(3) 19(3) 2(2) 1(2) -4(2)
N(3) 23(3) 24(3) 26(3) 4(2) -6(2) -1(2)
C(1) 19(4) 24(4) 17(3) -3(3) -2(3) 2(3)
C(2) 27(4) 20(4) 16(3) 3(3) 2(3) -2(3)
C(3) 20(3) 23(4) 23(3) -1(3) -2(2) 5(3)
C(4) 10(3) 21(4) 24(3) 0(3) 3(3) 1(3)
C(5) 16(3) 16(3) 16(3) -3(3) 3(2) -5(3)
C(6) 15(3) 18(3) 15(3) -4(3) -1(2) 4(3)
C(7) 20(3) 25(4) 19(3) 8(3) 5(3) 5(3)
C(8) 14(3) 23(4) 17(3) 1(3) 1(2) 3(3)
C(9) 20(3) 16(4) 30(3) -3(3) -4(3) -4(3)
C(10) 23(4) 27(4) 31(3) 7(3) 1(3) -4(3)
C(11) 32(4) 27(4) 18(3) 2(3) 3(3) -4(3)
C(12) 29(4) 23(4) 27(3) 7(3) -1(3) -3(3)
C(13) 18(3) 23(3) 24(3) 0(3) -1(3) -1(3)
C(14) 15(3) 22(3) 20(3) 6(3) 0(2) -11(3)
C(15) 23(4) 34(4) 40(4) 10(3) 3(3) -7(3)
C(16) 31(4) 62(5) 31(4) 26(4) -1(3) -19(4)
C(17) 31(4) 71(6) 27(4) -2(4) 11(3) -23(4)
C(18) 28(4) 55(5) 33(4) -9(4) 7(3) -7(3)
C(19) 14(3) 37(4) 31(4) -7(3) 1(3) -6(3)
C(20) 22(4) 31(4) 61(5) -10(4) 3(4) 7(4)
C(21) 30(4) 14(3) 33(3) -7(3) 10(3) 3(3)
C(22) 22(4) 26(4) 22(3) -18(3) 9(3) -7(3)
C(23) 24(4) 24(4) 23(3) -4(3) 5(3) 4(3)
C(24) 24(4) 27(4) 22(3) 0(3) 4(3) -5(3)
C(25) 15(3) 29(4) 30(3) -2(3) 2(3) 3(3)
C(26) 36(4) 28(4) 54(4) -13(4) 3(3) -4(3)
C(27) 23(4) 53(5) 27(3) -17(3) -2(3) 0(3)
C(28) 31(4) 39(4) 24(3) -4(3) 1(3) 4(3)
C(29) 20(4) 37(4) 31(3) 3(3) 10(3) 4(3)
C(30) 25(3) 33(4) 48(4) 5(4) 8(3) 6(3)
Fe(2) 23(1) 24(1) 21(1) -2(1) 4(1) 2(1)
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S(101) 30(1) 28(1) 24(1) -3(1) -3(1) -1(1)
F(101)28(2) 63(3) 53(2) -6(2) 3(2) -2(2)
F(102) 49(2) 34(2) 44(2) -6(2) -13(2) 6(2)
F(103)45(2) 54(3) 36(2) -8(2) -17(2) 1(2)
O(101)35(2) 39(3) 20(2) -3(2) 5(2) -2(2)
O(102)42(3) 24(3) 29(2) 0(2) -7(2) -3(2)
N(101)26(3) 23(3) 17(3) 2(2) 1(2) -1(3)
N(102)25(3) 20(3) 22(3) 6(2) -1(2) 1(2)
N(103)31(3) 30(3) 17(2) 0(2) -3(2) -4(3)
C(101)27(4) 24(4) 17(3) -7(3) 8(3) -7(3)
C(102)20(4) 29(4) 14(3) 7(3) 0(3) 4(3)
C(103)25(4) 17(4) 27(3) 1(3) 10(3) -1(3)
C(104)25(4) 23(4) 21(3) 4(3) 3(3) 2(3)
C(105)20(3) 20(4) 16(3) 0(3) 4(2) 7(3)
C(106)20(3) 28(4) 16(3) -8(3) 3(3) 1(3)
C(107)38(4) 22(3) 18(3) 0(3) 6(3) -3(4)
C(108)27(4) 27(4) 21(3) -6(3) 3(3) -4(3)
C(109)29(4) 24(4) 33(4) 0(3) 0(3) 2(3)
C(110)41(4) 30(4) 42(4) 2(3) -7(3) 5(3)
C(111)45(4) 37(4) 30(4) 3(3) -6(3) 15(3)
C(112)34(4) 32(4) 30(4) -1(3) -7(3) 7(3)
C(113)24(4) 23(4) 22(3) 8(3) -1(3) -3(3)
C(114) 18(3) 34(4) 15(3) -2(3) -7(3) -1(3)
C(115)24(4) 35(4) 22(3) 1(3) -3(3) -6(3)
C(116)18(4) 54(5) 26(4) -10(4) 5(3) 3(4)
C(117)26(4) 42(5) 31(4) -19(3) -10(3) 9(3)
C(118)26(4) 35(4) 32(4) -4(3) -11(3) 6(3)
C(119)19(4) 31(4) 23(3) 0(3) -3(3) 3(3)
C(120)37(4) 35(4) 28(4) -9(3) 0(3) 0(4)
C(121)31(4) 25(4) 19(3) -3(3) 6(3) 3(3)
C(122)30(4) 20(4) 21(3) -6(3) 11(3) 7(3)
C(123)41(4) 24(4) 24(3) 1(3) 16(3) 4(3)
C(124)27(4) 33(5) 35(4) -6(3) 15(3) 2(3)
C(125)29(4) 28(4) 26(3) -4(3) 10(3) 10(3)
C(126)45(4) 25(4) 24(3) -5(3) 4(3) 4(3)
C(127)41(4) 40(4) 25(3) -4(3) 2(3) 7(4)
C(128)57(5) 42(5) 45(4) 4(4) 26(4) -11(4)
C(129)26(4) 55(5) 58(4) -23(4) 14(3) -1(4)
C(130)33(4) 41(5) 34(4) -9(3) 4(3) 15(3)
N(1S) 97(6) 50(5) 70(5) 20(4) -20(4) -21(4)
C(1S) 64(6) 37(5) 61(5) 0(4) -10(5) -8(4)
C(2S) 63(6) 71(6) 59(5) -9(5) 5(4) -4(5)
N(2S) 43(4) 56(5) 57(4) -3(4) 22(3) -6(3)
C(3S) 22(4) 39(5) 45(5) 11(4) 10(3) 2(3)
C(4S) 33(4) 45(5) 40(4) 11(4) 4(3) 0(3)
N(3S) 77(5) 33(4) 55(4) -3(3) -11(4) 11(4)
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C(5S) 85(7) 28(4) 36(5) 1(4) -2(4) 20(4)
C(6S) 82(6) 56(5) 39(4) -9(4) -27(4) 34(5)
202
Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) for 3.
x y z U(eq)
H(2) -2245 -8872 -2451 26
H(3) -490 -8134 -2044 27
H(4) -285 -6484 -2651 22
H(7) -3430 -5552 -4322 25
H(8) -4448 -6880 -4089 22
H(9A) -59 -5628 -3592 27
H(9B) -389 -4765 -3055 27
H(10A) 153 -4504 -4488 32
H(10B) 477 -3794 -3814 32
H(11A) -1009 -3181 -4669 31
H(11B) -1173 -3098 -3831 31
H(12A) -2587 -4071 -4188 32
H(12B) -1997 -4611 -4805 32
H(13) -3766 -9098 -3295 26
H(15) -3764 -9687 -2139 39
H(16) -4286 -9628 -987 50
H(17) -5382 -8351 -653 51
H(18) -5968 -7144 -1487 47
H(19) - 5397 -7152 -2627 33
H(26A) -2397 -10248-3931 59
H(26B) -1504 -10502-3320 59
H(26C) -1397 -10870-4119 59
H(27A) -2394 -8912 -5380 52
H(27B) -2717 -7897 -5001 52
H(27C) -3015 -8961 -4681 52
H(28A) -217 -6442 -4772 47
H(28B) -1434 -6617 -4943 47
H(28C) -629 -7114 -5439 47
H(29A) 1727 -7920 -4107 43
H(29B) 1397 -7628 -3333 43
H(29C) 1117 -6895 -3993 43
H(30A) 1000 -10165-3438 53
H(30B) 150 -10073-2870 53
H(30C) 1050 -9252 -2885 53
H(102) -1550 -5945 -895 25
H(103) -3195 -6760 -1415 27
H(104) -4054 -5615 -2346 28
H(107) -1987 -2446 -2708 31
H(108) -584 -2794 -1935 30
H(10C) -4868 -4263 -2627 35
H(10D) -4575 -4641 -3398 35
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H(11C) -5950 -3616 -3750 46
H(l1D) -5708 -2861 -3089 46
H(11E) -5045 -2003 -4014 46
H(11F) -4579 -3014 -4335 46
H(11G) -3122 -2433 -3687 39
H(11H) -3783 -1944 -3085 39
H(113) -320 -4572 -614 28
H(115) 1072 -4171 -2182 33
H(116) 2182 -5339 -2652 39
H(117) 2296 -6966 -2186 40
H(118) 1406 -7391 -1211 38
H(119) 300 -6236 -731 29
H(12A) -2712 -2139 -105 47
H(12B) -2431 -2351 -903 47
H(12C) -1781 -2883 -249 47
H(12D) -1689 -4312 418 53
H(12E) -2183 -5408 472 53
H(12F) -2551 -4518 964 53
H(12G) -4602 -5904 486 70
H(12H) -3649 -6391 118 70
H(12I) -4778 -6373 -296 70
H(12J) -5729 -5503 -1228 69
H(12K) -5837 -4441 -1623 69
H(12L) -6270 -4582 -858 69
H(13A) -5028 -2969 -1805 54
H(13B) -3957 -2385 -1635 54
H(13C) -4900 -2201 -1152 54
H(2S1) 2029 -12092-1395 96
H(2S2) 2669 -11345-1860 96
H(2S3) 2917 -12522-1855 96
H(4S1) -6168 -6311 -5031 59
H(4S2) -7333 -6623 -4905 59
H(4S3) -6391 -7344 -4638 59
H(6S1) 299 -10483-1618 91
H(6S2) -85 -11000-920 91
H(6S3) -193 -9813 -1027 91
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Determination of Absolute Configuration
Chapter 2, Table 6, Entry 8. Crystals of the P-lactam product were
suitable for X-ray structural analysis were obtained by dissolving the b-
lactam in benzene and adding pentane at 0 'C.
A colorless needle of dimensions 0.4 x 0.19 x 0.16 mm 3 was
mounted under STP and transferred to a Bruker AXS/CCD three-circle
diffractometer equipped with a cold stream of N2 gas. An initial unit
cell was determined with monochromated Mo Kct radiation (1 = 0.71073 A). The cell thus
determined was triclinic.
The raw data frames were integrated using the Bruker program SAINT+ for NT version
6.01. The data that were collected (4966 total reflections, 4073 unique, Rint = 0.0266) had the
following Miller index ranges: -9 to 8 in h, -12 to 13 in k, and -13 to 10 in 1. SADABS
absorption correction was performed, and the maximum and minimum effective transmissions
were 0.808038 and 0.251115, respectively.
All aspects of the solution and refinement were handled by SHELXTL NT version 5.10.
The structure was solved by direct methods in the triclinic space group P1, a = 8.7897(7) A; b =
12.2246(9) A; c = 12.4432(9) A; a= 93.8300(10)*; P3 = 108.5630(10)*; y = 100.5330(10)0, and
refined using standard difference Fourier techniques. Final, full-matrix least-squares refinement
(4073 data for 616 parameters) on F2 yielded residuals of R1 and wR2 of 0.0558 and 0.1485 for
data I > 2s(I), and 0.0577 and 0.1508, respectively, for all data. During the final refinement, all
non-hydrogen atoms were treated anisotropically. Hydrogen atoms were included in calculated
positions and refined isotropically on a riding model. No extinction coefficient was used in the
refinement. Residual electron density amounted to a maximum of 0.871 e/A 3 and a minimum of
-0.562 e/A 3.
The absolute structure (Flack) parameter for the correct enantiomer is 0.060(12). The
structure was inverted and refined in order to confirm the initial assignment of absolute
stereochemistry.
Tables 1-6 provide the full crystallographic data for the X-ray structure.
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C16
C12
C10
026 %L
C25
C21
C22
C23
C24
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Table 1. Crystal data and structure refinement for Chapter 2, Table 6, Entry 8.
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 26.370
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
Chapter 2, Table 6, Entry 8
C17H13BrF3NO3S
448.25
100(2) K
0.71073 A
Orthorhombic
P212121
a = 7.2080(3) A a= 900.
b = 8.7647(3) A 13= 90*.
c = 27.1374(11) A y = 90*.
1714.43(12) A3
1.737 Mg/m 3
2.568 mm-1
896
0.20 x 0.20 x 0.10 mm3
2.44 to 26.37*.
-8<=h<=9, 0<=k<=10, 0<=1<=33
26769
3480 [R(int) = 0.0329]
99.9 %
Semi-empirical from equivalents
0.7833 and 0.6276
Full-matrix least-squares on F2
3480 / 0 / 236
1.059
R1 = 0.0260, wR2 = 0.0653
R1 = 0.0272, wR2 = 0.0657
0.024(6)
0.691 and -0.276 e.A -3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x
103) for Chapter 2, Table 6, Entry 8. U(eq) is defined as one third of the trace of the
orthogonalized Uij tensor.
x y z U(eq)
N(1) -4399(3) -4545(2) 1849(1) 18(1)
S(1) -2700(1) -5527(1) 2099(1) 17(1)
0(1) -3468(3) -6760(2) 2373(1) 23(1)
0(2) -1314(3) -5738(2) 1735(1) 24(1)
C(4) -1777(4) -4213(3) 2568(1) 20(1)
F(1) -888(2) -3063(2) 2362(1) 26(1)
F(2) -3176(2) -3681(2) 2837(1) 26(1)
F(3) -634(2) -4977(2) 2858(1) 25(1)
C(1) -6718(4) -4183(3) 1371(1) 16(1)
C(10) -7810(4) -2692(3) 1359(1) 20(1)
C(11) -7465(4) -5436(3) 1036(1) 19(1)
C(12) -8898(4) -5168(3) 706(1) 23(1)
C(13) -9524(4) -6322(3) 399(1) 29(1)
C(14) -8730(4) -7752(3) 412(1) 30(1)
C(15) -7311(4) -8046(3) 743(1) 28(1)
C(16) -6684(4) -6893(3) 1055(1) 23(1)
C(2) -4516(4) -4008(3) 1328(1) 17(1)
C(21) -3748(4) -2432(3) 1235(1) 17(1)
C(22) -3550(4) -1377(3) 1618(1) 19(1)
C(23) -2897(4) 88(3) 1530(1) 21(1)
C(24) -2411(4) 525(3) 1057(1) 22(1)
C(25) -2598(4) -500(3) 666(1) 22(1)
C(26) -3280(4) -1955(3) 763(1) 18(1)
Br(1) -3610(1) -3295(1) 214(1) 24(1)
C(3) -6367(4) -4755(3) 1899(1) 17(1)
0(3) -7253(3) -5202(2) 2237(1) 21(1)
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Table 3. Bond lengths [A] and angles [o] for Chapter 2, Table 6, Entry 8.
N(1)-C(3)
N(1)-C(2)
N(1)-S(1)
S(1)-O(2)
S(1)-O(1)
S(1)-C(4)
C(4)-F(1)
C(4)-F(3)
C(4)-F(2)
C(1)-C(11)
C(1)-C(10)
C(1)-C(3)
C(1)-C(2)
C(11)-C(12)
C(11)-C(16)
C(12)-C(13)
C(13)-C(14)
C(14)-C(15)
C(15)-C(16)
C(2)-C(21)
C(21)-C(26)
C(21)-C(22)
C(22)-C(23)
C(23)-C(24)
C(24)-C(25)
C(25)-C(26) I
C(26)-Br(1) I
C(3)-O(3) I
C(3)-N(1)-C(2)
C(3)-N(1)-S(1)
C(2)-N(1)-S(1)
O(2)-S(1)-O(1)
O(2)-S(1)-N(1)
O(1)-S(1)-N(1)
O(2)-S(1)-C(4)
O(1)-S(1)-C(4)
N(1)-S(1)-C(4)
F(1)-C(4)-F(3)
F(1)-C(4)-F(2)
F(3)-C(4)-F(2)
F(1)-C(4)-S(1)
F(3)-C(4)-S(1)
F(2)-C(4)-S(1)
1.437(4)
1.494(3)
1.642(2)
1.417(2)
1.4250(18)
1.842(3)
1.319(3)
1.322(3)
1.329(3)
1.524(3)
1.526(3)
1.537(3)
1.599(4)
1.387(4)
1.396(4)
1.386(4)
1.377(4)
1.386(4)
1.394(4)
1.509(3)
1.391(3)
1.397(3)
1.388(4)
1.384(4)
1.399(4)
.391(4)
.911(2)
.185(3)
94.17(19)
129.08(17)
126.68(18)
122.66(11)
107.88(11)
108.90(11)
107.99(12)
104.62(11)
103.08(11)
109.7(2)
109.5(2)
108.9(2)
111.06(18)
108.68(16)
108.97(17)
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C(11)-C(1)-C(10)
C(11)-C(1)-C(3)
C(10)-C(1)-C(3)
C(11)-C(1)-C(2)
C(10)-C(1)-C(2)
C(3)-C(1)-C(2)
C(12)-C(11)-C(16)
C(12)-C(11)-C(1)
C(16)-C(11)-C(1)
C(13)-C(12)-C(11)
C(14)-C(13)-C(12)
C(13)-C(14)-C(15)
C(14)-C(15)-C(16)
C(15)-C(16)-C(11)
N(1)-C(2)-C(21)
N(1)-C(2)-C(1)
C(21)-C(2)-C(1)
C(26)-C(21)-C(22)
C(26)-C(21)-C(2)
C(22)-C(21)-C(2)
C(23)-C(22)-C(21)
C(24)-C(23)-C(22)
C(23)-C(24)-C(25)
C(26)-C(25)-C(24)
C(21)-C(26)-C(25)
C(21)-C(26)-Br(1)
C(25)-C(26)-Br(1)
O(3)-C(3)-N(1)
O(3)-C(3)-C(1)
N(1)-C(3)-C(1)
115.0(2)
112.23(19)
112.6(2)
112.1(2)
115.4(2)
86.37(18)
118.6(2)
121.7(2)
119.6(2)
120.4(3)
120.9(3)
119.5(3)
119.9(3)
120.6(3)
115.2(2)
87.47(19)
117.7(2)
117.4(2)
121.2(2)
121.3(2)
121.4(2)
120.0(2)
120.2(2)
118.6(2)
122.4(2)
120.19(18)
117.37(19)
130.3(2)
137.8(3)
91.95(19)
Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement
The anisotropic displacement factor
b* U12 ]
parameters (A2x 103) for Chapter 2, Table 6, Entry 8.
exponent takes the form: -2_2[ h2 a*2U11 + ... + 2 h k a*
U11 U22 U33 U23 U13 U 12
N(1)
S(1)
0(1)
0(2)
C(4)
F(1)
F(2)
F(3)
C(1)
C(10)
C(11)
C(12)
C(13)
C(14)
C(15)
C(16)
C(2)
C(21)
C(22)
C(23)
C(24)
C(25)
C(26)
Br(1)
C(3)
0(3)
20(1)
18(1)
25(1)
22(1)
19(1)
27(1)
23(1)
23(1)
18(1)
20(1)
20(1)
26(2)
27(2)
30(2)
31(2)
24(1)
20(1)
16(1)
21(1)
21(1)
20(1)
22(1)
17(1)
33(1)
20(1)
22(1)
20(1)
17(1)
19(1)
30(1)
21(1)
21(1)
31(1)
29(1)
19(1)
22(1)
22(1)
28(1)
41(2)
35(1)
21(1)
24(1)
22(1)
18(1)
22(1)
20(1)
19(1)
25(1)
21(1)
26(1)
14(1)
24(1)
12(1)
17(1)
23(1)
20(1)
18(1)
31(1)
24(1)
23(1)
13(1)
18(1)
14(1)
17(1)
18(1)
25(1)
33(2)
22(1)
9(1)
18(1)
15(1)
23(1)
28(1)
17(1)
16(1)
14(1)
17(1)
17(1)
3(1)
0(1)
4(1)
-2(1)
-2(1)
3(1)
-9(1)
2(1)
0(1)
0(1)
-1(1)
0(1)
-2(1)
-14(1)
-6(1)
-4(1)
0(1)
1(1)
1(1)
-4(1)
2(1)
5(1)
-3(1)
-1(1)
-2(1)
1(1)
-1(1)
-1(1)
-3(1)
1(1)
-3(1)
-3(1)
2(1)
-8(1)
-1(1)
-2(1)
4(1)
-2(1)
-3(1)
7(1)
9(1)
2(1)
0(1)
-2(1)
-1(1)
-2(1)
-2(1)
1(1)
0(1)
0(1)
-2(1)
3(1)
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-1(1)
1(1)
0(1)
4(1)
1(1)
-6(1)
3(1)
1(1)
0(1)
2(1)
-4(1)
-2(1)
-11(1)
-14(1)
-4(1)
-1(1)
-2(1)
1(1)
2(1)
2(1)
0(1)
0(1)
0(1)
-4(1)
2(1)
-1(1)
Table 5.
Chapter
Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) for
2, Table 6, Entry 8.
x y z U(eq)
H(10A) -7694 -2225 1033 30
H(10B) -7318 -1994 1609 30
H(10C) -9121 -2901 1428 30
H(12) -9455 -4187 691 28
H(13) -10513-6125 177 34
H(14) -9153 -8530 196 36
H(15) -6765 -9032 757 34
H(16) -5717 -7101 1283 28
H(2) -3979 -4773 1095 20
H(22) -3870 -1668 1944 23
H(23) -2783 791 1795 25
H(24) -1949 1524 999 27
H(25) -2267 -209 340 26
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Determination of Absolute Configuration:
Ar = 6-OMe-2-naphthyl
Chapter 3, Table 2, Entry 11. Crystals of an a-chloroester (derived from a reaction catalyzed
by (+)-PPY*) that were suitable for X-ray analysis were obtained by dissolving the ester in
ethanol (200 proof) and crystallizing at 0 TC.
Low-temperature diffraction data were collected on a Siemens Platform three-circle
diffractometer coupled to a Bruker-AXS Apex CCD detector with graphite monochromated Mo
Ka radiation (k = 0.71073A), performing ý- and 4-scans. Raw data frames were integrated
using the Bruker program SAINT+ for NT version 6.01. All structures were solved by direct
methods using SHELXS and refined against F2 on all data by full-matrix least squares with
SHELXL-97 (Sheldrick, G. M. SHELXL 97, Universitdit Gtttingen, G6ttingen, Germany, 1997).
SADABS absorption correction was performed. All non-hydrogen atoms were refined
anisotropically. All hydrogen atoms were included in the model at geometrically calculated
positions and refined using a riding model. The isotropic displacement parameters of the
hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked to (1.5 times for
methyl groups).
A colorless needle of dimensions 0.20 x 0.15 x 0.05 mm3 was mounted under STP and
transferred to a Siemens Platform three-circle diffractometer equipped with a cold stream of N2
gas. The data that were collected (43730 total reflections, 5535 unique, Rint = 0.0472) had the
following Miller index ranges: (-9 to 9 in h, -10 to 10 in k, and -51 to 51 in 1). The structure was
solved in the triclinic space group P2(1)2(1)2(1), a = 6.7317(10) A, b = 7.9098(11) A, c =
37.107(6) A, a = 900; 03 = 900; y = 900, and refined using standard difference Fourier techniques.
Final, full-matrix least squares refinement (5535 data for 258 parameters) on F2 yielded residuals
of R1 and wR2 of 0.042 and 0.1000 for data I > 2o(I), and 0.0457 and 0.1015, respectively, for
all data. Residual electron density amounted to a maximum of 0.553 e/A 3 and a minimum of -
0.435 e/A3 . The absolute structure (Flack) parameter for the correct enantiomer is 0.05(6), thus
confirming the absolute stereochemistry.
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Table 1. Crystal data and structure refinement for Chapter 3, Table 2, Entry 11.
Identification code
Empirical formula
Formula weight
Temperature
Wavelength
Crystal system
Space group
Unit cell dimensions
Volume
Density (calculated)
Absorption coefficient
F(000)
Crystal size
Theta range for data collection
Index ranges
Reflections collected
Independent reflections
Completeness to theta = 29.560
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole
Chapter 3, Table 2, Entry 11
C20 H18 C14 03
448.14
100(2) K
0.71073 A
Triclinic
P2(1)2(1)2(1)
a = 6.7317(10) A a= 900.
b = 7.9098(11) A b= 90*.
c = 37.107(6) A g = 900 .
1975.8(5) A3
1.507 Mg/m 3
0.618 mm- 1
920
0.20 x 0.15 x 0.05 mm3
2.20 to 29.560.
-9<=h<=9, -10<=k<=10, -51<=1<=51
43730
5535 [R(int) = 0.0472]
99.9 %
Semi-empirical from equivalents
0.9698 and 0.8864
Full-matrix least-squares on F2
5535 / 37 / 258
1.161
R1 = 0.0422, wR2 = 0.1000
R1 = 0.0457, wR2 = 0.1015
0.05(6)
0.553 and -0.435 e.A -3
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